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Quantitative proteomics is a powerful and versatile tool for the study of biological systems. In this 
work, quantitative proteomics was applied to the investigation of a novel endocytic pathway and 
to the characterisation of a murine model of motor neuron disease. 
 
Fast endophilin-mediated endocytosis (FEME) is a recently discovered clathrin-independent 
endocytic route notable for its speed and its reliance on receptor-ligand interaction for cargo 
uptake. Active in a range of cell types, the pathway is known to be hijacked by bacterial toxins 
and is important in signalling and cell motility.  
 
Incomplete knowledge of the receptors internalised by FEME limits understanding of the 
pathway’s functional roles. Label-free quantitative mass spectrometry (MS) workflows were 
optimised to identify candidate FEME receptors. Plasma membrane extracts from mammalian 
cells were profiled by MS following genetic perturbation of different endocytic routes. This data 
was used to identify Junction Plakoglobin, Dysferlin and others as candidate FEME-associated 
proteins for future study. Progress was also made towards establishing an affinity-purification 
mass spectrometry (AP-MS) pipeline for probing plasma membrane extracts with FEME bait 
proteins. 
 
Growth factor availability in cell media was shown to modulate FEME in mammalian cell culture. 
AP-MS experiments aimed at investigating how the endophilin interactome changes upon 
manipulation of growth factor supply identified several candidate FEME regulators, including 
GSK3β. Further studies showed that GSK3β, but not GSK3α, interacts with the endophilin SH3 
domain under conditions of low growth factor signalling, shedding light on how kinases regulate 
FEME. 
 
Finally, quantitative MS experiments were conducted to help elucidate the causes of neuron 
death in a murine model of motor neuropathy. Lumbar spinal cord extracts from mice lacking the 
co-chaperone HSJ1 were compared to their wild-type counterparts using in-gel tryptic digestion 
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followed by quantitative MS. These studies failed to identify differentially expressed proteins at 
the depth of coverage achieved, but network analysis of our qualitative data showed potential 
disruption of mTORC1 signalling and lipid homeostasis and identified several proteins as 
candidate HSJ1 clients including Gdap1, Ataxin-10 and Ubiquilin-1. 
 
The datasets presented here serve as a resource for future studies of FEME and HSJ1-
associated neurodegeneration.  
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1.1. Quantitative proteomics by Mass spectrometry 
 
1.1.1. Mass spectrometry in the biological sciences 
 
Mass spectrometry is an analytical technique which enables the characterisation of ionised 
molecules based on their mass-to-charge (m/z) ratio. A variety of mass spectrometer 
configurations exist, but all possess the following 3 features: a source where analytes are ionised 
and volatised, a mass analyser where analytes are separated on the basis of their m/z and a 
detector where analyte m/z values are recorded.  
 
Due to their thermal instability and non-volatile nature, proteins were historically unsuited for 
analysis by MS. The development of two ‘soft’ ionisation techniques in the late 1980s and early 
1990s – electrospray ionisation (ESI) and matrix-assisted laser desorption ionisation (MALDI) – 
enabled the production of ionised biomolecules in the gas phase without excessive damage to 
the sample, thus marking the advent of MS-based proteomics (Karas and Hillenkamp, 1988; 
Fenn et al., 1989).  
 
1.1.2. Electrospray Ionisation 
 
In electrospray ionisation analytes in solution are infused into a narrow capillary under 
atmospheric pressure. An electric potential (3 – 6 kV) is applied between the tip of the capillary 
and a counter electrode. This causes the emission of a fine spray of solvent droplets, with 
accompanying analytes, from a Taylor cone at the probe tip (Taylor, 1964). Droplets (initially ~10 
µm) rapidly shrink due to solvent loss by evaporation but retain their charge, resulting in droplet 
fission by “coulombic explosion” as the accumulated repulsive forces overcome the cohesive 
surface tension of the solvent (Figure 1.1 and Equation 1.1). This process produces smaller 
progeny droplets which are susceptible to undergoing further fission events. There is still debate 
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as to the exact mechanism of ion formation (Figure 1.2). The ion evaporation model (IEM) 
proposes that the build-up of charge in a Rayleigh-charged nanodroplet (< 10 nm radius) would 
be sufficient to eject solvated analyte ions of low molecular weight from the droplet surface 
(Iribarne, 1976). Under the charged residue model (CRM), the analyte remains stably hydrated 
within a charged droplet that evaporates to dryness. As the solvent shell is removed, its charge 
is transferred to the analyte. This has been shown experimentally for intact globular proteins 
between 5-500kDa in size (Iavarone and Williams, 2003; Kaltashov and Mohimen, 2005). 
Unfolded proteins appear to undergo ionisation by the chain ejection model (CEM). The 
hydrophobic nature of unfolded protein chains causes their migration to the surface in a Rayleigh-
charged nanodroplet. A single chain terminus is expelled and the polymer is ejected in a stepwise 
fashion. Mobile protons are deposited on the analyte through charge equilibration (Ahadi and 
Konermann, 2012; Konermann, Rodriguez and Liu, 2012). 
 
Whatever the mechanism, this process culminates in the formation of desolvated, multiply-
charged analyte ions in gas phase. The tendency to form multiply-charged ions is particularly 
significant, as this improves instrument sensitivity and allows the use of mass analysers with a 
relatively poor mass range.  
 
ESI performance can be improved by using narrow capillary tips (<10 µm) and very low flow rates 
(tens of nl min-1).  It is believed that the smaller initial droplet sizes produced by nanoESI require 
fewer fission/evaporation cycles before analytes are fully desolvated, resulting in increased 















Figure 1.1   Schematic representation of an ESI source for generating positive ions. Oxidation of 
solvent at the capillary tip produces free protons. Under the influence of the electric field charge 
accumulates at the surface of the analyte solution and is deformed into a Taylor cone upon the 
application of sufficient voltage. Emmitted droplets reduce in size due to the combined forces of 
solvent evaporation and droplet fission. Analytes are eventually fully desolvated and enter the gas 
phase as multiply charged ions by a number of proposed mechanisms based on analyte properties. 
 
Equation 1.1   The Rayleigh limit zR describes the maximum number of charges e that a liquid droplet 
of given radius (R) and surface tension (γ) can hold. ε0 describes the vacuum permittivity of the 






Figure 1.2  Experimental evidence and in-silico modelling support a number of ESI ionisation 
mechanisms, shown here in positive mode. 
 
(adapted from Konermann et al., 2013) 
 
IEM CRM CEM 
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1.1.3. Measuring mass-to-charge using a Time-of-flight instrument 
 
In the field of proteomics, the Orbitrap and the Quadrupole-Time of Flight (QTOF) are the two 
most commonly used instrument configurations. In this report, MS data was collected using a 
NanoESI-QTOF instrument (Waters Synapt G2-Si). Ions entering the instrument first pass 
through a quadrupole analyser which uses electric fields emanating from a set of 4 electrodes to 
filter the sample, excluding ions outside of a given m/z range (see Figure 1.3). The ions pass 
through an ion mobility separation (IMS) cell between two collision cells, before entering the TOF 
analyser. Here, they are accelerated toward and bounced off a reflectron, which increases the 
distance travelled and helps coordinate the arrival of ions with the same m/z at the detector. 
 
Time of flight analysers operate on the principle of measuring the time taken for an ion to travel 
from an ion source to a detector. Ions from an ion source are accelerated towards a detector by 
a pulse V, following which they enter a field free region (maintained at high vacuum). All ions 
receive the same kinetic energy in the acceleration region, which is expressed by: 
 




Where q = total ion charge, V = push voltage, z = ion charge, e = electron charge, E = total 
energy and v = ion velocity.  
 






Where t = time, s = distance and v = ion velocity. Substitution of v with Equation 1.2 gives: 











Rearrangement of Equation 1.4 reveals the relationship between time taken for an ion to reach 
the detector and its m/z: 










 is a constant, we see that t and m/z are proportional. The mass analyser can be 
calibrated with reference to a compound of known m/z to calculate the constant in Equation 1.5. 
 
1.1.4. Tandem mass spectrometry and Collision induced dissociation 
 
Tandem MS refers to the collection of mass spectra for a single analyte before and after a 
dissociation event, yielding information about the composition of the analyte under study. CID is 
a fragmentation process during which ions analytes are accelerated through a chamber that 
contains inert gas molecules (e.g. H2, Ar or N2). Collisions between the analyte and the gas 
molecules can cause fragmentation within the analyte. Because CID tends to cause 
fragmentation of the weakest bonds within an ion between analysed, peptides undergoing CID 
Equation 1.5 





tend to fragment at the amide bond. This produces a convenient series of so-called b- and y- 
ions, from which the original sequence of a peptide can be assembled, given that a sufficient 
range of peptide fragments are measured.  
 
The Roepstorff-Fohlmann-Biemann (Roepstorff and Fohlman, 1984; Biemann, 1992) product ion 
nomenclature is based on which side of the fragmented analyte retains charge. Retention of 
charge on the N-terminal fragment results in b-ion formation, whilst retention of charge on the C-
terminal fragment results in y-ion formation. The ions are numbered in sequence from the 
corresponding N- or C-terminus as shown in Figure 1.4.  
 
The use of a protease with well-defined specificity, such as trypsin (which only cuts at lysine and 
arginine residues C-terminally, but not before proline) to generate peptides for analysis by 








1.1.5. Proteomic workflows 
 
The goal of bottom-up proteomics is the identification and quantification of proteins in a complex 
sample based on their mass spectra. A typical bottom-up workflow involves sample clean-up 
followed by enzymatic digestion. The resultant peptides are then analysed by tandem mass 
spectrometry and their m/z spectra recorded. Data processing software then compare these 
recordings to a database of theoretical peptide spectra, generated in silico from genomic data. 
Matches are assigned based on correlation between the experimental dataset and the theoretical 
dataset, resulting in a ‘hit list’ of statistically significant protein groups. Features of the collected 
mass spectra such as spectral counts or ion intensity can be used to estimate protein quantity in 
the original sample. 
 
1.1.6. Peptide separation in proteomics experiments by liquid chromatography 
 
A typical biological sample exhibits differences in protein abundance in the region of 6 orders of 
magnitude, whilst very complex samples such as blood plasma can exhibit protein abundances 
spanning 9 orders of magnitude. This level of complexity currently exceeds the dynamic range 
of LC-MS instrumentation (Zubarev, 2013). A solution to this problem is to partition the sample 
following enzymatic digest on the basis of peptide physicochemical properties.  
 
ESI is particularly suitable for the analysis of complex mixtures as it can be readily coupled to 
liquid chromatography (LC) (Hunt et al., 1992). The most common form of LC used in the context 
of MS proteomics is reversed-phase LC. In this form of chromatography, peptides produced by 
enzymatic digestion are loaded onto an analytical column containing C18 stationary phase. The 
proportion of non-polar solvent in the mobile phase is gradually increased, with polar peptides 
eluting faster than non-polar ones. This allows for pre-separation of the sample of the basis of 




An important innovation which facilitated highly reproducible analysis of complex biological 
samples was the commercial availability of chromatography systems capable of operating at 
backpressure limits > 15,000 psi. This allowed the use of chromatographic columns packed with 
sub-2µm particles, dramatically increasing peak capacity and resolution (Nováková, Matysová 
and Solich, 2006).  
 
1.1.7. Ion-mobility-assisted MSE data acquisition 
 
Data-dependent acquisition (DDA) is the traditional mode of data acquisition in bottom-up 
proteomics experiments. A survey scan is conducted using a wide m/z range to identify prominent 
m/z peaks eluting at a given time from the chromatographic column. A selection of these (usually 
the Top 10 – 30 most intense) is selected for tandem MS/MS. The ions are isolated with a 
quadrupole or an ion trap mass analyser and fragmented to obtain simplified precursor and 
product ions. This cycle of survey, selection and tandem MS is repeated throughout the 
chromatography gradient to acquire tandem MS/MS data for all peptides from the sample. 
Limitations of this approach include the bias towards abundant peptides and the reliance on a 
survey scan to select ions to fragment. Variability in chromatographic performance can shift 
survey scan timings away from a peptides chromatographic apex in repeated runs, resulting in 
the loss or gain of peptides with intensities near the threshold for selection, even when analysing 
the same sample.  
 
Data-independent modes of acquisition were developed as an unbiased alternative to DDA 
methods by removing the requirement for peptide pre-selection. The MSE data acquisition mode 
developed by Silva and colleagues (Silva et al., 2005, 2006) is a form of data-independent 
tandem mass spectrometry (MS/MS) suitable for peptide identification from a complex sample. 
Under MSE, the instrument rapidly and continuously switches between a high and low energy 
mode of operation. In the low energy mode, ions are accelerated through the Trap collision cell 
at low kinetic energy (4 eV), resulting in transmission of ions through the cell with no 
fragmentation. In the high energy mode, an energy ramp (15-35 eV) is used to facilitate collision 
induced dissociation (CID) of the analyte through high energy collisions with the Argon atoms in 
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the collision cell. Mass spectra from the low energy mode represent intact precursor ions (MS1), 
with spectra acquired in high energy mode representing their fragmented counterparts (MS2). 
Cycling between both modes is usually completed in just over a second. This high scan rate 
ensures peptides species are not lost between scans. 
 
Ion mobility separation is an analytical technique whereby ionised analytes are separated in a 
drift cell on the basis of their shape and size. The drift cell is filled with inert gas molecules which 
impede the transit of the analyte. As larger/ more extended molecules experience more collisions, 
they take a longer period of time to traverse the drift cell. A variant of this method known as 
travelling wave ion mobility separation (TWIMS) can be implemented in the IMS cell of the Waters 
Synapt G2-Si. Ions are accelerated through the IMS cell by a series of stacked ring ion guides 
(SRIG). Collisions with a neutral gas (typically N2 maintained at 0.2 mBar) facilitate separation of 
analytes over a millisecond timescale.  
 
Peptides undergoing UPLC separation elute over a chromatographic width in the order of 
seconds, whilst TOF measurements are completed in a µs timescale. IMS and can therefore be 
easily incorporated into bottom-up proteomics workflows as an additional chromatographic 
dimension. IMS-assisted MSE data acquisition is termed High-definition MSE (HDMSE) and 
conveys a variety of advantages when analysing complex samples. HDMSE workflows display 
up to 60% better proteome coverage in comparison to MSE alone. This effect is attributed to 
several factors including measurement of IMS drift times enabling better matching between 
precursor and fragment ions during database searching, improved fragmentation of peptides, 
and an increased peptide detection dynamic range, particularly for lower abundance peptides. 
An additional factor which boosted identifications is the ability to separate isobaric species in the 






1.1.8. Database searching 
 
Making sense tandem mass spectra requires significant computational investment. A number of 
MS search algorithms automate data processing to obtain monoisotopic peaks for each peptide/ 
peptide fragment, which are then aligned by retention time to assign hits with reference to a 
database of protein sequences in the FASTA file format (Perkins et al., 1999; Craig and Beavis, 
2004; Geer et al., 2004; Cox et al., 2011). For MSE data produced by Waters instruments, this is 
performed by the Protein Lynx Global Server (PLGS) (G. Z. Li et al., 2009; Geromanos et al., 
2009) or Progenesis software packages. 
 
Because MSE data is acquired continuously, precursor and fragment ions must be matched 
following data acquisition. PLGS is a database search tool which aligns precursor and product 
ions by retention time to reduce the complexity of the data. Tentative precursor/product 
associations are then matched to peptides and proteins in a 3-stage process using an iterative 
ion depletion strategy. Briefly, PLGS implements 2 algorithms to pre-process data after lockmass 
correction. Apex3D performs noise subtraction and integrates ion current across the 
chromatographic profile of all putative ions. The algorithm also identifies the chromatographic 
peak apex, which serves as the ion’s retention time. The Pep3D algorithm then de-isotopes and 
performs charge-state reduction on all features. This process associates the combined ion 
current from all isotopic peaks and all instances of the same peptide at a higher charge state with 
a single [M+H]1+ monoisotopic mass. This generates an exact mass and retention time (EMRT) 
for all precursor and product ions.  
 
After ion detection, retention time alignment of precursors and products is performed. Precursor 
and product ions with closely matching retention times (product RT ±10% of the FWHM 
chromatographic peak width of precursor RT) are putatively associated. Ion mobility drift times 
can also be used to align precursor and product ions if data were acquired in HDMSE mode. 




EMRT clusters are now submitted to the database search algorithm. The user provides a 
database of protein FASTA sequences which is digested in-silico to generate a list theoretical 
peptide masses to be queried. Database searching is performed in three stages (“passes”).  
 
During Pass 1, EMRT clusters are matched to fully tryptic peptides (with fixed modifications) on 
the basis of exact mass. Peptides matches are putatively associated with proteins, and these 
matches are scored using physicochemical models which account for peptide retention time, 
preferred fragmentation sites and number of product ion spectra for a protein of given mass and 
intensity among other parameters (G. Z. Li et al., 2009). Proteins are ranked by score and the 
highest ranked protein is considered identified. This protein and its top-ranked peptide/product 
EMRT clusters are removed from consideration from subsequent iterations of the search (ion 
depletion). The database search process is then repeated until one of two conditions is met: none 
of the proteins identified have scores higher than the minimum threshold or, the user-set false 
discovery rate (FDR) is reached. FDR is controlled empirically by using a randomised/ reversed 
(decoy) database. When the number of hits from the decoy database exceeds the user-set limit, 
the iterative search is stopped. 
 
During Pass 2, the search space is expanded to identify modified forms of the proteins identified 
in Pass 1. These modifications include missed cleavages, post-translational modifications 
(PTMs), oxidation of methionine, neutral losses, acetylation, deamidation and in-source 
fragmentation. Finally, a third search (Pass 3) is implemented which can identify highly labile 
peptides which are susceptible to in-source fragmentation. The search parameters are expanded 
further to include peptides with multiple modifications. The search iterates until the user-specified 
FDR is reached. 
 
Progenesis is a database search software which uses the PLGS search engine to perform EMRT 
matching to a FASTA database but incorporates novel steps in the ion detection (peak picking) 
part of the algorithm. Progenesis converts data from MSE or HDMSE experiments into a 3D map 
with axes representing m/z, retention time and ion intensity. The software selects a reference run 
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on the basis of similarity to all other runs. The retention times of ions in all runs are adjusted in a 
non-linear manner to align them to the reference run. This is achieved by placing a series of 
landmarks called vectors on selected ions. Vectors are representations of the distance between 
ion retention times in the reference run and the run being aligned. 
 
During automatic alignment, the software first performs adjustments to vector retention times to 
bring the two runs into general alignment. Next, vectors are adjusted in smaller increments to 
finely optimise the alignment. 
 
Following retention time alignment, Progenesis creates an aggregate dataset of all runs. Ions 
detected in any given run are searched for in all other runs in a process analogous to the “match 
between runs” feature in the MaxQuant software package (Cox et al., 2014). This process confers 
greater sensitivity to the workflow by using information from all runs during peak picking. A further 
feature is the elimination of missing data as an ion current is measured even where peaks are 
not present, facilitating downstream statistical analysis. 
 
Selected ions are converted into EMRTs using the Apex3D and Pep3D algorithms as detailed 
above for PLGS. EMRTs are matched to peptides and proteins from a FASTA database using 




1.1.9. Quantitation by mass spectrometry 
 
The relationship between amount of analyte in a sample and signal intensity in MS is not 
straightforward and mass spectrometers are thus inherently poor quantitative instruments. 
Numerous innovations have enabled quantitative measurements using MS which can be divided 
into label-based and label-free methods. 
 
 
Label-based methods involve the addition or incorporation of a chemical label to distinguish 
proteins/peptides from different experimental conditions, allowing relative or absolute 
quantitation of proteins on the basis of differences in MS1 or MS2 spectra. Stable isotope 
labelling with amino acids in cell culture (SILAC) was an early development in this field and 
gained widespread popularity (Ong et al., 2002).  In this technique, cells from one experimental 
condition are grown in media containing heavy isotope-labelled amino acids (e.g. C13 Lysine or 
Figure 1.5 Three common quantitative proteomics workflows. Coloured boxes indicate two 
experimental conditions. Horizontal lines indicate when samples are combined. Empty boxes 




C13 Arginine), such that virtually all the proteins in cells from this condition have incorporated 
heavy amino acids. Following cell lysis, protein extracts are mixed and undergo enzymation 
digestion and MS analysis together (Figure 1.5). The distinctive difference in m/z introduced by 
stable isotope labelling allows confident identification of peptides from the same protein and 
quantitation of their relative abundance in MS1 scans. Because almost all experimental steps 
are performed under the same conditions, the technique displays excellent analytical precision 
through minimisation of handling errors (e.g. pipetting errors) and run-to-run variability in 
instrument conditions. Initially restricted to experiments performed on mammalian cell culture, 
the technique has now been successfully expanded to include in vivo labelling of many animal 
species (Sowell et al., 2007; Larance et al., 2011; Konzer et al., 2013). Although a version of the 
technique which enabled comparisons of 5 different conditions simultaneous was quickly 
developed (Blagoev et al., 2004), in practice the complexity introduced in MS1 spectra upon 
multiplexing, and the high cost of reagents often limits comparisons to duplex or triplex 
experiment designs. 
 
Isobaric labelling techniques are alternative label-based methods which feature MS2-based 
quantitation. The most popular versions of this method are Tandem Mass Tag (TMT) and isobaric 
tag for relative and absolute quantitation (iTRAQ) (Ross et al., 2004; Dayon et al., 2008). These 
techniques feature labelling of samples from different conditions with different isobaric chemical 
tags, generally conducted post digestion. These tags are composed of a reactive group which 
facilitates covalent attachment to peptides (e.g. via reactions with primary amines on the N-
terminus or on Lysine residues), a reporter group of varying mass, and a balancer group which 
ensures that all tags are of equivalent total mass. Following labelling, peptides are mixed and co-
analysed by MS (Figure 1.5). Because all tags are isobaric, peptides from different conditions 
are detected at the same m/z during MS1 and are selected for fragmentation by the mass 
analyser. However, because the reporter group is attached to the tag by a labile bond, these are 
released upon fragmentation by CID during MS2 acquisition. The relative intensities of the 
reporters in the MS2 scan reflect the relative intensities of each peptide in the different conditions 
under investigation enabling quantitation. Isobaric labelling techniques boast two major 
advantages. Firstly, these techniques display very high technical precision, often outperforming 
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SILAC-based workflows (Sonnett, Yeung and Wühr, 2018). Secondly, they offer the highest 
degree of multiplexing currently possible with label-based methods, with simultaneous analysis 
of up to 11 different conditions the same time with TMT tags (Pappireddi, Martin and Wühr, 2019). 
This high degree of multiplexing represents a major saving in instrument time, especially in 
comparison to label-free methods. The main weakness of isobaric labelling techniques is their 
reliance on isolation of single peptides for MS2 analysis. Current instrumentation is unable to 
isolate peptides in a mass window narrower than ~0.5 m/z. Consequently, MS2 scans often 
isolate more than one peptide for fragmentation. Often, this has been shown to cause a “ratio 
distortion” effect, bringing the measured ratios of reporter tags in a given MS2 scan close to 1:1. 
This problem has been addressed in newer instrumentation through implementation of an MS3 
scan which provides greater selectivity for peptides of interest, but remains a major technical 
hurdle (McAlister et al., 2014). 
 
Label-free quantitative proteomics is enjoying a surge in popularity. These techniques do not rely 
on prior labelling steps, but instead use intrinsic features of MS spectra to provide relative and 
even absolute quantitation of protein abundances between samples analysed separately (Figure 
1.5). The earliest attempts to glean quantitative data from non-labelled samples utilised spectral 
counts (Liu, Sadygov and Yates, 2004; Old et al., 2005). This technique was based on the 
observation that the total number of spectra featuring peptides assigned to a given protein was 
roughly proportional to its abundance. A popular iteration of this method known as Exponentially 
Modified Protein Abundance Index (emPAI) takes the number of tryptic peptides produced by a 
protein into account (Ishihama et al., 2005). Whilst easy to implement, the method never 
performed comparably to label-based techniques. 
 
By contrast, the quality of quantitative data obtained with label-free methods which rely on 
comparisons of ion intensity has improved enormously in recent years. This is due in no small 
part due to technological factors. These techniques typically rely on quantifying ion intensity on 
the basis of integration of the area under a chromatographic peak, or by finding the peak apex. 
Improvements to chromatographic instrumentation and mass analyser resolving power and 
especially the maturation of LC-nanoESI has greatly improved the comparability of analyte ion 
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intensity in separate analytical runs. The smaller inital size of droplets generated by nanoESI is 
believed to lower the contribution of ionic matrix components (e.g. salts) to variability in ESI 
efficiency. This has greatly reduced the imperative to perform quantitative MS experiments on 
peptides in the same run.  
 
Intensity-based absolute-quantification (iBAQ) is a technique for absolute quantitation of proteins 
by label-free MS which uses the summed extracted ion chromatograms (XICs) of all peptides for 
a protein and normalises this to the number of peptides theoretically generated by enzymatic 
digestion to generate an abundance score (Schwanhüusser et al., 2011). This technique was 
used to generate protein copy numbers/cell where the original cell number was known. The 
MaxLFQ algorithm developed by the Mann group also features the use of summed XICs from all 
peptides assigned to a protein to calculate protein abundances suitable for comparison with 
samples analysed in separate runs (Cox et al., 2014). 
 
An alternative method of label-free method of protein quantification known as Top3/ Hi3 was 
described by Silva and colleagues (2006). The authors showed that the average intensity of the 
3 most intense peptides for a given protein correlates with its concentration in the source sample 
(Silva et al., 2006). This property can be used to assign absolute concentrations for all proteins 
in a sample with reference to a spiked-in standard of known concentration and displays an 
average CV of 10-15% (Silva et al., 2006). Importantly, Hi3 can only be used for proteins with at 
least 3 unique peptides, and measurement error increases for proteins with < 5 peptides (Silva 
et al., 2005; Dator, Gaston and Limbach, 2014). The performance of Top3 and iBAQ were 
assessed using a dataset of 27 different human tissues and bodily fluids, representing an MS-
derived map of the human proteome. The methods performed comparably, but Top3 displayed 
a slightly worse quantitative error in protein abundance among proteins with < 5 peptides, in 
agreement with the other reports (Wilhelm et al., 2014). 
 
Overall, label-free methods still suffer lower quantitative precision and place heavier demands 
on instrument time than label-based methods owing to the fact that samples are analysed 
separately. However, they avoid costly and laborious labelling steps and do not have intrinsic 
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limits on the number of conditions which can be compared. In this work, the ability to identify and 
quantify proteins from small amounts of complex samples through quantitative label-free LC-MS 
has been applied to the study of endocytosis and neurodegeneration.  
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1.2. Endocytosis and fast endophilin-mediated endocytosis 
 
1.2.1. Endocytosis in eukaryotic cells 
 
Endocytosis is the process by which cells internalise extracellular molecules and surface plasma 
membrane components. Internalisation is achieved through the invagination of portions of the 
plasma membrane, along with receptors and their ligands, which are then sealed off in 
intracellular compartments called vesicles and released for onward trafficking. Endocytosis is a 
key component of many cellular processes including nutrient uptake, signalling, growth, mitosis 
and motility (Doherty and McMahon, 2009).  
 
Several pathways of endocytosis exist, delineated by vesicle size, target ligands and the protein 
and lipid factors required for vesicle maturation. Of these, clathrin-mediated endocytosis (CME) 
is the best-studied, while the so-called clathrin-independent endocytosis (CIE) pathways have 
proven more difficult to characterise.  
 
CME is constitutive in all known eukaryotic cell types and does not strictly require receptor 
activation for internalisation. In mammals, CME cargoes are assembled into clathrin-coated 
vesicles 60-200nm in diameter over the course of ~1 minute (Gaidarov et al., 1999; Kaksonen 
and Roux, 2018). Separation of the maturing vesicle from the plasma membrane (termed 
“scission”) is dependent on the action of the mechanochemical enzyme dynamin (Kosaka and 
Ikeda, 1983), which is recruited to the neck of the forming vesicle by Bin/Amphiphysin/Rvs (BAR) 
domain containing proteins (Sundborger et al., 2011). Uptake of the largely CME-specific 
transferrin receptor is often used as a proxy for CME efficiency (Motley  et al., 2003).  
 
A number of distinct CIE pathways have been described but the predominance of CME in most 
cells has complicated efforts to study them. Experiments involving deletion or knockdown of CME 
components tend to cause disruption to cellular function, resulting in dramatic compensatory 
changes in clathrin-independent pathways. A lack of pathway-specific cargoes (such as 
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transferrin for CME) further obscures the picture, resulting in a much poorer understanding of the 
functional role of CIE. 
 
1.2.2. A novel clathrin-independent endocytic pathway  
 
Perturbation of the BAR domain protein Endophilin A causes defective endocytosis in flies, 
worms and mice (Guichet et al., 2002; Verstreken et al., 2002; Schuske et al., 2003; Milosevic et 
al., 2011). Endophilin was also found to recruit the endocytic proteins dynamin and synaptojanin 
(Ringstad, Nemoto and De Camilli, 1997). The protein was  initially assigned as a component of 
the CME pathway, after it was observed to colocalise with clathrin-coated pits in the early stages 
of the CME pathway (Taylor, Perrais and Merrifield, 2011) and was also found to play a role in 
uncoating of clathrin-coated vesicles during the latter stages of CME (Milosevic et al., 2011). 
Further studies, however, argued against a central role for endophilin in CME. For instance, 
endophilin was only detected in ¼ of early-stage clathrin-coated pits (Taylor, Perrais and 
Merrifield, 2011), and knockdown of all three Endophilin A genes (A1, A2 and A3) did not have 
any effect on the internalisation of transferrin (Meinecke et al., 2013). Interestingly, endophilin 
was found to bind directly or indirectly to several membrane receptor proteins (Tang et al., 1999; 
Soubeyran et al., 2002). 
 
Investigating these interactions led Boucrot et al. (2015)  to the discovery of a novel clathrin-
independent pathway of endocytosis, marked and controlled by endophilin. This endocytic route 
is characterised by the rapid formation of endophilin-dependent, clathrin-independent tubular 
vesicles upon receptor activation, and was dubbed fast endophilin-mediated endocytosis 
(FEME). Activation of a variety of receptors was tested for the ability to stimulate FEME, including 
the β1-adrenergic receptor (β1-AR). Stimulation with the β1-AR agonist denopamine caused 
accumulation of endophilin at clathrin-free zones of the leading edge (front of a migrating cell) of 
BSC1 cells and subsequent formation of β1-AR-positive endocytic tubules ~1µm in size. These 
tubules then rapidly (<7 secs) proceeded to the interior of the cell. For all tested FEME receptors, 
disruption of clathrin and/or the central CME adaptor protein AP-2 had no effect on cargo uptake, 
demonstrating the clathrin-independent nature of this pathway. Furthermore, receptor activation 
38 
 
(through agonist stimulation) was found to be an absolute requirement for FEME activity. Small 
molecule and genetic manipulation established that the budding of endophilin-positive tubules 
from the plasma membrane was dependent on the activity of dynamin, Rac, phosphatidylinositol-
3-OH kinase (PI3K), PAK1 and actin polymerization. 
 
A molecular mechanism by which FEME events occur has been elucidated. The inhibition of 
FEME in class I PI3K-deficient cells, coupled with the prominence of FEME at the cell’s leading 
edge suggested a role for phosphatidylinositol (PtdIns) patterning in FEME initiation (Boucrot et 
al., 2015). The leading edge of a migrating cell is the area of the plasma membrane which is 
being extended outwards in the direction of migration, and thus features active cytoskeletal 
reorganisation (Ridley, 2011). In lammellipodia of growing cells, the inner leaflet of the plasma 
membrane is enriched in PtdIns(3,4,5)P3 through the action of class I PI3Ks downstream of 
receptor activation (Servant et al., 2000; Srinivasan et al., 2003; Nalbant et al., 2004; MacHacek 
et al., 2009). This results in local activation of the RhoGTPase Cell division control protein 42 
homolog (Cdc42), which recruits the F-BAR domain proteins Cdc42-interacting protein 4 (CIP4) 
and Formin-binding protein 1 (FBP17) via their Ras exchanger motif (REM) domains (Chan Wah 
Hak et al., 2018). These, in turn, recruit the 5’ phosphatases Src homology 2 (SH2) domain 
containing inositol polyphosphate 5-phosphatase 1 (SHIP1) and Src homology 2 (SH2) domain 
containing inositol polyphosphate 5-phosphatase 2 (SHIP2) to the plasma membrane where local 
activity of SHIP1/2 converts PtdIns(3,4,5)P3 into PtdIns(3,4)P2 (Chan Wah Hak et al., 2018). This 
promotes the CIP4/FBP17-assisted recruitment of lamellipodin, a scaffolding protein which 
contains at least 10 proline rich motifs (PRMs) suitable for targeting by Endophilin A SH3 domains 
(Vehlow et al., 2013). This serves to cluster multiple Endophilin A proteins at the leading edge, 
ready to initiate FEME upon receptor activation. In the absence of receptor activation these 
endophilin clusters disassemble quickly (within a few seconds) through the action of GTPase 
activator proteins (GAPs) which stimulate Cdc42’s GTPase activity and thus exert tight control 
over FEME events (Chan Wah Hak et al., 2018). This priming cycle is summarised in Figure 1.6. 
 
In the presence of activated FEME cargo receptors, Endophilin A is stabilised and can 
oligomerise on the plasma membrane, bending it to form tubular invaginations (Boucrot et al., 
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2015). FEME cargoes are sorted into these tubules through direct or indirect contacts between 
the Endophilin A SH3 domain and receptor cytoplasmic tails. Endophilin recruits the GTPase 
dynamin to constrict the vesicle neck and separate it from the plasma membrane. Endophilin-
coated FEME carriers are then transported into the cell interior through the action of Dynein as 
summarised in Figure 1.7 (Ferreira et al, submitted).  
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Figure 1.6  The FEME priming cycle. A model summarizing the priming cycle of FEME in resting 
cells: active GTP-loaded Cdc42 recruits FBP17 and CIP4 through their REM domains (step 1). FBP17 
and CIP4 cluster the 5′ -phosphatases SHIP1 and SHIP2 as well as lamellipodin through their SH3 
domains (step 2). Lamellipodin is further stabilized by PtdIns(3,4)P2 , which is locally produced by 
SHIP1/2. Endophilin is recruited and concentrated by lamellipodin (step 3). Pre-enriched 
endophilin mediates prompt FEME carrier formation upon cargo activation. In the absence of 
cargo activation, the FEME priming complex disassembles (step 4) upon local Cdc42 deactivation 
by GTPase-activating proteins (GAPs). 
 






Figure 1.7  FEME carrier budding after receptor activation. FEME cargo activation by extracellular 
ligands, here illustrated in the case of a GPCR,  facilitates direct engagement by the endophilin SH3 
domain. In the case of RTK cargoes, this engagement is indirect. In the presence of active cargo, 
Endophilin dimers can oligomerise on the inner face of the plasma membrane (PM) and bend it to 
form tubular invaginations. Cargoes are sorted into the nascent FEME carriers. Endophilin recruits 
dynamin to the neck of mature tubules to trigger scission. 
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1.2.3. What is the functional role of FEME? 
 
At the time of writing, the FEME pathway is known to internalise 15 receptors including a range 
of G-protein coupled receptors (including α2a- and β1-adrenergic, muscarinic acetylcholine 
receptor 4 and dopmaninergic D3 and D4 receptors), receptor tyrosine kinases (including 
Hepatocyte growth factor receptor and Epidermal growth factor receptor) and the Interleukin 2 
receptor (Table 3.1). With such a broad range of cargoes, FEME is likely to play a role in many 
cellular processes. 
 
Renard et al. (2015) have demonstrated that the pathway is subverted by the clathrin-
independent cargoes Shiga and cholera toxin to gain entry into cells. Notably, the membrane 
deformation caused by Shiga toxin appears to be sufficient to induce FEME without receptor 
activation. It is probable that a host of pathogens and toxins gain entry to cells by exploiting this 
pathway. 
 
Examining the dynamics of this novel endocytic route in a range of cell types will greatly inform 
our understanding of cell function. For example, it was reported that an ultrafast endophilin-
dependent, clathrin-independent endocytic pathway is favoured over CME during the bulk uptake 
of synaptic vesicles in highly stimulated hippocampal neurons (Kononenko et al., 2014). 
Excitingly, this phenomenon may be the neuronal manifestation of FEME, where the pathway 
might play a role in neurite outgrowth and function. In the broader field of endocytosis, the relative 
contribution of CME and CIE pathways to overall endocytic flux has been a subject of some 
contention (Howes, Mayor and Parton, 2010; Bitsikas, Corrêa and Nichols, 2014). It will be 
interesting to see how the discovery of FEME factors into this debate, ultimately shedding light 
on the reason why distinct endocytic pathways exist at all. 
  
A study of the role of FEME in disease is also warranted. Internalised receptors are often recycled 
back to the cell surface in clathrin-mediated endocytosis. This tendency becomes problematic if 
cycling receptors are being expressed at oncogenic levels. If FEME cargoes are found to be 
target cargoes to a degradative fate, forceful downregulation of oncogenic signalling by 
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upregulating FEME activity could be a viable cancer therapy. In combatting pathogens which 
hijack the pathway like Shiga and cholera toxins, inhibition of FEME may be a worthwhile 
intervention. Another promising aspect of FEME is its dependence on ligand stimulation for 
activity. This feature could prove advantageous for specifically targeting drugs to tumours or 
infected cells. 
 
1.2.4. Research questions and strategy 
 
There are many questions to be addressed in the newly discovered field of FEME. A major 
hindrance in the analysis of CIE is a dearth of marker cargoes. The identification of a FEME-
specific cargo receptor will greatly benefit research in this field. The normal human hTERT-
immortalised cell line RPE1 was chosen as a model system for this work, as it displays a normal 
diploid karyotype and adopts a stretched morphology ideal for recording endocytic events via 
microscopy. Furthermore, FEME has been well characterised in this human cell line from past 
work. 
 
Owing to the disparate nature of the analyses undertaken in the course of this work, additional 






2. Materials and methods 
 
2.1. Cell culture and siRNA knockdown 
 
2.1.1. Mammalian cell culture 
 
Normal human epithelial h-TERT-RPE1 cells (ATCC, CRL-4000) were maintained at 37°C, 5% 
CO2 in DMEM:F12 HAM (1:1 v/v; Sigma), 0.25% sodium bicarbonate (w/v; Sigma), 1mM 
GlutaMax-I (Gibco), 10% foetal bovine serum (FBS, Life Technologies), 1X antibiotic-antimycotic 
and 20 µg/ml hygromycin. HEK293 cells were grown in DMEM supplemented with 10% FBS, 1X 
antibiotic -antimycotic (Gibco) and 1 mM Glutamax (Gibco). Cells were passaged by 5-10 min 
incubation in enzyme-free cell dissociation solution (S-014-B, Millipore) at 37 °C, resuspension 
in full growth medium and re-seeding at a 1:5 to 1:10 ratio, 3 times per week. Cells were regularly 
tested for mycoplasma contamination by polymerase chain reaction (PCR) with mycoplasma 
DNA-specific primers. 
 
2.1.2. siRNA-mediated knockdown of gene expression 
 
Human RPE1 cells were counted using a CASY Cell Counter and Analyser Model TT (Roche 
Applied Science) and seeded at the densities between 3.3 and 13.3 x103 cells/cm2, as indicated 
in main text 6 hours prior to transfection. Oligofectamine (Thermo Fisher) or Lipofectamine 
RNAiMAX (referred to as RNAiMAX hereafter; Thermo Fisher) were used as transfection 
reagents in this work as indicated (Table 2.1). siRNA oligonucleotides and indicated transfection 
reagent were diluted separately in 500 µl OptiMEM (Thermo Fisher), gently mixed and incubated 
at room temperature for 20 min (proportions shown in Table 2.1) before pipetting dropwise onto 
cells in culture media (Day 1). A second transfection was performed 24 hours after the first 
transfection, preceded by exchange of cell media 1 hour in advance (Day 2). Cell media was 
changed 24 hours after the second transfection (Day 3), and cells were harvested on Day 4 or 




35 mm Single 
KD 
35 mm Triple KD 
100 mm Single 
KD 
100 mm Triple 
KD 
siRNA (total in 2 
transfections using 
20 µM stock 
solutions) 
80 pmol 
(2 x 2 µl) 
80 pmol  
(2 x 2 µl)* 
624 pmol 
(2 x 15 µl) 
624pmol  
(2 x 15 µl)* 
Oligofectamine/µL 
siRNA 
0.4 µl 0.27 µl 0.4 µl 0.27 µl 
RNAiMAX/ µL siRNA 0.4 µl 0.27 µl 0.4 µl 0.27 µl 
Table 2.1  Reagents used for RNA interference. *siRNA amounts for triple knockdown experiments are 
reported per duplex. 
 






























2.2. Sample preparation for liquid chromatography mass 
spectrometry 
 
2.2.1. In-gel digestion 
 
For In-gel digestion, proteins were separated by SDS-PAGE and stained using Coomassie 
Brilliant Blue G250 (Bio Basic Canada Inc.), InstantBlue protein stain (Expedeon) or Pierce™ 
Silver Stain for Mass Spectrometry (Thermo Scientific) as indicated. All staining and destaining 
steps were performed in clean covered containers on a rotating platform (75 rpm) in a fume hood. 
All gel cutting steps were performed in a laminar flow hood. 
 
For Coomassie staining, gels were incubated on a rocking platform in Coomassie staining 
solution (0.3% w/v Brilliant Blue G250; 45% methanol, 10% glacial acetic acid in ddH2O) for ≥ 1 
hour. Gel pieces were washed twice in ddH2O (10 min) and fixed by incubation in 30% methanol 
for 5 mins. Background was reduced by treatment with Coomassie destain solution (40% ethanol, 
10% glacial acetic acid in ddH2O) (2 x 30 min washes, followed by overnight incubation in 1:1 
Coomassie destain: ddH2O). For InstantBlue Protein staining, gels were incubated on a rocking 
platform in InstantBlue solution for 15 min – 1 hour. Destaining was performed in water to reduce 
background staining.  
 
For Silver staining using Pierce™ Silver Stain for Mass Spectrometry (Thermo Fisher), the 
following procedure was followed. The gel was washed twice in LC-MS grade water for 5 min, 
then fixed in Fixing solution (Fixing Solution: 30% ethanol, 10% acetic acid) for 2 x 15 min 
incubations with agitation (20 rpm). The gel was washed twice in 10% Ethanol for 5 min, then 
washed twice in LC-MS grade water for 5 min. A sensitiser working solution was prepared by 
mixing 1 part Silver Stain Sensitizer (Thermo Fisher) with 500 parts LC-MS grade water and 
incubated with the gel for 1 min. The gel was then quickly washed in LC-MS grade water for 2 x 
1 min washes. A silver stain enhancer solution was prepared by mixing 1 part Silver Stain 
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Enhancer (Thermo Fisher) with 100 parts Silver Stain (Thermo Fisher) and immediately added 
to the gel, and incubated for 5 min. A developer working solution was prepared by mixing 1 part 
Silver Stain Enhancer with 100 parts Silver Stain Developer. Gels were washed twice briefly in 
LC-MS grade water and incubated in developer solution for 2-3 min to allow bands to appear. 
When staining was optimal, developer solution was exchanged for a 5% acetic acid “Stop 
solution” and gel bands were immediately excised. 
 
Gel lanes were cut into sections as indicated in the text using a clean scalpel, and sections were 
cut into ~1 mm3 pieces. Pieces from each section were collected into separate Lobind 1.5 ml 
tubes (Eppendorf) for destaining. Coomassie stained gel pieces were destained in a mixture of 
40% acetonitrile, 60% 50 mM ammonium bicarbonate (2 x 15 min washes on sample tube rotator 
(750rpm; Fisher Scientific). Silver stained gel pieces were destained by 2 x 15 min in a Destaining 
working solution (74 µl of Silver Destain Reagent A, 245 µl of Silver Destain Reagent B and 4 ml 
of LC-MS grade water). Gel pieces were then washed 3 times in a silver staining wash solution 
(50% acetonitrile in 25 mM ammonium bicarbonate). 
 
Following destaining, neat acetonitrile was used to dehydrate the pieces and removed. Proteins 
were reduced by incubation in a solution of 10 mM dithiothreitol in 50 mM ammonium bicarbonate 
for 30 min at 80°C. Exposed cysteine residues were then capped by alkylation with 55 mM 
iodoacetamide in 50 mM ammonium bicarbonate, at room temperature, for 20 min in the dark. 
The pieces were washed in 50 mM ammonium bicarbonate and subjected to 2 “shrink and swell” 
steps: pieces were shrunk by dehydration in neat acetonitrile before rehydration in 50 mM 
ammonium bicarbonate. Pieces were then dehydrated in acetonitrile and dried by incubation with 
tubes open at 50 °C for 5 min. 
 
Only LC-MS grade reagents were used beyond this point unless otherwise stated. Gel pieces 
were immersed in 10 ng/μl trypsin (Promega) in 50 mM ammonium bicarbonate (using a volume 
sufficient to cover pieces) overnight at 37°C unless otherwise stated. An equal volume of 
Extraction buffer (1% formic acid; J. T. Baker, 2% acetonitrile; Biosolve, in LC-MS grade water; 
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Thermo Scientific) was added following digest and samples were agitated in a sample tube 
rotator (750 rpm; Fisher Scientific) for 15min. Supernatant was collected and the extraction step 
was repeated. A final extraction step was conducted in a small volume of neat acetonitrile. The 
peptides were dried down in a vacuum concentrator (SpeedVac DNA 120, Thermo Scientific) 
and re-solubilised in 10/20 μl of mobile phase solution A (3% LC-MS grade acetonitrile, 0.1% 
formic acid in H2O) for processing by LC-MS or frozen at -20°C for storage. 
 
For samples prepared from mouse spinal cord, a C18 StageTip clean-up step was performed 
following elution of peptides from gel pieces. A 200 µl pipette tip was plugged with a frit cut from 
an Empore C18 disc (3M). Following extraction from gel pieces, peptides were dried in a 
SpeedVac and resuspended in 20 µl 0.5% acetic acid. Using Table 2.3 as a reference, StageTips 
were washed in methanol, then equilibrated in Solutions 3 then Solution 2. Peptides were added 
and washed once in 50µl Solution 2, then eluted in 20 µl Solution 3. Peptides were then dried 
down in a vacuum concentrator in preparation for resuspension in LC-MS running buffer.  
 
For profiling of plasma membrane extracts from RPE1 cells with RNAi-induced endocytic 
inhibition, an SCX fractionation step was performed using C18-SCX Stop-and-go extraction tips 




(StageTips). Solutions used for In-gel-SCX are shown in Table 2.3. C18-SCX StageTips were 
assembled with two plugs each of Empore C18 discs (3M) and  Empore Strong Cation exchange 
discs (SCX; 3M) taking care to avoid tight packing and ensuring correct orientation as described 
in Rappsilber, Mann and Ishihama, (2007). Following extraction from gel pieces, peptides were 
dried in a SpeedVac and resuspended in 20 µl 0.5% acetic acid. Using Table 2.3 as a reference, 
StageTips were washed in methanol, then equilibrated sequentially in 50 µl of  Solutions 3, 2 
then 10 and finally 2 again. Peptides were added and washed once in 50 µl Solution 2, then 
eluted from the C18 bed in solution 50 µl Solution 3. Peptides were then eluted from the SCX 
matrix sequentially into separate sample tubes using 20 µl of Solutions 6, then 8 and finally 10. 
Peptides were dried in a vacuum concentrator and resuspended in LC-MS running buffer prior 
to LC-MS analysis.  
 
For preparation of lumbar spinal cord extracts using in-gel digestion, sections of lumbar spinal 
cord (L1-L5) weighing between 20-25 mg were prepared from 3 Hsj1+/+ wild-type (WT) and 3 
Hsj1-/- knockout (KO) mice 10 days after birth (P10), coincident with a detectable unfolded protein 
response (UPR), but before neuronal death. HSJ1 KO mice were generated by genOway (Lyon, 
France) in a C57BL/6 mouse strain by deletion of exons 2 and 3 in Hsj1. Neither HSJ1 isoform 
could be detected by immunoblotting of HSJ1 KO brain extracts (Cheetham Lab). Lumbar tissue 
was lysed in a Tris-SDS lysis buffer (0.1 M Tris-HCl pH 7.8, 0.05 M DTT, 2% SDS with protease 
and phosphatase inhibitors). Samples were boiled for 5 minutes and centrifuged at 16,000 x g 
for 10 min at 4°C. The cleared lysate was mixed with SDS-PAGE sample buffer and 30ul of each 
sample separated on a 1D SDS-PAGE gel (10%) and prepared for LC-MS analysis by in-gel 
digestion (6 bands) followed by C18-StageTip clean-up as described in above. All the above 





2.2.2. On-bead digestion and On-bead digestion coupled to SCX (Plasma membrane 
fraction) 
 
On-bead digestion and on-bead digestion coupled to strong cation exchange (‘On-bead-SCX’) 
were performed on affinity purified plasma membrane fractions from 6 x 100 mm dishes of 80 - 
90% confluent RPE1 cells. Solutions used in this protocol are listed in Table 2.4 and were all MS-
grade. Following biotinylation, cell surface proteins were captured on 500 µl neutravidin beads 
and washed 4 times in proprietary kit wash buffer (Thermo Fisher,), then washed again 3 times 
in 800 µl Tris-buffered saline (TBS) to reduce detergent concentration. Beads were resuspended 
in 400 µl Tris-Urea buffer (TU; Table 2.4) containing 115/300/600/1800 ng of trypsin as indicated 
and incubated at 27°C for 30 min. Sample was centrifuged (1000 x g, 1min) and supernatant was 
transferred to a fresh sample tube. Beads were washed twice in 200 µl DTT buffer and 
supernatants from wash steps were combined with the supernatant from the trypsin step. The 
reaction mixture was incubated at room temperature overnight for a combined reduction/ 
digestion step. Alkylation was then performed by adding 138 µl of IAA Buffer (Table 2.4) and 
incubating mixture for 20 min in the dark, before adding formic acid to 1% total volume to stop 
the trypsin reaction.  
 
Samples were desalted using Sep-Pak tC18 cartridges (Waters). All solutions utilised beyond 
this point were MS-grade. Cartridges were washed with 500 μl acetonitrile and equilibrated with 
2 x 500 μl washes in SPE wash solution (5% acetonitrile, 0.1% formic acid in water). Samples 
were then loaded onto the cartridge and washed with 2 x 500 μl SPE wash solution. Samples 




were then eluted using 2 x 250 μl of SPE elution solution (50% acetonitrile, 0.1% formic acid in 
water). Samples were dried in a vacuum centrifuge and resuspended in LC-MS running buffer or 
coupled to C18-SCX StageTip fractionation. 
 
For On-bead-SCX samples, StageTip cleanup was coupled to 5-fraction SCX on SCX-StageTips. 
Solutions used for On-bead-SCX are shown in Table 2.5. SCX StageTips were assembled in 200 
µl pipette tips with two plugs of Empore Strong Cation exchange discs (SCX; 3M), taking care to 
avoid tight packing and ensuring correct orientation as described in Rappsilber, Mann and 
Ishihama (2007). Using Table 2.5 as a reference, StageTips were washed in methanol, then 
equilibrated sequentially in 50 µl of Solutions 3, 2 then 7 and finally 2 again. Peptides were added 
and washed once in 50 µl Solution 2, then sequentially eluted into separate sample tubes from 
the SCX bed in 20 µl using of Solutions 2, 4, 5, 6 and finally 7. Peptides were dried in a vacuum 
concentrator and resuspended in LC-MS running buffer (3% acetonitrile. 0.1% formic acid in 
water) prior to analysis.  
 
  




2.2.3. On-bead digestion coupled to SCX (eGFP-EndophilinA2 AP-MS) 
 
Following immunoprecipitation, GFP-Trap® beads were washed 3 times in 500 µl ice-cold Tris-
buffered saline (TBS) solution using a magnetic rack. Solutions used in this protocol are listed in 
Table 2.4 and were all MS-grade. Beads were resuspended in 120 µl Tris-Urea buffer (TU; Table 
2.4) containing 400 ng of trypsin and incubated at 27°C for 30 min. Beads were sedimented on 
a magnetic rack and the supernatant was transferred to a fresh “Digest” sample tube. Beads 
were washed twice in 50 µl DTT buffer (Table 2.4) and supernatants from wash steps were 
combined with the supernatant from the trypsin step in the “Digest” tube. The reaction mixture 
was incubated at room temperature overnight for a combined reduction/ digestion step. Alkylation 
was then performed by adding 40 µl of IAA Buffer (Table 2.4) and incubating the mixture for 20 
min in the dark, before adding acetic acid to 0.5% total volume to stop the trypsin reaction. 
 
Samples were desalted using C18-SCX StageTips in an effort to reduce the amount of NP-40 
detergent in the final sample for injection onto the LC column.  C18-SCX StageTips were 
assembled in 200 µl pipette tips with two plugs each of Empore C18 SPE and Empore Strong 
Cation exchange discs (SCX; 3M), stacking the C18 plugs above the SCX plugs. Care was taken 
to avoid tight packing and ensuring correct orientation as described in Rappsilber, Mann and 
Ishihama (2007).  
 
Using Table 2.5 as a reference, C19-SCX StageTips were washed in methanol, then equilibrated 
sequentially in 50 µl of Solutions 8, 3 and finally 2. Peptides were added and washed once in 50 
µl Solution 2, then eluted into the SCX bed using 50 µl of Solution 3. Peptides were eluted from 
the SCX bed using 20µl of Solution 8. Peptides were dried in a vacuum concentrator and 






2.2.4. Filter-aided sample preparation (FASP) 
 
Samples were mixed with denaturing and reducing solution (100 mM dithiothreitol; Fisher 
Scientific, 8 M Urea; Sigma, in 100 mM Tris-HCl pH 8.5) to a final volume of 400 µl and incubated 
for 20 min at room temperature in a Vivacon 500 30K molecular weight cutoff (MWCO) column 
(Sartorius). Samples were centrifuged at 14,000 x g for 20 min. DTT was exchanged out by 
washing in 200 µl Urea solution (8 M Urea in 100 mM Tris-HCl pH8.5) (3 x 20 min washes, 14,000 
x g). Cysteine residues were alkylated by resuspending protein in 100 µl Iodoacetamide solution 
(50 mM iodoacetamide; Sigma, 8 M Urea in 100 mM Tris-HCl pH 8.5) and incubating for 20 min 
in the dark. Iodoacetamide was exchanged out (3 x 20 washes in Urea solution, 14,000 x g) and 
Urea was then removed through 3 x 200µl washes in 50mM ammonium bicarbonate (10 min, 
14,000 x g). 
 
Trypsin digest was conducted using a 1:100 enzyme:protein ratio (w/w). An appropriate amount 
of trypsin (Promega) based on sample quantitation was added to a final volume of 40 μl 50 mM 
ammonium bicarbonate and incubated at 37°C overnight. 
 
Peptides were recovered by centrifugation (14,000 x g, 10min) and dried in a vacuum dryer. 
Peptides were then subjected to C18 StageTip desalting or C18-SCX fractionation.  
 
For unfractionated FASP samples, a C18 StageTip clean-up step was performed following 
elution of peptides from gel pieces. A 200 µl pipette tip was plugged with a frit cut from an Empore 
C18 disc (3M). Following extraction from gel pieces, peptides were dried in a SpeedVac and 
resuspended in 20 µl 0.5% acetic acid. Using Table 2.3 as a reference, StageTips were washed 
in methanol, then equilibrated in Solutions 3 then Solution 2. Peptides were added and washed 
once in 50µl Solution 2, then eluted in 20 µl Solution 3. Peptides were then dried down in a 
vacuum concentrator in preparation for resuspension in LC-MS running buffer.  
 
For FASP-SCX, an SCX fractionation step was performed using C18-SCX Stop-and-go 
extraction tips (StageTips). Solutions used for FASP-SCX are shown in Table 2.3. C18-SCX 
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StageTips were assembled with two plugs each of Empore C18 discs (3M) and  Empore Strong 
Cation exchange discs (SCX; 3M) taking care to avoid tight packing and ensuring correct 
orientation as described in Rappsilber, Mann and Ishihama (2007). Following extraction from gel 
pieces, peptides were dried in a SpeedVac and resuspended in 20 µl 0.5% acetic acid. Using 
Table 2.3 as a reference, StageTips were washed in methanol, then equilibrated sequentially in 
50µl of Solutions 3, 2 then 10 and finally 2 again. Peptides were added and flow through was 
retained as 0 mM fraction and washed once in 50µl Solution 2, then eluted from the C18 bed in 
solution 50 µl Solution 3. Peptides were then eluted from the SCX matrix sequentially into 
separate sample tubes using 20 µl of Solutions 4 through 10. Peptides were dried in a vacuum 





2.3. SDS-PAGE and Western Blotting 
 
Samples were suspended in 2X SDS-PAGE sample buffer (125 mM Tris/HCl (pH 6.8), 20% 
glycerol, 4% SDS and 0.02 % bromophenol blue), heated at 95 °C for 5 min and centrifuged at 
16,000 x g for 1.5 min prior to loading on Bolt® Bis-Tris Plus precast gels (Thermo Scientific). 
Samples were separated by SDS-PAGE in MOPS buffer (45 min at constant 150 V, or 60 min at 
130 V for quantitation) then transferred to a PVDF membrane using a Lightning Blot Semi-Dry 
Transfer System (Perkin Elmer) (20-24 min at constant 24V). 
 
Membranes were blocked for 1 hour in Blocking Buffer (5% BSA in 0.2% TBS-Tween) at room 
temperature then incubated overnight with primary antibody at 4°C as indicated in Table 2.6. 
Membranes were washed in 0.2% TBS-Tween (3 x 10 min washes) and incubated with HRP-
conjugated secondary antibody for 30 min at room temperature. Membranes were then washed 
in 0.2% TBS-tween (3 x 10 min washes) and immersed in ECL Plus Western Blotting Substrate 
(Thermo Scientific) for 5 min then imaged using an X-ray film developer. 
Antibody target Company Species 
Dilution factor or final 
concentration (µg/ml) 
EGFR CST Rabbit 1:1000 
Calnexin Santa Cruz Rabbit 1:500 
Transferrin Receptor Millipore Rabbit 1:2000 
Adaptin-α clone 8/Adaptin-a BD Biosciences Mouse 1:250 
GAPDH Santa Cruz Mouse 1:20000 
Histone H3 Upstate Mouse 0.5 
Goat anti-Mouse IgG 
Secondary Antibody, HRP 
BioRad Goat 1:10000 
Goat anti-Rabbit IgG 
Secondary Antibody, HRP 
BioRad Goat 1:10000 
β1-AR Abcam Rabbit 1:500 
HGFR R&D systems Rabbit 1:1000 
Integrin-αV CST Rabbit 1:1000 
Integrin β1 CST Rabbit 1:1000 
Endophilin A2 Santa Cruz Mouse 1:500 
eGFP Roche Mouse 1:1000 
GSK3α/β CST Rabbit 1:500 




2.4. Silver staining 
 
Following SDS-PAGE, gels were stained using the Pierce™ Silver Stain for Mass Spectrometry 
(Thermo Fisher). The gel was washed twice in LC-MS grade water for 5 min, then fixed in Fixing 
solution (30% ethanol, 10% acetic acid) for 2 x 15 min incubations with agitation (20 rpm). The 
gel was washed twice in 10% Ethanol for 5 min, then washed twice in LC-MS grade water for 5 
min. A sensitiser working solution was prepared by mixing 1 part Silver Stain Sensitizer (Thermo 
Fisher) with 500 parts LC-MS grade water and incubated with the gel for 1 min. The gel was then 
quickly washed in LC-MS grade water for 2 x 1 min washes. A silver stain enhancer solution was 
prepared by mixing 1 part Silver Stain Enhancer (Thermo Fisher) with 100 parts Silver Stain 
(Thermo Fisher) and immediately added to the gel, and incubated for 5 min. A developer working 
solution was prepared by mixing 1 part Silver Stain Enhancer with 100 parts Silver Stain 
Developer. Gels were washed twice briefly in LC-MS grade water and incubated in developer 
solution for 2-3 min to allow bands to appear. When staining was optimal, developer solution was 
exchanged for a 5% acetic acid “Stop solution”. Gels were washed in water and stored in the 
cold. 
 
2.5. Densitometric analysis 
 
Images were analysed using ImageJ v1.49. Raw images were converted to 8-bit grayscale and 
adjusted to obtain optimum signal. Profile plots for each lane were obtained using ImageJ gel 
analysis tools. The rightmost signal (representing the bottom of each lane) was assumed to 
represent background noise and used to draw a horizontal line across the plot. The area above 
this line was used for calculation of relative protein levels. Alternatively, densitometric analysis 
was performed using ImageStudio Lite v 5.2. Signals for each band were corrected using relative 




2.6. LC-MS analysis of samples 
 
1 μl – 4 μl of each sample was loaded onto a reversed-phase UPLC Symmetry C18 Trap column 
(180 μm internal diameter, 20 mm length, 5 μm particle size, Waters Corp.). Samples were 
desalted (99.5% Buffer A) at a flow rate of 8 μl/min for 2 min. Peptides were then separated using 
a linear gradient (0.3 μl/min, 35°C column temperature; 3% - 40% mobile phase B) by a BEH130 
C18 analytical column (75 μm internal diameter, 400 mm length, 1.7 μm particle size, Waters 
Corp.) over the course of 40 min, 60 min or 90 min as indicated.  
 
Mobile phase A: LC-MS grade H2O, 0.1% formic acid 
Mobile phase B: LC-MS grade Acetonitrile, 0.1% formic acid 
 
The nanoUPLC was coupled through a nanoflow sprayer to a quadrupole time-of-flight (QToF) 
mass spectrometer (HDMS Synapt G2-Si; Waters Corp.) operating in Resolution mode. The ToF 
analyser was externally calibrated from m/z 175.11 to 1285.54 using the fragment ions of a 320 
fmol/μl solution of [Glu1]-fibrinopeptide B (GFP; Sigma Aldrich). Data were lockmass-corrected 
following acquisition using the monoisotopic mass of the doubly charged precursor of GFP 
(785.8426 m/z), delivered to the mass spectrometer via a LockSpray interface. This reference 
sprayer was sampled every 30 s. Mass measurements were made using a data independent 
mode (MSE) of acquisition. Briefly, energy in the collision cell was alternated from low energy (4 
eV) to high energy (energy ramp from 15-35 eV) whilst continuously acquiring MS data. 
Measurements were made over an m/z range of 50-2000 Da with a scan time of 0.6s One cycle 
of MS and MSE data were acquired every 1.2s. 
 
In HDMSE acquisition mode, IMS was performed by applying a constant wave height of 40 V 
whilst a constant wave velocity of 650 m/s was maintained. Wave heights within the trap and 
transfer were both set at 4 V whilst the wave velocities were 311 and 175 m/s, respectively. MS 
data were acquired over 50-2000 m/z for each mode. Spectral acquisition time for each mode 
was 0.5 s with a 0.015 interscan delay. During the low energy MS mode data were acquired 
whilst applying a constant collision energy of 4 eV within the transfer travelling wave region. High 
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energy MS/MS data were acquired by ramping the collision energy within the transfer cell, post 
IMS, between 25 V and 55 V. One cycle of low and elevated energy data was acquired every 1.1 
s. To ensure that ions with m/z less than 350 observed in the LC-MS data were derived 
exclusively from peptide fragmentation within the transfer region the radio frequency applied to 
the quadrupole mass analyser was adjusted to optimise transmission within the region of 350 – 
2000 Da. 
 
2.6.1. Database searching 
 
Data collected by LC-MS was processed using Protein Lynx Global Server (PLGS) v3.0.2 
(Waters Corp.) or Progenesis v4.0 (Waters Corp.). For experiments presented in chapters 3 and 
4, data were queried against a Homo sapiens FASTA protein database (UniProt proteome: 
UP000005640) concatenated with a list of common contaminants obtained from the Global 
Proteome Machine (The Global Proteome Machine, 2016) and the Hi3 standard, E. coli ClpB.  
For experiments presented in chapter 5, data were queried against a Mus musculus protein 
database (UniProt proteome: UP000000589), concatenated with a list of common contaminants 
obtained from the Global Proteome Machine (The Global Proteome Machine, 2016) and the Hi3 
standard, E. coli ClpB. In both cases, a 1-fold randomised decoy database was concatenated 
onto the target database to facilitate false discovery rate (FDR) estimation. Carbamidomethyl-C 
was specified as a fixed modification and Oxidation (M) was specified as a variable modification. 
For experiments described in Section 3.2.4, CAMthio-propanoylation of lysines and N-termini 
were selected as variable modifications. For experiments described in chapter 5, phosphorylation 
of serine, threonine and/or tyrosine were specified as variable modifications. For all experiments, 
a maximum of 2 missed cleavages were tolerated in the analysis to account for incomplete 
digestion. For peptide identification 3 corresponding fragment ions were set as a minimum 
criterion whereas for protein identification a minimum of 7 fragment ions were required. Protein-
level FDR was set at 1% as estimated by the number of proteins identified from the randomised 
decoy database. Where indicated, samples were spiked post-digestion with E. coli ClpB peptide 
(50 fmol/injection). Absolute or relative quantitation was performed by PLGS or Progenesis v4.0 
(Waters Corp.) using the Hi3 approach (Silva et al., 2005, 2006).  
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2.6.2. Data normalisation 
 
Data was normalised to global intensity or to median Intensity as described.  Normalisation was 
performed using the NormalyzerDE platform where indicated (Willforss, Chawade and Levander, 
2019). In the following paragraph, “protein intensity” refers to Top3 intensity (the summed 
intensity of the top3 best ionising peptides for a given protein) or Hi3 protein abundance (the 
absolute amount of a given protein as calculated via the Hi3 method with reference to a spiked-
in peptide standard of known concentration). 
 
Normalisation to global intensity (GI) was performed by dividing the measured protein intensity 
for a given protein in a given replicate by the sum of protein intensity of all proteins in that 
replicate, then multiplying this by the median of summed protein intensities among all replicates. 
Data was then log2 transformed. Normalisation to median intensity was performed by dividing 
the measured protein intensity for a given protein in a given replicate by the median protein 
intensity for all proteins in that replicate, then multiplying this by the median of protein intensities 





2.7. Statistical analysis and data visualisation 
 
2.7.1. Analysis of Western blots 
 
Measurements of western blot signal were performed as described in Section 2.5. Normalised 
protein amounts were compared pairwise between conditions using an unpaired, 2-way 
Student’s t-test assuming equal variances.  
 
2.7.2. Volcano plots, PCA analysis and multi-scatterplots 
 
P-value calculations for volcano plots were performed in Perseus, using a 2-sided t-test with 
equal variances and correcting for multiple comparisons using a permutation-based FDR 
correction (FDR cut-off of 0.05). Proteins were denoted as differentially expressed upon fulfilment 
of two criteria: p-value < 0.05 and a fold change (ratio of average protein intensity) greater than 
1.3-fold in either direction. Quantitative measurements of peptides using MSE have been shown 
to display an error in signal intensity of 10-15% (Silva et al., 2006; Patel et al., 2009). Thus, a 
fold change cut-off of 1.3 represents a value 2-3 times larger than that expected given normal 
technical variation. Plots were rendered using Rstudio. PCA analysis and multi scatter plots with 
Pearson correlation calculations were created using the tools in the Perseus software platform 
(Tyanova et al., 2016). 
 
2.7.3. Network analysis in STRING 
 
Following annotation as differentially expressed, proteins were processed using the STRING 
database search tool to identify interaction networks. Interaction sources were limited to 
Experiments, Databases and Gene Fusion to increase confidence. The minimum interaction 





2.7.4. DAVID functional annotation 
 
Gene Ontology enrichment analysis was performed using the DAVID functional annotation suite 
assessing biological process and cellular compartment terms for enrichment (Huang et al., 2009; 
Huang, Sherman and Lempicki, 2009). The software calculates enrichment based on the number 
of gene ontology terms present in a chosen background. A p-value is calculated by comparing 
the number proteins with a given gene ontology (GO) term present in a query list to the number 
present in the background, in relation to the total number of proteins tested. Enrichment analysis 
in DAVID was performed using all 1099 well-replicated proteins as a background and enrichment 
was defined as a p value ≤ 0.05, corrected for multiple testing using a FDR cut-off of 0.05 
(Benjamini and Hochberg, 1995). 
 
2.8. Preparation of plasma membrane fractions 
 
2.8.1. Surface biotinylation of plasma membranes 
 
Surface Plasma Membrane proteins were isolated using the Pierce Cell Surface Protein Isolation 
Kit (Thermo Scientific). RPE1 or HEK293 cells in 100 mm dishes were washed four times in 2 ml 
ice-cold Phosphate Buffered Saline (PBS), then incubated in 8mL of ice-cold sulfo-NHS-SS-
Biotin (Thermo Scientific) for 30 min at 4°C with gentle agitation. Cells were covered in a 1 ml of 
a 1:1 mixture of TBS and proprietary Quenching Solution (Thermo Scientific) and gently scraped 
into solution and transferred to a 50 ml sample tube. Plates were rinsed with 5 ml Tris Buffered 
Saline (TBS) and the rinse volume was added to the 50 ml sample tube. Where indicated, cells 
from 6 plates were pooled. Cells were pelleted at 500 x g for 3 min and washed once in ice-cold 
TBS, then resupended in 600 μl Lysis Buffer (Thermo Scientific) with EDTA-free Protease 
Inhibitor (Cell Signalling). Cells were sonicated at low power (1.5) on ice using 5 x 1-second 
bursts (Soniprep 150, MSE). Samples were incubated on ice for 30 min, vortexing briefly every 
5min. The lysate was sonicated again at low power (1.5; 5 x 1-second bursts). The lysate was 
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then centrifuged at 10,000 x g for 2 min at 4°C. Clarified supernatant was collected in a fresh 1.5 
ml sample tube. The pellet was resuspended in SDS-PAGE sample buffer (Thermo Scientific) 
and used as “Pellet” control. 
 
The clarified supernatant was then incubated with 400 µl pre-washed 50% NeutrAvidin Agarose 
slurry (Thermo Scientific) for 1 hour at room temperature. Beads were centrifuged at 1000 x g 
and supernatant was retained as “Flow Through” control. Beads were then washed (1000 x g) in 
500 μl Wash Buffer (Thermo Scientific) with protease inhibitor 4 times. Supernatants from the 
first and fourth washes were retained as “Wash 1” and “Wash 4” controls. Affinity purified proteins 
were then eluted from beads in SDS-PAGE sample buffer by boiling for 5 min (for western 
blotting) or 1 hour incubation at room temperature (for in-gel digestion) or prepared for LC-MS 
directly by on-bead digestion. 
 
Alternatively, captured proteins were subjected to mild elution in a range of buffers and elution 
conditions as indicated in Section 3.3.2. 
 
2.8.2. Preparation of crude membrane extracts 
 
All steps were performed on ice. RPE1 cells were subjected to mechanical lysis in hypotonic 
buffer. RPE1 cells grown in 100 mm dishes were grown to 80-90% confluence, washed 2 times 
in hypotonic buffer (20 mM HEPES, 10 mM KCL, 2 mM MgCl2, 1 mM EDTA, 1mM DTT with 
phosphatase and protease inhibitors) then scraped into a sample tube and allowed to swell for 
15 min in 1 ml hypotonic buffer. Cells were then lysed by 20/40 passes through a 23-gauge/ 30-
gauge needle or 100 strokes of a Dounce homogeniser as indicated. Intact cells and nuclei were 
collected by centrifugation of the lysate at 1000 x g for 5 min and the supernatant was centrifuged 
for 1 hour at 100,000 x g to collect a membrane pellet and cytosolic fraction (supernatant). Where 
indicated, the membrane pellet was washed 3 times by resuspension in 400 µl hypotonic buffer 




2.9. Secondary GST pulldown from plasma membrane fraction 
 
2.9.1. Overexpression of eGFP constructs 
 
HEK cells were grown for 24 hours to reach a confluence of 70% in 100 mm dishes. For each 
100 mm dish of HEK293 cells to be transfected, 300 µl of OPTIMEM (Thermo Fisher) was mixed 
with 18 µl GeneJuice (Millipore) and 6 µg of plasmid containing β1-AR-eGFP (EB1019) or Dyn1-
eGFP construct (B148) was added, and the solution was mixed and allowed to incubate at room 
temperature for 20 min. The transfection mixture was added in a drop-wise manner to cells in full 
growth medium. Cells were placed in an incubator and used for further analysis 16-24 hours post 
transfection. 
 
2.9.2. Making GST and GST-EndoA2-SH3 coated magnetic beads 
 
A single colony of pre-selected BL21 transformed with a glutathione S transferase (GST) vector 
plasmid (GV38) or a GST-EndoA2-SH3 domain construct (EB5007) was used to inoculate a 20ml 
starter culture of autoclaved LB media with ampicillin (additional GST construct details are listed 
in Table 2.7). Starter cultures were grown overnight at 37°C to reach stationary phase. 10ml of 
this culture was used to inoculate 0.5L-1L of autoclaved LB media, which was grown at 37°C on 
a rotating platform. IPTG was added as to a final concentration of 1mM upon reaching OD600 
0.5-0.6 and cultures were grown overnight at 25°C.  
 
Pellets were obtained by centrifugation (4500 x g, 20min, 4°C) (SX4750A rotor, Beckman 
Coulter). Pellets were frozen at -20°C overnight prior to resuspending in 5 volumes of Lysis buffer 
(137 mM NaCl, 2.7 mM KCl, 12.5 mM Na2HPO4, 2mM KH2PO4, 0.5% Triton X-100 with DNaseI, 
Lysozyme and protease inhibitor) at 4°C on a rotating platform (100 rpm). The lysate was 
sonicated if required then centrifuged at 11,000 rpm in (rotor JA 25.50, Beckman Coulter) for 1 




The supernatant was concentrated using a Centricon Plus-70 assembly (10K MWCO; Millipore) 
by centrifugation at 3,500 x g, 4°C for 40 min to 2 hours as necessary, to a final volume of 5-10 
ml. Concentrated extract was incubated with a minimal volume of Glutathione agarose magnetic 
beads (Thermo Fisher)  on a wheel rotor for 1 hour at 4°C. Beads were then washed 10 times in 
PBS (5 min washes on a wheel rotor, 4°C), and stored at 4°C, or stored in 50% glycerol at -20°C. 
 
2.9.3. Pulldown from plasma membrane eluate 
 
Plasma membrane fractions were obtained from RPE1 cells or from HEK293 cells 
overexpressing β1-AR-eGFP as indicated. Following release in low DTT CHAPS buffer, the 
plasma membrane eluate was incubated with 2/5/10 µl decorated GST beads (pre-washed 3 x 
in 500 µl low DTT CHAPS) overnight at 4°C with end over end rotation. Following incubation 
beads were collected at the side of the tube using a magnetic rack and the supernatant was 
retained as “Flow Through” control. Beads were then washed 3 times in 500µl Low DTT CHAPS 





2.10. Immunoprecipitation of endogenous endophilin A2 with 
modulation of serum in cell media 
 
2.10.1. Stimulation of growing RPE1 cells with serum and immunoprecipitation of 
endogenous endophilin A2 
 
Cell culture and immunoprecipitation and subsequent in-gel digestion steps were performed by 
Mr J. Panambalana. RPE1 cells were grown on 100 mm dishes to a confluence of 80% before 
harvest. For Stimulated condition, cell media was supplemented with an extra 10% FBS (20% 
final) for 5 min at 37°C. For Resting condition, no additional treatment was performed prior to cell 
lysis. Cells were washed 2 times in ice-cold PBS before being gently scraped into lysis buffer (10 
mM Tris HCL pH7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP40 with protease and phosphatase 
inhibitor cocktail (Thermo Scientific)) and incubated on ice for 30 min, then centrifuged at 17,000 
x g for 10 min.  Anti-endophilin antibodies (Endophilin II A-11) were coupled in-house to 
hydrazide-terminated magnetic beads (H-beads). 10 µl of H-beads pre-washed in lysis buffer 
was incubated with 470 µl of cell lysate overnight at 4°C with end-over-end rotation. The beads 






2.11. GST pulldown of GSK3 from RPE1 cell lysate 
 
2.11.1. Serum stimulation/ withdrawal, cell lysis and GST Pulldown 
 
For the experiments described here, A. Casamento prepared RPE1 cell extracts and performed 
pulldowns, S. Subramaniam performed Western blotting and analysis. RPE1 cells grown to a 
confluence of 80% in 100 mm dishes and serum levels in cell media were modified prior to cell 
lysis as follows. For serum starvation, cell media was aspirated and cells were washed 3 times 
in 2 ml of pre-warmed (37°C) RPE1 cell media without FBS (serum-free; SF). 12 ml of SF media 
was then added to each dish and cells were incubated in SF media for 2 hours. For serum 
stimulation, pre-warmed (37°C) FBS was added to cell media to a final concentration of 20% v/v 
(resting RPE1 cell media contains 10% FBS v/v) and incubated at 37°C for 5 min in a tissue 
culture incubator. For Resting conditions, no treatment was performed. 
 
Following treatment, cells were washed 3 times with 1 ml ice-cold PBS and harvested by gently 
scraping into 500 µl Lysis buffer (25 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100 with protease and phosphatase inhibitors added at 1X working concentration). Samples were 
incubated on ice for 30 min then sonicated (10 sec On, 30 sec Off, 3 cycles, 50% amplitude) 
using a probe sonicator (Soniprep 150, MSE). Samples were then centrifuged at 17,000 x g for 
10 min to remove the nuclear fraction and insoluble material. The resulting supernatant was 
mixed with 10 µl of GST or GST-EndoSH3-coated magnetic agarose slurry (beads were prepared 
as described in Section 2.9.2) and incubated for 16-18 hours at 4°C with end-over-end mixing. 
Using a magnetic rack, beads were washed 3 times in 500 µl Lysis buffer prior to elution in 100 
µl SDS sample buffer at 95°C for 10 min. Samples were analysed by western blotting as 




2.12. Expression and immunoprecipitation of GFP-tagged 
constructs in RPE1 cells 
 
2.12.1. Transient overexpression of eGFP constructs 
 
RPE1 cells were seeded into 100 mm dishes (106 cells/ dish) and grown for 24 hours. Four dishes 
were seeded for each sample to generate enough material for MS sample preparation. For each 
100 mm dish of RPE1 cells to be transfected, 500 µl of OPTIMEM (Thermo Fisher) was mixed 
with 15 µl GeneJuice (Millipore) and 3 µg of plasmid was added (V04 or EB1004; see Table 2.7) 
to the solution, with mixing. Following 20 min incubation at room temperature the transfection 
mixture was added in a drop-wise manner to cells in full growth medium. Cells were placed in an 
incubator and used for further analysis ≥24 hours post transfection. 
 
2.12.2. Kinase inhibitor treatment, cell lysis and immunoprecipitation 
 
Cells were grown in an incubator for 24 hours following transfection. For kinase inhibition, cells 
were treated with the CDK1/2/5/9 inhibitor Dinaciclib (MedChemExpress) and GSK3α/β inhibitor 
CHIR-9902 (Cayman Chemical Corp.) at a working concentration of 1 µM for 10 min at 37°C in 
an incubator prior to cell lysis. Following treatment, cells were washed 3 times with 1 ml cold PBS 
and harvested by gently scraping into 500 µl Lysis buffer (25 mM Tris pH 7.4, 150 mM NaCl, 1 
mM EDTA, 1% NP-40 with protease and phosphatase inhibitors added at 1X working 
concentration) and combining the lysates from all 4 dishes into a single 2 ml sample tube. 
Samples were incubated on ice for 30 min then centrifuged at 17,000 x g for 10 min to remove 
the nuclear fraction and insoluble material. The resulting supernatant was mixed with 20 µl of 
GFP-Trap® magnetic agarose slurry and incubated for 3 hours at 4°C with end-over-end mixing 
to facilitate capture of eGFP-tagged proteins in complex with cytosolic binding partners. Using a 
magnetic rack, beads were washed 3 times in 500 µl Lysis buffer prior to starting On-bead-SCX 




2.13. Plasmid constructs used in this study 
 
Name Vector Insert Tag Promoter Origin 
Insert 
Species 
























































3. Identifying candidate cargoes for fast endophilin-
mediated endocytosis (FEME) using label-free 




3.1.1.  Research aims and strategy 
 
The FEME pathway rapidly internalises a range of receptors upon receptor-ligand engagement. 
At the time of writing, 15 receptors have been identified (Table 3.1), including receptor tyrosine 
kinases (RTKs), G-protein coupled receptors (GPCRs) and the Interleukin 2 receptor (IL2R) 
(Boucrot et al., 2015). Given the wide range of functions represented by this pool, it can be 
assumed that FEME plays a role in diverse cellular processes. Expanding the set of known FEME 
cargoes will help shed light on the physiological roles of FEME and assist in pathway 
characterisation, with a view to define therapeutic targets for future studies.  
 
The central role of endophilin in FEME can be exploited for the discovery of novel cargoes. 
Endophilin acts as an adaptor for cargo recruitment into FEME carriers through its SH3 domain. 
Direct interactions between the endophilin SH3 domain and proline-rich regions in the third 
intracellular loop (TIL) of a number of GPCRs were shown to mediate their uptake via FEME 
(Boucrot et al., 2015). Similarly, for the RTKs EGFR and HGFR, recruitment into FEME carriers 
was mediated by the endophilin SH3 domain indirectly via the CIN85-Cbl complex. Two 





Receptor Abbreviation Type Publication 
β1-adrenergic receptor β1-AR GPCR 
Boucrot et al., 
2015 
α2a-adrenergic receptor α2a-AR GPCR 
Boucrot et al., 
2015 
Dopaminergic D3 receptor DR3 GPCR 
Boucrot et al., 
2015 
Dopaminergic D4 receptor DR4 GPCR 
Boucrot et al., 
2015 
Muscarinic acetylcholine receptor 4 mAchR4 GPCR 
Boucrot et al., 
2015 
Epidermal growth factor receptor EGFR RTK 
Boucrot et al., 
2015 
Hepatocyte growth factor receptor HGFR RTK 
Boucrot et al., 
2015 
Platelet-derived growth factor 
receptor 
PDGFR RTK 
Boucrot et al., 
2015 
Neuronal growth factor receptor NGFR RTK 
Boucrot et al., 
2015 
Insulin-like growth factor 1 receptor IGF1R RTK 
Boucrot et al., 
2015 
Interleukin-2 receptor IL2R 
Type I cytokine 
receptor 
Boucrot et al. 
(2015) 
Vascular endothelial growth factor 
receptor 
VEGFR RTK 
Boucrot et al., 
2015; Genet et 
al., 2019 
Tropomyosin receptor kinase B TrkB RTK Fu et al., 2011 
Plexin A1 PLXNA1 
Semaphorin complex 
co-receptor 
Ferreira et al., 
submitted 
Roundabout homolog 1 ROBO1 Roundabout receptor 
Ferreira et al., 
submitted 
  
Table 3.1  Receptors known to internalise via FEME. GPCR – G-protein coupled receptor, RTK – receptor 




3.1.2. Part A: Identifying candidate FEME cargoes by comparing plasma membrane 
extracts from FEME-competent and FEME-blocked cells using quantitative mass 
spectrometry 
 
The pool of receptors at the plasma membrane is maintained by a homeostatic balance between 
secretory/ recycling pathways which localise receptors to the plasma membrane, and endocytic 
pathways which remove them. Blockade of an endocytic pathway’s activity can result in 
accumulation of receptors which are normally internalised via that pathway at the plasma 
membrane. Endocytic pathways can be blocked by depletion of key adaptor proteins from the 
cell by RNA interference (RNAi) For instance, Boucrot and colleagues (2015) showed that RNA 
interference (RNAi)-based knockdown of all three endophilin A proteins blocked formation of 
FEME carriers and caused steady-state accumulation of β1-AR and EGFR at the plasma 
membrane, in cells grown in full serum and without stimulation of the receptors in Table 3.1. It 
has also been previously shown that RNAi-induced blockade of Clathrin-mediated endocytosis 
(CME) via knockdown of components of adaptor protein complex 2 causes plasma membrane 
accumulation of ~40% of plasma membrane proteins as defined by surface biotinylation (Bitsikas, 
Corrêa and Nichols, 2014), consistent with the notion that a large proportion of receptors at the 
plasma membrane are internalised via CME. Figure 3.1 shows the hypothetical impact of 
endocytic blockade on the populations of different receptors at the plasma membrane. Receptors 
that internalised exclusively via FEME can be expected to accumulate at the plasma membrane 
when FEME is blocked relative to untreated cells but will not accumulate at the plasma 
membrane of CME-blocked cells (Figure 3.1), and vice-versa. In reality, receptors often enter 
cells via multiple endocytic routes so the behaviour of receptors which are internalised by multiple 
pathways is difficult to predict. In addition, some receptors might only use an endocytic route as 
a compensatory mechanism upon inhibition of their usual portal of entry into cells. By comparing 
the levels of receptors at the cell surface under different conditions of endocytic blockade, it 
should be possible to define a pool of candidate FEME receptors for further validation. 
 
Changes in protein levels of candidate FEME cargoes at the plasma membrane could be 
assessed by antibody-based methods such as surface labelling followed by fluorescent 
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microscopy; or by quantitative western blotting of a plasma membrane extract. However, these 
methods would only target a small number of candidates at a time, would be limited by cost and 
availability of antibodies against candidates. They would also be biased by candidate 
preselection. 
 
Quantitative proteomics provides a powerful alternative for unbiased profiling of subcellular 
protein populations. Workflows have steadily increased in quality and, given appropriate 
instrumentation and sample preparation, it is now possible to identify and quantify thousands of 
proteins from low amounts of complex sample (<20µg) (Wiśniewski et al., 2009; Hughes et al., 
2014; Kulak et al., 2014; Sielaff et al., 2017). This opens the possibility of performing quantitative 
proteomics experiments on plasma membrane isolates and the lower requirements for starting 
sample amount also help compensate for the cost of experimental procedures upstream of 
subcellular fractionation. 
 
A proposed quantitative proteomics workflow for comparing surface receptor levels in plasma 
membrane fractions from cultured mammal cells following RNAi-induced endocytic blockade is 
described in Figure 3.2. As shown, a number of steps must be optimised. Specific inhibition of a 
given endocytic pathway can be achieved by disrupting the expression or action of a key pathway 
component. For example, overexpression of the carboxy terminus of the neuron-enriched CME 
cargo adaptor AP180 causes a dominant negative phenotype. The COOH-terminus of AP180 
has many AP2 and clathrin binding sites, so overexpression titrates away free AP2 and clathrin 
from the cytosol, reducing the number of copies of available for recruitment into clathrin-coated 
Figure 3.1   Expected effect of endocytic blockade on cell surface receptor populations at the 
plasma membrane. Circles represent mammalian cells. Other shapes represent cargo receptors 
which enter cells exclusively via FEME/CME or via both pathways.  
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pits at the plasma membrane below functional levels (Ford et al., 2001). Despite the efficacy of 
this method, it relies upon inhibition of clathrin activity which may be undesirable due to disruption 
of clathrin’s other roles in the cell (Raiborg et al., 2001; Royle, Bright and Lagnado, 2005; 
Deborde et al., 2008). CME inhibition can also be achieved using small molecule inhibitors which 
target Clathrin such as Pitstop 2 (von Kleist et al., 2011) or Ikarugamycin (Elkin et al., 2016). It 
can also be achieved by using drugs targeting dynamin such as dynasore (Macia et al., 2006), 
Dyngo 4a (Mccluskey et al., 2013), quinone, Indole or Dynole series (Hill et al., 2009; Gordon et 
al., 2013; Macgregor et al., 2014) but these would also block other endocytic pathways, including 
FEME. Furthermore, the toxicity of these fast-acting inhibitors means they cannot be used for the 
extended periods of time (multiple days) required to induce significant accumulation of receptors 
on the cell surface.  
 
 An alternative technique for inhibition of CME is through RNAi-induced knockdown of central 
CME components. Knockdown of specific proteins can be achieved through transfection of small 
interfering RNA (siRNA) oligomers which target complementary sequences on target mRNAs for 
cleavage via the RNA induced silencing complex (RISC) and eventual degradation (reviewed in 
Wilson and Doudna, 2013). The resultant post-transcriptional gene silencing is almost always 
incomplete (especially for long-lived proteins whose levels drop mostly by dilution upon cell 
division) and require longer treatment to observe maximal effects but can effectively reduce the 
concentration of a target protein below functional levels. Effective CME inhibition has been 
demonstrated by transfecting mammal cells with siRNA oligomers targeting the µ- and α-subunits 
of the AP2 complex (Motley et al., 2003; Boucrot et al., 2010), as depletion of either subunit is 
sufficient to destabilise AP2 complexes and induce degradation of the other subunits. Because 
AP2 is the main adaptor recruiting Clathrin to the plasma membrane, its depletion blocks CME 
without affecting other cellular functions relying on Clathrin, such as in endosomal sorting 
(Raiborg et al., 2001), trans-Golgi network export (Deborde et al., 2008) and mitosis (Royle, 
Bright and Lagnado, 2005)). Similarly, simultaneous targeting of all three Endophilin A proteins 
using the same technique has been shown to inhibit FEME in an effective manner (Boucrot et 





The second step in the proposed workflow is the isolation of plasma membrane proteins for LC-
MS analysis. Due to the hydrophobic nature and low abundance of transmembrane receptor 
proteins, it is not generally possible to profile cell surface proteomes (surfaceomes) without an 
enrichment step. Many techniques have been developed for the enrichment of plasma 
membranes, some of which are explicitly designed for LC-MS coupling. 
 
Historically, ultracentrifugation of cells following gentle lysis (hypotonic shock, Dounce 
homogenisation, or needle shearing) was used to separate membranes from soluble proteins. 
Separation during centrifugation is dependent on differences in buoyant density, size and shape 
between intracellular proteins and organelles; and is divided into two categories: differential 
centrifugation and gradient density centrifugation (Brakke, 1953; Duve, 1975; Dormeyer et al., 
2008; Lewandrowski et al., 2009). Differential centrifugation separates cellular components 
primarily on the basis of size, with larger components tending to sediment faster. Gradient-
density centrifugation is performed in a medium containing a discrete or continuous density 
gradient, usually with the use of sucrose or Percoll. Following layering of the sample at the top 
or bottom of a gradient, centrifugation separates components of the sample on the basis of size 
(rate zonal centrifugation) or buoyancy (equilibrium centrifugation). An effective technique for 
Figure 3.2   Proposed workflow for quantitation of cell surface receptor populations by LC-MS. 
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obtaining a plasma membrane fraction is to perform a differential centrifugation to pellet cell 
membranes following lysis (crude membrane fraction), and then separate this membrane fraction 
by gradient centrifugation to obtain organellar subfractions (Golgi, endoplasmic reticulum, 
lysosomes, CCVs and plasma membrane among others). Due to heterogeneity in organelle size, 
and tight associations between some cytosolic proteins with integral membrane proteins, this 
technique displays lower purity relative to other plasma membrane isolation approaches. 
 
Biotinylation of cell surface proteins is an additional method for isolation of plasma membrane 
proteins. A range of chemical linkers have been developed which conjugate a biotin moiety, often 
with a linker region, to various functional groups on the cell surface (Table 3.2). If a membrane-
impermeable biotinylation reagent is used, only proteins exposed at the extracellular face of the 
plasma membrane will be labelled. This is followed by cell lysis and affinity purification of biotin-
conjugated proteins with an avidin resin. The strong biotin-avidin interaction (Kd~10-15M; Green, 
1975) allows for harsh washing steps, but presents difficulties during elution from the resin. 
Indeed, an early study using this technique reported just 2% of protein bound to avidin beads 
could be eluted through competition using free biotin (deBlaquiere and Burgess, 1999). This 
problem has been addressed by incorporation of a cleavable linker region in the biotinylation 
reagent, such as in sulfo-NHS-SS-Biotin (Figure 3.3). This molecule features a disulphide linker 
which can be cleaved under reducing conditions. Alternatively, enzymatic digestion can be 
performed on the avidin resin following capture of biotinylated protein, but risks overwhelming 
the eluate with avidin peptides. Eluted proteins can then be analysed by LC-MS. 
 
The use of sulfo-NHS-SS-Biotin was attractive due to its applicability to both approaches pursued 
in this work to facilitate the discovery of novel FEME cargo receptors. In addition to profiling 
quantitative changes in plasma membrane protein amounts between conditions, a 
complementary experimental workflow was optimised featuring secondary GST-pulldown from a 
plasma membrane fraction (described in Section 3.1.3). Ultracentrifugation techniques allow for 
purification of functional receptors but are laborious and produce relatively impure plasma 
membrane isolates. We reasoned that captured plasma membrane proteins labelled with sulfo-
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NHS-SS-Biotin could be eluted under gentle conditions, making this technique suitable for use 
in both discovery approaches (see also Section 3.1.3). Finally, the chosen reagent is membrane 
impermeable and reacts with accessible primary amines at the N-terminus or at Lysine side 
chains. This feature was expected to assist in labelling of GPCRs and RTKs (virtually all of which 
have extracellular N-termini), both classes of receptors with great relevance to FEME. Thus, 
biotinylation of surface proteins using sulfo-NHS-SS-Biotin was selected for plasma membrane 
isolation. 
 
A quantitative proteomics workflow was optimised to compare surface receptor levels in plasma 
membrane fractions from RPE1 cells following RNAi-induced endocytic blockade with the aim of 
identifying candidate FEME receptors and is described in Part A (Section 3.2). 
 
Table 3.2  Biotinylation reagents and their targets. 
  




3.1.3. Part B: Identifying candidate FEME cargoes by GST-Endophilin-SH3 pulldown 
from a plasma membrane extract 
 
Endophilin proteins play multiple roles in FEME, including cargo recruitment at the plasma 
membrane. This role is likely to be mediated by direct and indirect interactions between the 
endophilin SH3 domain and proline rich motifs in target cargoes and adaptor proteins. A workflow 
was developed to investigate the interaction of endophilin SH3 with integral membrane or 
membrane-associated proteins. 
 
Due to a number of biological and biochemical factors, the discovery and characterisation of 
membrane protein-protein interactions has proven challenging. Firstly, most membrane proteins 
are expressed at relatively low abundances in the cell (~1-100,000 copies/cell), posing a 
challenge for mass spectrometry detection. This can be circumvented though the use of large 
amounts of starting material (cultured cells or tissues), but this may be prohibitively expensive if 
treatment conditions are costly to induce and maintain. Overexpression of receptor proteins can 
be performed but is risky due to the exponential nature of signalling cascades whereby activation 
of a single receptor at the cell surface can trigger changes in thousands of downstream effector 
molecules. Further, integral membrane proteins are anchored in the lipid bilayer by 
transmembrane (TM) domains made up of hydrophobic amino acids. These TM domains are 
poorly soluble in aqueous solution, necessitating the use of detergents in most biochemical 
handling steps, which can interfere with downstream applications such as MS. Removal of 
detergents requires additional sample preparation steps, which reduce peptide yield and 
increase cost. Additionally, the wide range of non-denaturing detergents display heterogeneity in 
their capacity to functionally solubilise membrane protein. Solubilisation conditions must 
therefore be determined empirically on a case-by-case basis. 
 
These difficulties have prompted researchers to utilise indirect methods to screen for membrane 
protein interactions. One successful approach which does not necessitate the solubilisation of 
membrane proteins is the split ubiquitin yeast two-hybrid assay (first described in Johnsson and 
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Varshavsky, 1994). Pairs of candidate integral membrane protein binding partners are tagged 
with complementary fragments of the ubiquitin protein, one of which also features a transcription 
factor for a reporter gene. Close association of the partners in vivo causes functional 
reconstitution of a pseudo-ubiquitin protein, and its consequent cleavage by deubiquitinating 
enzymes. The transcription factor is released upon cleavage and can translocate to the nucleus 
to activate reporter gene expression. A recent adaptation of this system for use in mammalian 
cells shows great promise (Petschnigg et al., 2014; Saraon et al., 2017), but still suffers from 
several limitations: all tests are conducted pairwise between a set of pre-selected, manually 
tagged candidate proteins, and overexpression of candidate fusion proteins is a highly artificial 
situation which may not reflect protein behaviour in vivo. 
 
A powerful alternative for the discovery of novel protein-protein interactions is affinity purification-
mass spectrometry (AP-MS). In a general AP-MS workflow, the protein or protein domain of 
interest serves as a molecular bait and is exposed to a lysate or subcellular fraction containing 
potential prey proteins. The bait is purified by affinity chromatography under conditions which 
preserve protein-protein interactions, thus copurifying prey proteins. The resulting bait-prey 
complexes are then subjected to enzymatic digestion for identification by tandem mass 
spectrometry. AP-MS analyses are therefore not biased by pre-selection of candidates, and do 
not necessarily rely on overexpression of candidate proteins. 
 
Numerous factors contribute to the success of an AP-MS workflow. The affinity purification must 
be optimised for specificity and must provide enough starting material (generally a minimum of 
20 µg) for mass spectrometry sample preparation. The choice of MS sample preparation method 
is also reliant on the final elution conditions from the affinity purification step. Therefore, AP-MS 
experiments targeting membrane proteins must feature optimisation of the bait-prey binding step 
following detergent solubilisation and must feature appropriate MS sample preparation strategies 




The endophilin SH3 domain is an ideal bait for use in an AP-MS workflow to discover novel FEME 
cargoes. SH3 domains are relatively short (~60 amino acids) soluble domains which recognise 
proline-rich motifs (Kaneko, 2008; Kurochkina and Guha, 2013) and often serves as a dedicated 
scaffolding domain to promote protein-protein oligomerisation. Boucrot et al. (2015) described 
two modalities by which the endophilin SH3 domain recruits cargo into FEME carriers. GPCR 
cargoes were recruited by directly contact with targets whereas RTK cargoes were captured 
indirectly by association with cytosolic adaptors. Boucrot et al. (2015) showed that the endophilin 
A1 and A2 SH3 domains were able to interact directly with proline-rich motifs in a number of 
GPCR third-intracellular loops (TILs). Consistent with this observation, only GPCRs which could 
interact with the SH3 domain could be internalised by FEME upon agonist stimulation. The 
recruitment of EGFR and HGFR into FEME carriers was shown to be dependent on bridging of 
endophilin to the RTKs by the CIN85 adaptor and Cbl ubiquitin ligase following receptor activation 
(Petrelli et al., 2002; Soubeyran et al., 2002; Boucrot et al., 2015). The bridging of endophilin to 
tropomyosin receptor kinase B (TrkB) via retrolinkin is a further example of this indirect 
recruitment (Fu et al., 2011).  
 
The use of full length endophilin constructs as bait was avoided. Endophilin proteins share a 
common domain architecture, with an N-terminal N-BAR domain and a C-terminal SH3 domain 
connected by and a variable linker region. The N-BAR domain features an amphipathic helix (H0) 
which inserts into lipid bilayers to sense, stabilise or induce membrane curvature (Gallop et al., 
2006; Masuda et al., 2006; Chen et al., 2016; Simunovic et al., 2016). Endophilin proteins 
dimerize through interactions between their BAR domains adopting a rigid crescent-shaped 
structure (Gallop et al., 2006). In solution, endophilin A1 homodimers appear to display an 
autoinhibitory mechanism whereby the H0 helix and the SH3 domain make intermonomer, 
intradimer contacts, preventing both membrane sensing by the H0 helix, and protein-protein 
interactions by the SH3 domain (Wang et al., 2008; Meinecke et al., 2013; Vázquez, Unger and 
Voth, 2013; Chen et al., 2014). Indeed a similar autoinhibitory mechanism has been observed in 
the F-BAR protein Pacsin, where tubulation of liposomes was suppressed by the presence of 
full-length protein (Wang et al., 2009). Using full-length endophilin as a bait could retrieve mostly 
autoinhibited endophilin dimer complexes and thus reduce workflow sensitivity. Furthermore, 
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studies have reported protein-protein interactions between the endophilin family (Ralser et al., 
2005; Kristensen, Gsponer and Foster, 2012), raising the possibility that endophilins can 
heterodimerise with other BAR domain proteins. Thus, use of a full-length endophilin bait could 
purify complexes with no relevance to FEME, and may be inhibited through interactions with 
endogenous endophilin. Finally, Boucrot et al. (2015) compared the importance of all endophilin 
A proteins in FEME-mediated GPCR uptake, showing that endophilin A2 plays the most 
important role in non-neuronal cells, and established that all proteins bound by endophilins A1 
and A3 are also bound by endophilin A2. Bait-prey binding conditions were therefore optimised 
using a GST-EndoA2-SH3 construct. 
 
AP-MS efficacy can also be enhanced through subcellular fractionation. Affinity purification from 
a total cell lysate exposes the bait molecule to all possible binding partners in the cell, including 
ones which are ordinarily localised in separate compartments. This heightens the risk of detecting 
false positive and nonspecific interactions. Furthermore, low abundance true interactors (such 
as membrane proteins) may be unable to compete with highly abundant soluble proteins for 
occupancy in bait-prey complexes. During MS analysis, peptides with similar physicochemical 
properties co-elute during liquid chromatography and compete for charge during ionisation. 
Peptides from highly abundant proteins in an unfractionated sample can elute over an extended 
period and partially or completely mask the signal from lower abundance peptides. Pre-
enrichment of a relevant cellular compartment reduces interference from nonspecific and/or 
highly abundant proteins during affinity chromatography and aids mass spectrometric 
identification of proteins by reducing sample complexity and thus the frequency of co-eluting 
peptides. 
 
FEME cargo recruitment occurs at the plasma membrane, where transmembrane receptors are 
localised by secretory pathways. Well-established techniques for the enrichment of membrane 
proteins rely on separation of a plasma membrane fraction through differential or equilibrium 
density-gradient centrifugation (Brakke, 1953; Duve, 1975; Castle, 2003; Dormeyer et al., 2008). 
An alternative methodology relies on biotinylation of surface proteins with subsequent affinity 
purification (Deblaquiere and Burgess, 1999; Weekes et al., 2010; Bitsikas, Corrêa and Nichols, 
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2014). A workflow was developed employing recombinant GST-EndophilinA2-SH3 (GST-
EndoA2-SH3) to screen plasma membrane fractions from human RPE1 cells for potential FEME 




3.2. Part A: Identifying candidate FEME cargoes by comparing 
plasma membrane extracts from FEME-competent and FEME-
blocked cells using quantitative Mass spectrometry 
 
3.2.1. Plasma membrane enrichment via biotinylation of cell surface proteins 
 
As explained in section 3.1.2, we elected to perform plasma-membrane enrichment through 
biotinylation of plasma membranes using the sulfo-NHS-SS-Biotin reagent. A commercially 
available plasma membrane isolation kit utilising the cell surface biotinylation paradigm was 
tested following the manufacturer’s instructions (Pierce Cell Surface Protein Isolation Kit) (Figure 
3.4). Briefly, surface proteins on RPE1 cells grown to 80-90% confluence in 100 mm dishes were 
labelled with sulfo-NHS-SS-Biotin, a membrane impermeable reagent reactive against primary 
amines. The reaction was quenched and cells were lysed in a proprietary lysis buffer. Solubilised, 
biotinylated proteins were affinity purified from the lysate by exposure to agarose beads coated 
with NeutrAvidin monomers, which associate strongly with biotin. The bead resin was washed 4 
Figure 3.4  Schematic of surface biotinylation followed by affinity purification of plasma membrane 




times prior to elution. Cleavage of the disulphide linker by reduction in SDS-PAGE sample buffer 
supplemented with 50 mM dithiothreitol (DTT) released captured surface proteins in the elution 
step. 
 
Western blotting was used to characterise plasma membrane eluates obtained using this 
method. In a subcellular fractionation protocol, marker proteins with well validated localisation to 
specific cellular compartments can be used as a proxy for the purity of a given fraction. As shown, 
a number of plasma membrane proteins (EGFR, HGFR, Integrins β1 and αV and the Transferrin 
receptor) are well solubilised and retained in the eluate (Figure 3.5). Marker proteins for the 
cytosol (Glyceraldehye 3-phosphate dehydrogenase; GAPDH), endoplasmic reticulum 
(Calnexin) and nucleus (Histone H3; HH3) were significantly depleted in the eluate. The 
restriction of the majority of HH3 signal to the Pellet fraction indicates that nuclei remained largely 
intact under these lysis conditions, in agreement with the manufacturer’s claim that a “mild 
detergent” is used in the proprietary Kit lysis buffer.  Notably, some GAPDH signal is visible in 
the eluate and may be explained by reports that sulfo-NHS-SS-biotin is not strictly membrane-
impermeable (Luo, McDonald and Hanrahan, 2008). In addition, GAPDH is a highly abundant 
housekeeping protein and may simply adhere non-specifically to the surface of the agarose 
beads used in the affinity purification step.  
 
Figure 3.5   Western blotting of affinity purified plasma membranes demonstrates high purity in 
eluates. The presence of proteins from various cellular compartments in aliquots from different 
stages of the plasma membrane isolation workflow was assessed by western blotting. Elution was 
conducted in SDS-PAGE sample buffer with 50mM DTT.  cL – Clarified Lysate, P – Pellet, FT – 
Flowthrough, W1-4 – Wash 1-4, E – Elution, WCL – Whole Cell Lysate. 
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Comparison of the Pellet (P) and Clarified lysate (cL) fractions gives a measure of the efficacy of 
the lysis step. The presence of signal in the Pellet fraction for EGFR, GAPDH and Calnexin 
indicated incomplete lysis, so the ratio of lysis buffer to wet cell pellet volume was increased in 
future experiments. Interestingly, the capture of surface proteins was non-uniform (Figure 3.5). 
Comparison of the Clarified lysate, Flowthrough (FT) and Elution signal provides an estimate of 
the amount of available receptor which is successfully captured. A large proportion of available 
Integrin αV and Hepatocyte growth factor receptor (HGFR) were captured, as indicated by the 
near depletion of these species in the FT fraction. In contrast, a much smaller proportion of 
available Integrin β1, Transferrin receptor (TfR) and especially EGFR are retained in the eluate. 
This difference could be a function of the availability of extracellular primary amines for 
biotinylation or could represent an intracellular pool of receptors which are inaccessible to the 
Sulfo-NHS-SS-Biotin reagent. 
 
Quantitation of protein yield in plasma membrane fractions was important to determine the 
required quantity of starting material for tryptic digestion. Aliquots of affinity purified plasma 
membrane fractions from single 80-90% confluent 100 mm dishes were poorly visualised by 
Coomassie staining. Quantitation was then attempted on an increased scale (6 x 100 mm dishes, 
90% confluent RPE1 cells) using a detergent-compatible Lowry assay (Bio-Rad RCDC protein 
assay), but aliquots of the 400 µl Elution solution were measured below the lower limit of the 
assay dynamic range (0.2 mg/ml). This set an upper bound on protein amount in affinity purified 
plasma membrane to 80 µg/ 6 dishes RPE1 (assuming 0.2 mg/ml concentration in 400 µl) To 
obtain a rough estimate for the lower bound of protein amount in affinity purified plasma 
membranes, a 360 µl eluate from 6 x 100 mm dishes (90% confluent RPE1) was concentrated 
12-fold using a 30 kDa molecular weight cutoff (MWCO) spin filter. The concentrated eluate was 
assayed with the detergent-compatible Lowry assay at 2 dilution levels (0.7x and 0.4x) with 
success (Appendix 8.1) to obtain a lower boundary estimate of total protein yield from 6 x 100 
mm dishes of 31.5 µg ± 3.15µg (see Appendix Table 8.1, Table 8.2 and Figure 8.1). Given the 
expected loss of sample through use of the spin filter, and further possible losses of proteins 
larger than 30 kDa due to denaturing in SDS, this figure represents a lower boundary and the 
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yield of plasma membrane protein. Therefore, the yield of biotinylated surface protein from 6 x 








3.2.2. Optimisation of siRNA knockdown experiments 
 
RNAi-induced endocytic blockade of FEME and CME was optimised in RPE1 cells in order to 
generate biologically informative alterations in receptor populations at the cell surface for 
subsequent LC-MS analysis (see Figure 3.2). Endocytic blockade was first attempted on RPE1 
cells growing in 100 mm dishes. For CME suppression, 625 pmol of Invitrogen Stealth siRNA 
oligonucleotides targeting the µ2 subunit of adaptor protein complex 2 (HSS101955: 1 oligo 
targeting Human AP2M1) were used (AP2M KD). For FEME suppression, (Endophilin triple 
knockdown: EndoTKD) 625 pmol each of Invitrogen Stealth siRNA oligonucleotides targeting all 
three endophilin A proteins (HSS109709: 1 oligo against human SH3GL2; HSS109707: 1 oligo 
against SH3GL1; HSS109712: 1 oligo against human SH3GL3) were co-transfected into RPE1 
cells. Control cells were treated with 625 pmol of Invitrogen Stealth control (scrambled) oligo 
138782.  
 
Anticipating reduced cell growth in FEME- and CME-blocked cells, RPE1 cells were seeded onto 
100 mm dishes at two different densities (2.1 x 105 cells/dish for Control dishes, 2.3 x 105 
cells/dish for AP2M KD and EndoTKD dishes), 6 hours prior to transfection. siRNA 
oligonucleotides and Oligofectamine transfection reagent were diluted separately in 500 µl 
OptiMEM (Thermo Fisher), gently mixed and incubated at room temperature for 20 min before 
pipetting dropwise onto cells in culture media (Day 1). A second transfection was performed 24 
hours after the first transfection, preceded by exchange of cell media 1 hour in advance (Day 2). 
Cell media was changed 24 hours after the second transfection (Day 3), and cells were harvested 
on Day 4 or 5. The use of 2 transfections increases the percentage of cells transfected, improves 
the longevity of RNAi and the extended period of growth (4-5 days) prior to harvesting allows for 
multiple cell divisions to dilute the pool of target protein with a low turnover rate to achieve 
maximal knockdown efficiency. These optimisations were shown to be essential for achieving 
>90% reductions µ2-Adaptin levels (Motley et al., 2003) and >80% reduction in endophilin A 




Finally, it has been shown previously that knockdown of µ2-Adaptin causes instability and 
degradation of other AP2 subunits including α-Adaptin (Motley et al., 2003; Boucrot et al., 2010). 
-Adaptin is therefore an excellent proxy for AP2M knockdown and is used as such hereafter. 
 
Total cells extracts were obtained from siRNA-treated cells by harvesting them in 500 µl SDS 
sample buffer on Day 4 of the siRNA transfection procedure. Lysates were mildly sonicated (three 
10 second pulses, 10 m) to shear DNA, then centrifuged (16,000 xg, for 5 min) to remove 
insoluble material. Clarified lysates were then analysed by western blotting. Densitometric 
analysis of western blot images indicated highly significant and almost complete knockdown of 
EndoA2 levels (0.2% ± 0.1% of Control; P < 0.0001) in the EndoTKD condition (Figure 3.6a). 
Figure 3.6  Optimisation of siRNA knockdown using Oligofectamine transfection reagent. a, Left, 
representative western blot showing α-Adaptin and EndoA2 HRP signal upon different siRNA 
treatments. Right, Densitometric quantitation of siRNA efficacy. Bar graphs show GAPDH-
normalised α-Adaptin/EndoA2 signal expressed as a % of Control levels within each treatment 
condition (means ± s.e.m. from three independent experiments; *P < 0.05, **P < 0.01, ***P < 
0.001; 2-sided, unpaired Student’s t-test versus Control). b, Left, representative western blot 
showing α-Adaptin and EndoA2 HRP signal from siRNA experiments in 35 mm dishes. Right, 
Densitometric quantitation of siRNA efficacy. Bar graphs show GAPDH-normalised α-
Adaptin/EndoA2 signal expressed as a % of Control levels within each treatment condition; means 
± s.e.m. from four independent experiments; *P < 0.05, **P < 0.01, ***P < 0.001; 2-sided, unpaired 
Student’s t-test versus Control. 
100 mm dish format 





However, knockdown of µ2-adaptin appeared to be incomplete in the AP2M KD condition (36.3% 
± 23.1% of Control) with a high degree of variability in RNAi.  
 
Following RNAi induced knockdown of µ2-adaptin to levels undetectable by western blotting,  it 
is still possible for clathrin-coated pits to form (though at a greatly reduced density and rate) 
(Motley et al., 2003; Boucrot et al., 2010). It is probable that a population of cells with ~36% 
remaining µ2-adaptin may retain enough CME function to reduce the magnitude of receptor 
accumulation at the plasma membrane and thus reduce workflow sensitivity. 
 
Efforts to improve AP2M KD were undertaken in a smaller format (35 mm dishes) to conserve 
reagents and test multiple conditions. Inconsistent cell growth was observed whilst performing 
the initial 100 mm dish experiments and likely contributed to the large variability in knockdown 
performance observed in AP2M KD samples (Table 3.3, Original). To ameliorate this, small scale 
trials were conducted to ascertain a suitable seeding density for a 4-day RNAi protocol in 35 mm 
dishes (Table 3.3). These trials indicated that seeding 48,000 cells for Control and AP2M KD 
single knockdown conditions, and 96,000 cells for the EndoTKD triple knockdown condition 
would provide optimal growth during a 4-day RNAi experiment. 
 
Table 3.3  Optimisation of initial seeding conditions and seeding ratios for siRNA experiments. 
Original Trial refers to the data shown in Fig 3.3. Confluence is expressed as mean ± s.e.m. where 




Triplicate analysis of siRNA treated RPE1 cells in 35 mm dish format using optimised seeding 
was performed.  Densitometric analysis of western blot images show that these technical 
adjustments had mixed effects (Figure 3.6b). Firstly, the quality of EndoA2 knockdown in the 
EndoTKD condition deteriorated relative to initial experiments in the 100mm dish format (Figure 
3.3a), with a mean of 18.6% ± 7% of Control levels. The optimisations appeared to greatly reduce 
variability in α-Adaptin levels following AP2M KD (almost 5.5-fold decrease in s.e.m. relative to 
original trial in Figure 3.6a), although the levels of α-Adpatin still indicated incomplete knockdown 
(41% ± 4.2% of Control). 
 
In an effort to improve AP2M KD performance, siRNA was transfected into RPE1 cells using an 
alternative transfection reagent: Lipofectamine RNAiMAX (Thermo Fisher). Knockdown was 
performed exactly as previously described, but with exchange of the transfection reagent in 35 
mm dishes. A set of experiments was performed using Oligofectamine in parallel. When treated 
with RNAiMAX-siRNA complexes, Endophilin levels in EndoTKD were reduced to 2% of Control 
levels, indicating excellent knockdown (Fig 3.7). Interestingly, the reduction in α-Adaptin signal 
observed in RNAiMAX-treated AP2M KD cells (14% of Control) was the best knockdown 
observed for α-Adaptin so far, representing a 4.5-fold improvement in knockdown efficacy over 
the corresponding Oligofectamine-treated cells (Figure 3.7). Despite the use of a single biological 
replicate, these results were promising enough to warrant further trials using RNAiMAX. 
 
Figure 3.7  Comparison of siRNA knockdown efficiency using different transfection reagents. Left, 
western blot to show α-Adaptin and EndoA2 HRP signal upon siRNA transfection with 
Oligofectamine or RNAiMAX reagent. Experiments were performed in 35 mm dishes. Right, 
Densitometric quantitation of siRNA efficacy. Bar graphs show GAPDH-normalised α-
Adaptin/EndoA2 signal expressed as a % of Control levels within each treatment condition (n=1). 
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Seeding trials were performed to assess the optimal seeding density for 4-day siRNA treated 
using RNAiMAX in 100 mm dishes. These trials established optimal Day 1 seeding densities for 
Control (200,000 cells), EndoTKD (750,000 cells) and AP2M KD (400,00 cells) representing a 
seeding ratio of 1 : 3.75 : 2 (Control: EndoTKD: AP2M KD). Using these optimised conditions, a 
>95% reduction in target proteins was achieved following siRNA treatment of RPE1 cells in 100 
mm dishes (Figure 3.8). These conditions were taken forward and used for the discovery of 
FEME cargoes as described in section 3.2.4. 
 
  
Figure 3.8  The use of RNAiMAX transfection reagent causes large reductions in target protein 
levels following siRNA transfection in 100 mm dishes. Left, western blot to show α-Adaptin and 
EndoA2 HRP signal upon siRNA transfection with RNAiMAX reagent. Experiments were performed 
in 100 mm dishes. Right, Densitometric quantitation of siRNA efficacy. Bar graphs show GAPDH-
normalised α-Adaptin/EndoA2 signal expressed as a % of Control levels within each treatment 
condition (n=1). 
100 mm dish format, RNAiMAX 
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3.2.3. Optimisation of a liquid chromatography-mass spectrometry workflow for 
quantitation of membrane proteins 
 
Traditionally, sample preparation for mass spectrometry involves preparation of a protein sample 
for enzymatic digestion to generate peptides (by denaturing then alkylation and reduction of 
cysteines to prevent refolding during digestion), followed by peptide recovery and clean-up. Many 
reagents commonly used in the preparation of protein lysates are detrimental to MS performance 
or enzymatic digestion. For example, chelating agents such as EDTA, salts and detergents can 
suppress ionisation during ESI, either by competing with peptides for charge or by ion-pairing 
and neutralising analytes (Xu et al., 2005). Detergents such as sodium dodecyl sulphate (SDS) 
or chaotropes such as 8M Urea will denature and inactivate enzymes at concentrations 
commonly used in lysis buffers. In addition to these requirements, the target proteins of this 
analysis – membrane proteins – pose a number of challenges for conventional sample 
preparation in bottom-up proteomics. They possess dedicated hydrophobic regions which make 
them difficult to solubilise, are relatively low in abundance compared to cytosolic proteins and 
tend to produce large hydrophobic peptides upon tryptic digest, due to the low availability of 
lysine and arginine residues for cleavage in hydrophobic transmembrane regions. Techniques 
developed for the preparation of membrane protein samples for LC-MS often feature pre-
enrichment of membrane proteins followed by “in-gel” or “in-solution” digestion. 
 
Pre-enrichment for plasma membrane proteins has been achieved using biotinylation and affinity 
purification of surface proteins (Section 3.2.1). Following capture and washing of surface 
proteins, an in-gel or in-solution paradigm can be followed. 
 
In-gel digestion involves resuspension or direct elution of a sample in SDS sample buffer. The 
sample is boiled and subjected to 1 or 2-dimensional SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) to denature proteins and remove charged contaminants such as salts, with the 
added advantage of fractionating the sample by molecular weight (Shevchenko et al., 2007). 
Proteins in a gel lane are then manually excised, and the gel pieces are destained and washed.  
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Advantages of this method for the digestion of membrane proteins include elution of membrane 
proteins in SDS, which reduces the risk of sample precipitation prior to digest, and the opportunity 
to apply enzymes to fully unfolded proteins, avoiding potential steric hindrance from detergent 
molecules in in-solution techniques. Drawbacks of this method include labour-intensive sample 
processing and relatively poor peptide yield due to enzyme accessibility issues. Of particular 
concern for quantitative workflows, in-gel techniques feature more handling steps than in-solution 
techniques and thus introduce greater experimental error, especially during gel excision steps. 
 
Using an in-solution paradigm, the captured proteins could be eluted NeutrAvidin beads using a 
8M Urea/ DTT solution, then alkylated. As trypsin retains activity in low concentrations of Urea 
(<2 M), the sample can then be diluted and subjected to trypsin digest. This option is unattractive 
due to the danger of sample loss when diluting mass-limited samples. When handling samples 
with very low amounts of protein (<100 µg), loss of protein through adsorption to the walls of 
sample tubes is a constant danger. This can be ameliorated by reducing the number of handling 
steps, maintaining peptides and proteins at high concentration (i.e. low volumes) and the use of 
Lo-bind sample tubes (Feist and Hummon, 2015). For these reasons, a traditional in-solution 
digest was not considered. 
 
Alternatively, filter-aided sample preparation (FASP) is an attractive in solution/ on-filter digest 
method for membrane proteins. The sample can be eluted in SDS, and is then desalted and 
detergents removed through centrifugation and buffer exchange in a spin-filter prior to on-column 
tryptic digest (Wiśniewski et al., 2009). Importantly, by minimising handling steps and permitting 
the use of SDS during upstream steps, the technique has been shown to be effective in situations 
where sample starting material is low (<20 µg) (Sharma et al., 2012), although sample losses 
during preparation can be as high as 50%. 
 
Both traditional in-solution digest and FASP rely on an initial elution step, followed by sample 
alkylation and digestion. A number of “on-bead” digestion strategies have been reported which 
skip this elution step, featuring addition of trypsin to captured proteins without elution (Hubner et 
93 
 
al., 2010; Fukuyama et al., 2012; Turriziani et al., 2014). This has the advantage of minimising 
handling steps, labour time and quantitative reproducibility of the workflow. In the context of 
membrane proteomics, this method is limited by high dependency on the accessibility of 
extramembrane regions to enzymatic digest and on the effective removal of detergents during 
washing steps prior to digestion.  
 
The efficacy of in-gel digestion, FASP and on-bead digestion were tested using samples obtained 
from plasma membrane isolation (without siRNA knockdown) from RPE1 cells. To improve 
sensitivity, peptide level fractionation using strong cation exchange (SCX) was also trialled in 
conjunction with an on-bead digest (‘On-bead-SCX’). A FASP protocol was also attempted, but 
owing to poor initial results, was not revisited. 
 
In-gel digestion was performed on a plasma membrane fraction obtained from a single 100 mm 
dish of RPE1 cells (90% confluent). Briefly, biotinylated cell surface proteins were captured on 
neutravidin beads and washed. Beads were incubated in SDS-PAGE sample buffer (with 50mM 
DTT) for 1 hour at room temperature to release bound protein. 50 µl of the eluate was subjected 
to SDS-PAGE then stained with a mass spectrometry-compatible silver stain. Gel lanes were cut 
into 6 bands, and bands were further diced into 1 mm3 pieces. Gel pieces were destained, 
reduced and alkylated and finally washed using alternating incubations in ammonium 
bicarbonate and acetonitrile. Gel pieces were incubated in 10 ng/µl trypsin overnight at 37°C, 
and peptides were recovered by incubation in 1% formic acid, 2% acetonitrile extraction buffer 
and a final elution in acetonitrile. Peptides were then dried in a vacuum concentrator (SpeedVac 
DNA 120; Thermo Scientific) and re-solubilised in the desired volume of mobile phase solution 




On-bead digestion and On-bead-SCX was performed on six 100 mm dishes of 90% confluent 
RPE1 cells. Briefly, biotinylated cell surface proteins were captured on neutravidin beads and 
washed then was again in TBS to reduce detergent concentration. Beads were resuspended in 
a Tris-Urea buffer containing 115/300/600/1800 ng of trypsin as indicated and incubated at 27°C 
for 30 min. Trypsin solution was transferred to a fresh sample tube and incubated at room 
temperature overnight for a combined reduction/ digestion step. Alkylation was performed on the 
following day, and peptides were subjected to solid-phase extraction (SPE) StageTip desalting. 
For On-bead-SCX samples, StageTip cleanup was coupled to 5-fraction SCX. Peptides were 
then dried in a vacuum concentrator and prepared for LC-MS analysis. 
 
During in-gel digestion, trypsin diffuses through the polyacrylamide matrix to access and cleave 
the denatured proteins within. Due to the low efficiency of this process, a relatively high amount 
Figure 3.9  Comparison of sample preparation techniques for quantitative membrane proteome 
profiling on the basis of protein and peptide identifications. a, Bar chart showing number of 
peptides detected upon trypsin digest of equimolar amounts of plasma membrane fraction. b, 
Stacked bar chart to show total proteins ID/ condition. Numbers inset represent absolute number 
of IDs with GOCC:plasma membrane annotation. c, Stacked bar chart to compare number of 







of trypsin (10 ng/µl) is usually employed to ensure complete digestion of the sample. For on-bead 
digestion workflows, enzymatic cleavage is performed in solution, so lower amounts of trypsin 
can be used. This is desirable as it reduces the level of contaminating protease peptides in the 
final sample, improving quantitation of co-eluting peptides which otherwise may have been poorly 
ionised.  
 
A plasma membrane fraction from 6 x 100 mm dishes of RPE1 (90% confluence) was split into 
three equal parts and subjected to on-bead digestion with 115 ng, 300 ng or 600 ng trypsin 
(Figure 3.9a). Equal volumes of the resulting peptide samples were subjected to LC-MS analysis 
using a 90 min gradient, and peptide identifications were used to compare digest efficacy. The 
least efficient digest was with 115 ng (just 1 peptide detected) and the most effective digest was 
achieved using 600 ng trypsin (275 peptide IDs). Scaling this ratio up, sample preparation of 
plasma membrane isolations from a larger amount of starting material (six 100 mm dishes of 
RPE1 cells) was conducted using 1.8 µg trypsin. 
 
The results of each workflow were compared on the basis the following parameters: overall 
sensitivity, plasma membrane protein sensitivity, plasma membrane purity, digest quality and 
practicality (Figure 3.9 and Table 3.4). On-bead-SCX outperformed on-bead digestion without 
fractionation, identifying ~15% more protein groups (667 vs 579). Despite the use of 6-fold less 
starting material, in-gel digestion identified 345 proteins (Figure 3.9b). Gene ontology cellular 
compartment (GOCC) annotations are manually curated or computationally generated assertions 
of a protein’s subcellular localisation. In this study, proteins with a GOCC “plasma membrane” 
annotation were deemed to be plasma membrane proteins. In absolute terms, On-bead-SCX 
identified the highest number of proteins with a plasma membrane GO annotation (177) (Figure 
3.9b). Interestingly, in-gel digestion displayed comparable plasma membrane sensitivity to on-
bead digestion (135 and 128 proteins, respectively), and the highest plasma membrane purity 
(39.1%) of all datasets tested. The deciding factor between these digestion strategies is the 
proportion of plasma membrane identifications of sufficient quality to provide quantitative data (≥ 
3 peptides). Again, On-bead-SCX performed best with 149 quantifiable plasma membrane 
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proteins, with in-gel digestion performing well (131 proteins) and on-bead digestion without 
fractionation identifying ~110 quantifiable plasma membrane proteins. Interestingly, overall 
quality of digests as assessed by average sequence coverage was comparable across 
techniques ranging from a low of 19.9% (On-bead-SCX) to a high of 24.6% ±0.1% (On-bead 
digest) (Table 3.4). Similarly, quantifying the number of missed cleavages in each on-bead 
dataset did not reveal striking differences (Figure 3.9c).  
 
Comparison of isoelectric point (pI) and molecular weight (MW) at the protein level were 
performed to assess if the sample preparation methods displayed any physicochemical biases 
(Figure 3.10). All techniques exhibited a strong bias towards identification of proteins with an 
isoelectric point below physiological cell pH (pH 7.4). In-gel digestion exhibited the largest spread 
in pI and a bias towards larger proteins (Figure 3.10a). It was hypothesised that the bias towards 
larger proteins could be caused by the more effective fractionation in the in-gel digestion protocol. 
Consistent with this, in-gel sample fractions contain ~4-fold higher percentage of unique proteins 
per fraction than On-bead-SCX fractions (Figure 3.10b). 
Table 3.4  Comparison of sample preparation techniques for profiling affinity purified plasma 
membrane fractions by LC-MS. Values in On-bead digestion column represent means ± standard 




Practical aspects of each technique were also compared. In-gel digestion was the most laborious, 
and the relatively high number of fractions (usually 8-20 in the literature) necessitate very long 
sample preparation and analysis times. On-bead digestion without further fractionation provided 
the best balance of labour to sample coverage, with the addition of a 5-fraction SCX step only 
boosting sensitivity by 15%. 
 
In this analysis, in-gel digestion displayed superior purity of plasma membrane protein despite 
much lower starting amounts. However, the inevitable introduction of experimental error from this 
technique, and its burgeoning cost in labour and instrument time upon sample multiplexing, 
Figure 3.10  Fractionation efficiency assessment and physicochemical properties of identified 
proteins using different sample preparation strategies. a, Left, density plot to show spread of 
protein pI scores. Right, density plot to show distribution of protein MW. b, Line chart to show % 
of Unique protein IDs/ fraction. The x-axis features numbered gel bands or Ammonium acetate 





represented significant drawbacks. A compromise approach “In-gel-SCX” was proposed. 
Proteins would be eluted in SDS-PAGE sample buffer and run on a gel for a very short time 
period, allowing excision and in-gel digestion of the whole sample in a single gel band. This would 
be followed by fractionation at the peptide level by SCX. The compromise protocol was applied 















3.2.4. Identifying candidate FEME cargoes by comparing plasma membrane extracts 
from FEME-competent and FEME-blocked cells using quantitative Mass spectrometry 
 
A complete optimised workflow was performed to assess quantitative differences in plasma-
membrane receptor populations under conditions of CME or FEME endocytic blockade (Figure 
3.2). Six 100 mm dishes were seeded at optimised densities for each RNAiMAX treatment: 
Control, EndoTKD and AP2M KD (See section 3.2.2). Experiments were performed in biological 
triplicate. Following treatment with 625 pmol of respective siRNA oligos, plasma membrane 
fractions were harvested on Day 4 using by affinity purification following cell surface biotinylation.  
An aliquot of clarified lysate was retained for assessment of knockdown efficacy. Following 
capture of biotinylated protein using and washing of the plasma membrane fraction, proteins 
were prepared for LC-MS analysis using an ‘In-gel-SCX’ protocol.  
 
Figure 3.11  Assessment of siRNA knockdown for full discovery workflow. a,  Western blotting to 
assess knockdown efficacy of EndoTKD and AP2M KD treatments. b, Bar charts to show 
densitometric quantification of western blot shown in a. EndoA2 and α-Adaptin signals are shown 
following normalisation to GAPDH loading control and relative to within-biological repeat Control 
signal (means ± s.e.m. from 3 independent experiments; *P < 0.05, **P < 0.01, ***P < 0.001; 2-





Captured proteins were released through cleavage of the Sulfo-NHS-SS-Biotin linker through 
incubation in SDS-PAGE sample buffer containing >50 mM DTT at room temp for 1 hour. 
Samples were not boiled as this was found to greatly increased the incidence of Avidin monomers 
in eluates (data not shown). Following elution in 300 µl SDS-sample buffer, samples were 
normalised using quantitation of a silver stain, and up to a 50 µl of a sample was loaded into a 
gel for 1-dimensional SDS-PAGE. After running the gel for a short time (< 3min), and before the 
lagging electrophoretic front had exited the stacking gel, a second aliquot of protein (up to 50 µl, 
in accordance with normalisation), was loaded. Electrophoresis was resumed and proteins were 
allowed to proceed ~1 cm into the gel before stopping the run and excising the whole sample as 
a single gel band. Gel bands containing whole samples were subjected to in-gel digestion as per 
the protocol described in Section 3.2.3, but with the use of 300 ng of trypsin for overnight digest 
in accordance with the lower estimate of ~30 µg of capturable material using the surface 
biotinylation protocol optimised in section 3.2.1. Following in-gel digestion, the resultant peptides 
were resuspended in 0.5% acetic acid and subjected to SCX fractionation using 80 mM, 250 mM 
and 1000 mM Ammonium acetate as elution buffers. Peptides from each of the 3 fractions were 
dried in a vacuum concentrator and prepared for LC-MS analysis separately. 
 
Western blot analysis of the clarified lysate from plasma membrane harvests was performed to 
assess the efficacy of RNAi. RNAi-induced knockdown of Endophilin was highly effective with 
with almost no Endophilin A2 signal detectable in the EndoTKD condition in any of the biological 
repeats (Figure 3.11). Endophilin A2 levels in the AP2M KD condition did not significantly different 
from control levels and did not display wide variation (110% ± 6% of Control) However, despite 
optimisation for seeding density and RNAiMAX-mediated transfection in 100 mm dishes, RNAi-
induced knockdown of α-Adaptin was incomplete (46% ± 14% of Control). This indicated that 
CME was not fully inactivated in AP2M KD samples. 
 
Peptides from fractionated samples were analysed by nano-ESI-LC-HDMSE using a 40 min linear 
gradient in technical triplicate. Proteins were quantified using the Hi3 method, which uses the 
sum of intensity for the top 3 best ionising peptides for each protein identification as a proxy for 
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the protein’s concentration in the sample (Silva et al., 2006). A minimum of 3 peptides per protein 
were required, therefore, for consideration in quantitative analysis. A total of 1130 proteins were 
identified in all conditions. The Hi3 protein intensity for all technical repeats was normalised to 
total intensity protein intensity within each replicate. The median protein intensity from normalised 
technical replicates was then summed across all fractions from the same sample to generate a 
Hi3 intensity score for each protein within a sample. Due to the stochastic nature of peptide 
ionisation during ESI, missing values are often found in MS datasets. Only proteins that were 
observed in at least 2 of the 3 biological replicates were carried forward for quantitative analysis, 
leaving a subset of 560 proteins.  
 
Comparing the dataset on a global level, the total number of proteins identified with a minimum 
of 2 valid measurements was consistent across each condition. Principle component analysis on 
relative Hi3 protein abundance indicated that samples separated into 3 distinct groups. All Control 
samples were clustered and siRNA-treated samples from biological repeats 1 and 3 were 
separated from siRNA-treated samples from biological repeat 2.  
 
Further investigation revealed that a lower quantity of protein has been measured in these runs, 
resulting in a much lower no. of protein IDs (~250 vs 400+) and lower correlation in protein 
abundance when compared with other samples in the same condition. These 2 repeats were 
Figure 3.12  Global assessment of Plasma membrane dataset. Left, Bar chart to show total number 
of IDs with a minimum of 2 valid values in all 3 datasets. Right, Principle component Analysis (PCA) 
plot performed on relative Hi3 protein abundance to represent data similarity in 2 dimensions. 
CON – Control, EndoTKD – Endophilin triple KD, AP2M KD – µ-Adaptin knockdown. Numbers 
indicate biological replicate identifier. 
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therefore excluded from further analysis. The final dataset for ANOVA consisted of 283 proteins, 
129 of which annotated with the GOCC:plasma membrane term. 
 
Variation in this final dataset was analysed. Repeated measurements of Hi3 intensity within 
technical replicates displayed a median Pearson correlation coefficient of 0.85. Median Pearson 
correlation among biological replicates was also found to be 0.85, indicating high technical and 
biological reproducibility (Figure 3.13). PCA analysis was also performed on the minimal dataset 






Figure 3.13  Scatter plot to show correlation in relative Hi3 protein intensity across biological 
replicates.  




















One-way ANOVA was performed to determine if protein abundance of a given protein in a given 
condition displayed a statistically significant difference from any other group. False discovery rate 
was controlled using a permutation-based FDR of 0.05. Two proteins, Junction Plakoglobin (JUP) 
and Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1) were denoted as significantly 
different in at least one pairwise condition. Tukey’s Honest Significant difference (THSD) post-
hoc test was performed and found differences in protein intensity were significant in all three 
pairwise comparisons for both proteins. To further interrogate the data, pairwise t-tests were 
performed between conditions, using an unpaired, 2-sided t-test with equal variances and 
correcting for multiple comparisons using a permutation-based FDR correction (FDR cut-off of 
0.05). No hits reached significance using this method, likely due to loss of power incurred when 
reducing sample size. To glean more information from the dataset, the results of t-tests were 
plotted without correction for multiple testing, and the results were interpreted with the caveat of 
accepting a higher rate of type I errors. 
 
Proteins were denoted as differentially expressed upon fulfilment of two criteria: p-value < 0.05 
and a fold change (ratio of average protein intensity) greater than 1.3-fold in either direction. 
Quantitative measurements of peptides using MSE have been shown to display an error in signal 
intensity of 10-15% (Silva et al., 2006; Patel et al., 2009). Thus, a fold change cut-off of 1.3 
Figure 3.14  PCA plot to represent data similarity within minimal dataset in 2 dimensions. CON – 
Control, EndoTKD – Endophilin triple KD, AP2M KD – µ-Adaptin knockdown. Numbers indicate 




represents a value 2-3 times larger than that expected given normal technical variation. Using 
this definition 29 differentially expression proteins were identified in EndoTKD vs Control, 35 in 
Control vs AP2M and 18 in EndoTKD vs AP2M KD (Figure 3.15 and Tables 3.5, 3.6 and 3.7).  
  
Data was analysed with reference to the hypothetical responses to treatment as described in 
section 3.1.2 (Figure 3.16). Receptors that internalised exclusively via FEME can be expected to 
accumulate at the plasma membrane when FEME is blocked relative to untreated cells but will 
not accumulate at the plasma membrane of CME-blocked cells (Figure 3.16), and vice-versa. 
Receptors which are internalised via multiple endocytic routes can be expected to display 
variable responses.  
 
As of this writing, only 1 protein, β1-adrenergic receptor (β1-AR), has been shown to be 
internalised exclusively by FEME (Boucrot et al., 2015). Unfortunately, this analysis did not detect 
β1-AR successfully and it could not be used for validation. However, a number of other proteins 
for which relevant pathway information is known were detected and were used for dataset 
assessment. 
Figure 3.15  Volcano plots to visualise quantitative pairwise comparisons between each dataset. 
Plot colours are representative of Hi3 protein intensity for the highest expressed protein in each 
comparison. Fold changes (FC) are calculated by finding the ratio of average Hi3 protein intensity 
from each condition. Vertical dashed lines represent fold change cutoffs for significance. 
Horizontal dashed line represents -Log10(p-value) cutoff for significance as calculated using a 2-
sided t-test (α < 0.05). Proteins with data plotted in the upper left and right quadrants are denoted 
as differentially expressed. EvsC – EndoTKD vs Control, AvsC – AP2M KD vs Control, EvsA – 





Examining differentially regulated proteins between EndoTKD and AP2M KD conditions (EvsA 
in Figure 3.15), the highest enrichment for any protein in AP2M KD was the well validated CME 
cargo Transferrin receptor protein 1 (TFRC). Enrichment of the transmembrane proteins Matrix 
metalloproteinase-14 (MMP14) and V-type proton ATPase catalytic subunit A (ATP6V1A) was 
also observed in this comparison, both of which are known to enter cells via CME (Jiang et al., 
2001; Remacle, Murphy and Roghi, 2003). Furthermore, TFRC was strongly depleted (5-fold) in 
EndoTKD plasma membrane fractions relative to control (EvsC). Whilst these results appeared 
to validate the accumulation of CME cargoes upon AP2M KD, it was noted that TRFC did not 
appear enriched in plasma membranes from AP2M KD cells when compared to Control plasma 
membrane (AvsC in Figure 3.15). A further contradiction was the enrichment of CD44, a known 
CIE cargo (Eyster et al., 2009), in the AP2M KD condition upon AvsC comparison. These effects 
are consistent with the incomplete knockdown of AP2 complex components noted by western 
blotting (Figure 3.11).  
 
The behaviour of several RTKs identified in this work with links to FEME was examined. The only 
protein with a link to known FEME cargoes enriched in EndoTKD in the EvsC comparison is the 
receptor tyrosine kinase Platelet-derived growth factor receptor beta (PDGFRB). FEME could be 
stimulated upon treatment of cells with platelet derived growth factor (PDGF), and the 
demonstration that ligand-receptor engagement is a requirement for uptake of FEME cargoes 
argues that PDGFRB is likely to be an FEME receptor (Boucrot et al., 2015). However, this has 
not been specifically demonstrated. Furthermore, PDGFRB was found to be enriched in the 
Figure 3.16   Expected effect of endocytic blockade on cell surface receptor populations at the 
plasma membrane. Circles represent mammalian cells. Other shapes represent cargo receptors 
which enter cells exclusively via FEME/CME or via both pathways.  
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AP2M KD condition in an AvsC comparison, indicating that the PDGFRB may enter cells via 
CME as well. Two other RTKs known to be internalised by both FEME and CME were quantified 
in this work. Epidermal growth factor receptor (EGFR) was detected in all conditions but did not 
exhibit significant differences in any of the comparisons. Hepatocyte growth factor receptor 
(MET) was also detected in this analysis but was only enriched in AP2M KD plasma membranes 
in the AvsC comparison. Taken together, these results cannot unequivocally confirm the 
accumulation of FEME receptors at the plasma membrane as a cause of EndoTKD.  
 
FEME receptors are expected to be observed in EndoTKD plasma membranes upon comparison 
to the other conditions (EvsC and EvsA). A group of 4 proteins enriched in EndoTKD (EvsC) 
were identified through network analysis using the STRING database search tool (Figure 3.17). 
These included Desmoglein-2 (DSG2), Cadherin-6 (CDH6), Cadherin-13 (CDH13) and JUP, 
which was previously identified in ANOVA analysis. These proteins all play roles at cell-cell 
junctions and are interesting candidates for future analysis due to the observation of high FEME 
activity at cell-cell junctions in confluent cells (E. Boucrot, unpublished results). Indeed, JUP is a 
Figure 3.17  STRING network analysis to show interactome of proteins enriched in EndoTKD 
plasma membranes upon comparison of EndoTKD/Control samples (EvsC). Edges indicate 
interactions from experimental, databases and gene-fusion categories. The minimum interaction 
score required was 0.7 and clusters were demarcated using k-means clustering assuming 5 




cytosolic partner of the transmembrane glycoprotein DSG2 and contains a high confidence 
Endophilin SH3-target proline-rich motif (PRM). Whilst intriguing, these 4 proteins are unlikely to 
represent FEME-exclusive cargoes, as they were all found enriched in AP2M KD plasma 
membrane relative to control (AvsC). 
 
In contrast, Dysferlin (DYSF) was identified as enriched in EndoTKD plasma membrane fractions 
relative to Control (EvsC) but was not differentially expressed upon CME blockade (AvsC), thus 
representing a candidate for exclusive uptake via FEME. DYSF is a single-pass type II 
transmembrane protein found to be 54-fold enriched in the plasma membrane of FEME- blocked 
cells relative to Control. Structurally, the protein consists of a small extracellular C-terminal 
domain and a large N-terminal cytoplasmic domain, which contains a number of proline rich 



















Dysferlin DYSF 53.94 0.0130 
Voltage-dependent calcium channel subunit 
alpha-2/delta-1 
CACNA2D1 8.15 0.0042 
Cadherin-6 CDH6 4.69 0.0229 
Propionyl-CoA carboxylase beta chain_ 
mitochondrial 
PCCB 4.58 0.0463 
Trifunctional enzyme subunit alpha_ 
mitochondrial 
HADHA 4.19 0.0097 
Procollagen-lysine_2-oxoglutarate 5-
dioxygenase 1 
PLOD1 4.01 0.0024 
Procollagen-lysine_2-oxoglutarate 5-
dioxygenase 2 
PLOD2 3.76 0.0458 
Desmoglein-2 DSG2 3.68 0.0108 
Junction plakoglobin JUP 3.42 0.0059 
Platelet-derived growth factor receptor beta PDGFRB 3.17 0.0294 
Cadherin-13 CDH13 2.91 0.0242 
Methylcrotonoyl-CoA carboxylase subunit 
alpha_ mitochondrial 
MCCC1 2.76 0.0250 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 1 
RPN1 2.58 0.0381 
Protein disulfide-isomerase A3 PDIA3 2.52 0.0462 
Integrin alpha-11 ITGA11 2.33 0.0026 
Protein transport protein Sec23A SEC23A 2.13 0.0208 
Endoplasmin HSP90B1 2.06 0.0319 
Endoplasmic reticulum chaperone BiP HSPA5 1.75 0.0210 
Heterogeneous nuclear ribonucleoprotein K HNRNPK 1.70 0.0182 
26S proteasome non-ATPase regulatory 
subunit 3 
PSMD3 1.38 0.0457 
Ezrin EZR 0.69 0.0129 
Heat shock protein HSP 90-alpha HSP90AA1 0.57 0.0482 
Neuropilin-1 NRP1 0.56 0.0456 
Matrix remodeling-associated protein 8 MXRA8 0.47 0.0162 
Basigin BSG 0.46 0.0122 
Probable ATP-dependent RNA helicase DDX5 DDX5 0.36 0.0395 
ATP-citrate synthase ACLY 0.30 0.0262 
Trifunctional purine biosynthetic protein 
adenosine-3 
GART 0.27 0.0385 
Transferrin receptor protein 1 TFRC 0.22 0.0358 
Table 3.5 Differentially expressed proteins (EndoTKD/Control; EvsC). Shaded proteins are enriched in 
Control.   
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Endothelin-converting enzyme 1 ECE1 7.49 0.0376 
Thrombospondin-1 THBS1 6.98 0.0143 
Voltage-dependent calcium channel 
subunit alpha-2/delta-1 
CACNA2D1 6.79 0.0049 
Junction plakoglobin JUP 6.58 0.0004 
Trifunctional enzyme subunit alpha_ 
mitochondrial 
HADHA 4.52 0.0084 
CD276 antigen CD276 3.90 0.0260 
5'-nucleotidase NT5E 3.58 0.0220 
Platelet-derived growth factor receptor 
beta 
PDGFRB 3.43 0.0242 
Cadherin-6 CDH6 3.35 0.0447 
Ras GTPase-activating-like protein IQGAP1 IQGAP1 3.29 0.0116 
Tubulin beta-1 chain TUBB1 3.22 0.0209 
Desmoglein-2 DSG2 3.20 0.0363 
Prolyl endopeptidase FAP FAP 3.03 0.0090 
Dolichyl-diphosphooligosaccharide--
protein glycosyltransferase subunit 1 
RPN1 3.01 0.0247 
Integrin alpha-11 ITGA11 2.92 0.0241 
Mitochondrial proton/calcium exchanger 
protein 
LETM1 2.74 0.0073 
Cadherin-13 CDH13 2.71 0.0199 
Procollagen-lysine_2-oxoglutarate 5-
dioxygenase 1 
PLOD1 2.63 0.0052 
Neuropilin-2 NRP2 1.95 0.0370 
Heterogeneous nuclear ribonucleoprotein 
K 
HNRNPK 1.65 0.0061 
Myoferlin MYOF 1.65 0.0489 
Endoplasmic reticulum chaperone BiP HSPA5 1.56 0.0322 
Matrix metalloproteinase-14 MMP14 1.56 0.0146 
V-type proton ATPase catalytic subunit A ATP6V1A 1.49 0.0073 
Pyruvate kinase PKM PKM 1.47 0.0208 
Extended synaptotagmin-1 ESYT1 1.43 0.0174 
CD44 antigen CD44 0.64 0.0309 
Hepatocyte growth factor receptor MET 0.55 0.0285 
Importin-7 IPO7 0.49 0.0499 
D-3-phosphoglycerate dehydrogenase PHGDH 0.48 0.0276 
Basigin BSG 0.39 0.0021 
Catenin alpha-3 CTNNA3 0.33 0.0455 
Eukaryotic translation initiation factor 3 
subunit F 
EIF3F 0.32 0.0335 
Trifunctional purine biosynthetic protein 
adenosine-3 
GART 0.23 0.0033 
Inactive tyrosine-protein kinase 7 PTK7 0.21 0.0167 
Table 3.6 Differentially expressed proteins (AP2M KD/ Control; AvsC). Shaded proteins are enriched in 
Control.   
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Spectrin beta chain_ non-erythrocytic 4 SPTBN4 13.32 0.0475 
Talin-2 TLN2 7.48 0.0141 
Inactive tyrosine-protein kinase 7 PTK7 4.67 0.0447 
Methylcrotonoyl-CoA carboxylase subunit 
alpha_ mitochondrial 
MCCC1 4.22 0.0281 
Heat shock protein 105 kDa HSPH1 3.73 0.0299 
Procollagen-lysine_2-oxoglutarate 5-
dioxygenase 1 
PLOD1 1.52 0.0396 
ATP-dependent 6-phosphofructokinase_ 
platelet type 
PFKP 1.41 0.0379 
Matrix metalloproteinase-14 MMP14 0.62 0.0403 
V-type proton ATPase catalytic subunit A ATP6V1A 0.61 0.0068 
5'-nucleotidase NT5E 0.59 0.0044 
Matrix remodeling-associated protein 8 MXRA8 0.50 0.0218 
Tubulin beta-2A chain TUBB2A 0.42 0.0120 
Prolyl endopeptidase FAP FAP 0.37 0.0073 
Podocalyxin PODXL 0.35 0.0333 
Endothelin-converting enzyme 1 ECE1 0.32 0.0488 
Putative heat shock protein HSP 90-beta 2 HSP90AB2P 0.27 0.0454 
Tubulin alpha-1A chain TUBA1A 0.20 0.0461 
Transferrin receptor protein 1 TFRC 0.13 0.0347 
Table 3.7 Differentially expressed proteins (EndoTKD/ AP2M KD; EvsA). Shaded proteins are enriched in 
AP2M KD.  
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3.3. Part B: Identifying candidate FEME cargoes through GST-
Endophilin-SH3 pulldown from a plasma membrane extract 
 
3.3.1. Selection of plasma membrane enrichment strategy 
 
A workflow was developed employing recombinant GST-EndophilinA2-SH3 (GST-EndoA2-SH3) 
to screen plasma membrane fractions from human RPE1 cells for potential FEME cargoes by 
AP-MS (Figure 3.18). Pre-enrichment of plasma membranes, which aims to minimise non-
specific interactions from other cellular compartments and assist peptide identification during MS 
analysis, was optimised first. One well-established approach to enrich a membrane fraction 
features mechanical lysis of cells in hypotonic fractionation buffer, followed by differential 
centrifugation (e.g. Lai, 2013). Affinity purification of plasma membranes following biotin labelling 
of surface proteins is an alternative technique (Deblaquiere and Burgess, 1999; Weekes et al., 
2010; Bitsikas, Corrêa and Nichols, 2014).  Adapted protocols for both methods were created 
and assessed for suitability. 
 
Figure 3.18   Proposed AP-MS workflow. Plasma membrane enriched fractions will be exposed to 
GST-only- and GST-EndoA2-SH3-coupled beads during the affinity chromatography step. Following 
washing and elution from beads, captured proteins will be coupled to LC-MS using appropriate 
sample preparation. Identification and quantitation of eluting peptides will enable sorting of 
specific and nonspecific interactions by comparison to control “GST-only” beads. 
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A commercially available plasma membrane isolation kit utilising the cell surface biotinylation 
paradigm was tested (Pierce Cell Surface Protein Isolation Kit) (Figure 3.19a). Briefly, surface  
proteins on RPE1 cells grown to 80-90% confluence in 100 mm dishes were labelled with sulfo-
NHS-SS-Biotin, a membrane impermeable reagent reactive against primary amines. The 
reaction was quenched and cells were lysed in a proprietary lysis buffer. Solubilised, biotinylated 
proteins were affinity purified from the lysate by exposure to agarose beads coated with 
NeutrAvidin monomers, which associate strongly with biotin. The bead resin was washed 4 times 
prior to elution. Cleavage of the disulphide linker by reduction in SDS-PAGE sample buffer 
Figure 3.19  Techniques to enrich plasma membrane proteins. a, Schematic of surface biotinylation 
followed by affinity purification of plasma membrane protocol. Note the reduction of the 
disulphide linker in the elution step to release captured surface proteins. b, Schematic of crude 
membrane preparation workflow. Membrane pellets can be washed by resuspension in fresh lysis 





supplemented with 50 mM dithiothreitol (DTT) released captured surface proteins in the elution 
step. This protocol was found to solubilise and purify marker plasma membrane proteins (EGFR, 
HGFR, Integrins β1 and αV and the Transferrin receptor) whilst depleting contaminant markers 
for cytosol (GAPDH), nuclear (HH3) and ER (Calnexin) compartments (Figure 3.3a and see 
detailed evaluation in Section 3.2.1) 
 
Optimisation of crude membrane preparation was then performed. RPE1 cells were subjected to 
mechanical lysis in hypotonic buffer (Figure 3.19b). RPE1 cells were found to visually round and 
swell within 15 min incubation in a hypotonic fractionation buffer on ice. Preparation of crude 
membrane fractions then was attempted using two mechanical lysis techniques: Dounce 
homogenisation and needle shearing (see schematic in Figure 3.19b). Briefly, RPE1 cells from 
2 100 mm dishes were grown to 80% confluence, scraped into a sample tube and allowed to 
swell in hypotonic buffer. Cells were then lysed by 20 passes through a 23-gauge (23G) needle 
or 100 strokes of a Dounce homogeniser. Intact cells and nuclei were collected by centrifugation 
of the lysate at 1000 x g for 5 min and the supernatant was centrifuged for 1 hour at 100,000 x g 
to collect a membrane pellet and cytosolic fraction (supernatant). Western blotting indicated that 
neither mechanical lysis option dramatically outperformed the other, with similar a yield of EGFR 
and similar Membrane fraction purity achieved (Figure 3.20b, left). Both techniques displayed 
excellent exclusion of nuclear proteins, and clear enrichment of EGFR in the membrane instead 
of cytosolic fraction. As expected, the ER-resident protein Calnexin was not was excluded from 
the membrane fraction. However, membrane fractions from both techniques exhibited high levels 
of GAPDH, suggesting poor separation of membrane and cytosolic protein (Figure 3.20b, left). 
 
The crude membrane preparation protocol was adjusted by performing lysis in a smaller volume 
with a reduced needle bore size and increasing the number of passes to 40. The membrane 
pellet was also washed 3 times to remove non-specifically bound cytosolic proteins. These 
optimisations appeared to improve membrane fraction purity, with reduced GAPDH signal in the 
membrane fraction relative to the original method (Figure 3.20b, right). However, these 
optimisations did not reduce the levels of ER protein in the membrane fraction. The successful 
elimination of ER proteins from the plasma membrane fractions using biotin-labelling of surface 
114 
 
protein was the key difference between these two workflows and resulted in selection of this 
technique for further optimisation. 
   
Figure 3.20   Affinity purification of biotin-labelled plasma membranes outperforms crude 
membrane extraction protocols. a, The presence of proteins from various cellular compartments 
in aliquots from different stages of the plasma membrane isolation workflow was assessed by 
western blotting. Elution was conducted in SDS-PAGE sample buffer with 50mM DTT. b, 
Microscopy images to show swelling of RPE1 cells following incubation in hypotonic fractionation 
buffer. c, Western blotting to assess Membrane fraction purity during optimisation of crude 
membrane extraction protocol. cL – Clarified Lysate, P – Pellet, FT – Flowthrough, W1-4 – Wash 1-






3.3.2.  Optimisation of mild elution conditions for release of plasma membrane proteins  
 
Cell surface capture using sulfo-NHS-SS-Biotin is now well established (Deblaquiere and 
Burgess, 1999; Weekes et al., 2010; Bitsikas, Corrêa and Nichols, 2014). In the literature, 
cleavage of the sulfo-NHS-SS-Biotin linker is often performed in high concentrations of DTT (>50 
mM) to ensure timely reduction of all bound linkers. Elution is also usually performed in SDS to 
preserve solubility of the released plasma membrane proteins. Our experimental strategy 
requires the release of plasma membrane proteins in a state suitable for secondary GST 
pulldown, so optimisation to define non-denaturing, low DTT elution conditions was undertaken. 
 
The anionic detergent SDS strongly denatures protein secondary structure when present at 
concentrations above the critical micelle concentration (CMC). We therefore tested elution 
buffers containing the zwitterionic detergent CHAPS, which has been successfully employed to 
solubilise membrane proteins in AP-MS experiments (Hjelmeland, 1980; Kanellopoulos et al., 
2018). In addition, we reasoned that cleavage of the disulphide linker in sulfo-NHS-SS-Biotin 
could probably occur at much lower concentrations of DTT (1-2 mM). A Urea/CHAPS elution 
Figure 3.21  A significant proportion of captured plasma membrane protein is released under mild 
elution conditions. a, Silver staining to compare sequential elution of plasma membrane proteins 
following biotin labelling, capture and washing in three different elution buffers. E1 – low DTT  
CHAPS, E2 – High DTT Urea/CHAPS, E3 – SDS-PAGE sample buffer (see Table 3.2). Protein amount 
was quantified by densitometry and % total signal among all 3 lanes within a repeat is displayed. 
b, Western blot to assess the success of plasma membrane isolation workflow for the Elution 
samples presented in a. Note higher loading of eluates relative to other samples. cL – Clarified 
Lysate, P – Pellet, FT – Flowthrough, W1-4 – Wash 1-4, E1 – Low DTT CHAPS, E2 – High DTT 





buffer with high (50 mM) DTT was also tested in the ultimately futile hope that this buffer would 
be conducive to downstream UV absorbance protein quantitation (data not shown). 
 
Plasma membrane proteins were captured using the workflow in Figure 3.19a, with a modified 
elution step. Following washing, proteins were sequentially eluted in equal volumes of 3 different 
buffers representing a range of DTT concentrations, detergent/ chaotrope levels, temperatures 











No DTT CHAPS 
25mM Tris-HCl pH 7.4, 150mM 
NaCl, protease inhibitors 
1% CHAPS n/a RT, 1 hour 
Low DTT CHAPS 
25mM Tris-HCl pH 7.4, 150mM 
NaCl, protease inhibitors 
1% CHAPS 1mM RT, 1 hour 
High DTT 
urea/CHAPS 
25mM Tris-HCl pH 7.4, 150mM 
NaCl, protease inhibitors 
8M urea/ 
1% CHAPS 
50mM RT, 1 hour 
SDS-PAGE sample 
buffer 
60mM Tris-HCl pH 6.8, 10% 
glycerol, 0.002% Bromophenol 
Blue 
2% SDS 50mM 95°C, 5min 
Kit Lysis Buffer Proprietary Proprietary n/a n/a 
Table 3.8  Lysis and Elution buffer constitution. RT – room temperature. 
 
Silver staining labels total protein with high sensitivity (Weiss, Weiland and Görg, 2009). 
Densitometric software can be used to obtain a semi-quantitative estimate of protein amount in 
a given area of pixels, with darker pixels indicating more intense signal. ImageStudio Lite (LI-
COR) software was used to estimate protein amount in whole lanes in Figure 3.21a. On average, 
43% of bound protein was released in low DTT, CHAPS buffer (E1), 34% of bound protein was 
released in high DTT, urea/CHAPS buffer (E2) and 23% of bound protein was released in the 





Western blotting shown in Figure 3.21b gives confidence that the eluted material indeed 
represents a plasma membrane-enriched fraction, with cytosolic (GAPDH), ER (Calnexin) and 
nuclear (Histone H3) marker proteins depleted in the Elution fractions concomitant with retention 
of plasma membrane receptors EGFR and Integrin αV. Interestingly, the majority of plasma 
membrane protein appears to elute in the E2 fraction, despite indications from the silver stain 
that most protein overall elutes in the E1 fraction. This effect is particularly pronounced for 
Integrin αV, but less clear in the EGFR blot. These results indicate that although the majority of 
plasma membrane protein stays attached to the beads, a significant portion of these proteins are 
reproducibly eluted following incubation in Low DTT CHAPS elution buffer for 1 hour at room 
temperature.  
 
3.3.3.  Investigating if optimised elution conditions are conducive to a secondary GST 
pulldown using a recombinant β1-AR construct 
 
As a known cargo of FEME, β1-AR represented a key positive control for optimising bait-prey 
binding conditions in the AP-MS workflow. Having established mild elution conditions for 
obtaining a plasma membrane fraction, overexpression of a recombinant murine β1-AR tagged 
C-terminally with enhanced-green fluorescent protein (eGFP) in HEK293 cells (a cell line in which 
>80% transfection can be routinely achieved) was used to investigate the viability of a secondary 
GST pulldown step. 
 
Recombinant GST-EndoA2-SH3 was expressed in E. coli and coupled to GSH-coated magnetic 
agarose beads. A β1-AR-eGFP construct was transiently expressed in HEK293 cells. Upon visual 
confirmation of construct overexpression, plasma membrane fractions were obtained using Low 
DTT CHAPS elution conditions. Plasma membrane proteins were then exposed to GST-EndoA2-
SH3 beads overnight, washed and eluted from beads by heating at 65°C for 15 min (to avoid 




Immunoblotting revealed successful enrichment of the plasma membrane protein EGFR in the 
Elution fraction (E), with low levels of cytosolic (GAPDH), ER (Calnexin) and nuclear (HH3) 
marker protein signal (Figure 3.22a). Two bands (~80 kDa and ~100 kDa) were visibly enriched 
in the anti-eGFP Elution fraction (E) and represent good candidates for surface-resident β1-AR-
eGFP. Firstly, the lower band is close in size to the theoretical mass of the construct (81 kDa). 
In addition, a highly intense species observed at ~60kDa in the cL fraction was not retained well 
in the Elution fraction (Figure 3.22a, right, red arrowhead), arguing for specific cell surface 
labelling of the ~80 kDa and ~100 kDa species. The ~100 kDa band may represent a post-
translationally modified form of the construct, as β1-AR is known to be glycosylated at several 
extracellular sites (Park et al., 2017) and phosphorylated at a number of intracellular sites (Hinz 
et al., 2017). Neither protein was retained in the secondary pulldown Bound fraction (B), 
remaining in the Flowthrough (FT) following exposure to GST-only and GST-EndoA2-SH3 beads 
(Figure 3.22a). This result indicated that no interaction occurs between B1-AR-eGFP and GST-
EndoA2-SH3 under the conditions tested. 
 
A number of factors could disrupt the interaction between β1-AR-eGFP and GST-EndoA2-SH3. 
The constructs may not fold correctly, or the eGFP domain may interfere with binding. 
Alternatively, the constructs may not retain structure upon solubilisation in the detergents present 
in the Kit lysis buffer and/or in low DTT CHAPS elution buffer. 
 
GST construct folding was assessed using recombinant Dynamin-1-eGFP (Dyn1-eGFP), a 
known endophilin binding partner. When cells were lysed in a Triton X-100 lysis buffer, Dyn1-
eGFP displayed low binding to a GST-only construct but was highly enriched following pulldown 
with GST-EndoA2-SH3, indicating that the GST constructs were correctly folded (Figure 3.22b).  
 
To assess if the Low DTT elution buffer was detrimental to secondary pulldowns, HEK293 cells 
expressing β1-AR-eGFP were lysed directly in Low DTT CHAPS buffer and a pulldown was 
conducted without pre-enrichment of the plasma membrane (Figure 3.22c). No specific binding 
was observed, raising two possibilities: i) overexpressed β1-AR-eGFP cannot be solubilised in a 
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Figure 3.22  A β1-AR-eGFP construct expressed in HEK293 cells does not copurify with GST-EndoA2-
SH3 following plasma membrane elution in Low DTT CHAPS buffer. a, Left, β1-AR-eGFP construct 
expression in HEK293 cells following transient transfection. Right, Western blot to assess plasma 
membrane capture and secondary GST pulldown in low DTT CHAPS buffer. Red arrowhead 
indicates ~60 kDa band of interest. b, Western blots to assess GST pulldown of Dyn1-eGFP 
constructs overexpressed in HEK293 cells in Triton X-100 Lysis buffer. c, Western blotting to assess 
GST pulldown of β1-AR-eGFP constructs overexpressed in HEK293 cells in Low DTT CHAPS buffer. 





3.3.4. A small proportion of endogenous β1-AR is captured by GST-EndoA2-SH3 beads 
 
Transient overexpression of recombinant proteins is subject to well documented artefacts such 
as the promotion of non-native protein-protein interactions and mislocalisation, even when 
performed in a mammalian expression system (Reaves and Banting, 1994; Sakaue-Sawano et 
al., 2008; Chudakov et al., 2010). To avoid these issues, the secondary pulldown workflow was 
evaluated using endogenous β1-AR from RPE1 cells. 
 
b 
Figure 3.23  A small proportion of endogenous β1-AR is captured on GST-EndoA2-SH3 beads by 
secondary elution in Low DTT CHAPS buffer. a, Western Blot analysis of a complete secondary 
GST-pulldown from plasma membrane fraction workflow conducted on RPE1 cells. Ponceau stain 
panel indicates the relative sizes and intensity of both GST constructs in Bound fraction (B). b, 
Western blot analysis of an improved secondary GST-pulldown workflow. P – Pellet, cL – Clarified 






In accordance with the fact that endogenous β1-AR is expressed at relatively low levels in RPE1 
cells (Boucrot et al., 2015), starting material for the secondary GST-pulldown workflow was 
increased 12-fold (12 x 100 mm dishes). Western blot analysis indicated successful enrichment 
of a 60-70 kDa doublet believed to represent surface-resident β1-AR in the plasma membrane 
fraction (Figure 3.23a, Lane E). As expected, the blots reveal no interaction between either GST 
construct and GAPDH or EGFR. By contrast, a small amount of β1-AR appears to copurify with 
GST-EndoA2-SH3 but not with GST-only, suggesting that a limited pool of endogenous β1-AR 
can interact specifically with GST-EndoA2-SH3 in Low DTT CHAPS buffer. In support of this 
notion, β1-AR appears to be depleted in the GST-EndoA2-SH3 flow-through but not in the GST-
only flow-through (Figure 3.23a). However, the low yield of β1-AR was puzzling given its 
abundance in the Elution fraction. It was established that no β1-AR protein remains on the beads 
following heating in SDS-PAGE sample buffer (data not shown), so an incomplete elution step is 
not the cause. The interaction between β1-AR and EndoA2-SH3 may be mediated by 
phosphorylation sites on β1-AR which are not preserved as phosphatase inhibitors were not used 
in these trials. Another possibility is that the majority of β1-AR is captured but does not withstand 
the subsequent GST-pulldown wash steps, which were not collected for evaluation in this 
instance. Finally, the proteins may degrade during the overnight secondary pulldown step. An 
improved workflow was performed to address these possibilities.  
 
Immunoblots of marker proteins show that plasma membrane enrichment was achieved 
successfully (Figure 3.23b, left). An aliquot of the Elution fraction was subjected to the same 
handling steps for the secondary GST-pulldown protocol (end-over-end agitation overnight at 
4°C) but without exposure to the GST beads, with no noticeable degradation of the membrane 
protein proxy Integrin αV observed (degradation control aliquot - DCA lane, Figure 3.23b, left). 
The use of phosphatase inhibitors did not cause a dramatic improvement in β1-AR signal in the 
Bound/ FT fractions following secondary GST pulldown, with very faint bands observed (Figure 
3.23b, right). However, β1-AR’s binding pattern was consistent with previous results. A more 
intense β1-AR signal was observed in the GST-EndoA2-SH3 Bound fraction than in the GST-
only Bound fraction. Furthermore, β1-AR is dramatically depleted in the GST-EndoA2-SH3 
flowthrough in comparison to the clear β1-AR signal observable in the GST-only flow-through. 
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Although pulldown wash fractions were included, they did not show definitive evidence of β1-AR 
loss (Figure 3.23b, right). Together, these results suggest that proteins in the plasma membrane 
fraction are not degraded by temperature or mechanical handling during the secondary GST-
pulldown and that the use of phosphatase inhibitors does not have a large impact on pulldown 






Optimisation of two workflows aimed at discovering novel receptor cargoes for fast endophilin-
mediated endocytosis was performed.  Section 3.2 (Part A) detailed optimisation of a workflow 
for comparing quantitative differences between proteins in plasma membrane extracts from cells 
following RNAi-induced endocytic inhibition. Section 3.3 (Part B) described optimisation of a 
workflow to identify candidate FEME cargoes through GST-Endophilin-SH3 pulldown from a 
plasma membrane extract. 
 
Plasma membrane enrichment was a key step in both workflows and was achieved using cell 
surface biotinylation with sulfo-NHS-SS-Biotin (which targets primary amines) and affinity 
purification of membrane proteins. A key limitation for both workflows, therefore, is the restriction 
of possible targets for affinity purification to the subset of surface proteins which have exposed 
lysine residues in their extracellular regions or an extracellular N-terminus. At present, the extent 
to which this limitation affected the scope of this work, in terms of yield of plasma membrane 
proteins and subsequent depth of LC-MS protein coverage, is unknown. Indeed, studies have 
shown that the use of different surface labelling methods can have dramatic effects on purity and 
quality of membrane protein data obtained by LC-MS (Weekes et al., 2010). Future trials of 
alternative methods for plasma membrane labelling would be a desirable step in answering this 
question. One method which has been used to map the cell surface with great effect Cell Surface 
Capture (CSC). Introduced by Wollscheid et al. (2009), this technique involves chemical labelling 
of N-linked glycoproteins at the cell surface with biotin. Periodate is used to oxidise sugar 
moieties on N-glycosylated proteins at the cell surface to generate aldehyde groups for targeting 
by biotin hydrazide, forming a covalent linkage between biotin and the target glycoprotein. Cells 
are then lysed, and the contents subjected to enzymatic digestion. Biotin-conjugated 
glycopeptides are then purified from the sample using an avidin resin. The resin is washed 
extensively and subjected to enzymatic digestion by peptide N-glycosidase F (PNGase F), which 
cleaves the N-glycosidic bond and releases peptides for LC-MS analysis. This 2-stage affinity 
purification was shown to be highly selective for cell surface proteins, and was further developed 
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to perform cell surface profiling of 41 human and 31 mouse cell types, identifying a pool of 1492 
human and 1296 mouse cell surface glycoproteins (Bausch-Fluck et al., 2015). This technique 
suffers from the limitation that only N-glycosylated proteins can be detected, but this pool may 
outnumber the pool of receptors with accessible primary amine residues and should be tested. 
A similar glycoprotein-targeting technique which could trialled is lectin-based affinity purification 
of plasma membrane (Deeb et al., 2014).  
 
The quality of data obtained from the workflow in Part A was compromised by the inconsistent 
siRNA knockdown of µ-Adaptin and technical issues with mass spectrometry sample preparation. 
With respect to improving the quality/robustness of endocytic inhibition in RPE1 cells, gene 
editing using CRISPR-Cas9 technology could be attempted. The advantage of using this 
technique is that generation of a complete knockout of µ-Adaptin could be achieved. Drawbacks 
would include the length of time required to select and expand suitable clones, and the dangers 
of selecting clones which have reverted to a wild-type phenotype stochastically (so-called 
“escapers”). With respect to improving the performance of the sample preparation for LC-MS, 
focusing on fractionation of the sample would likely yield the best immediate improvements, given 
that the yield of protein from plasma membrane isolation is sufficient for microproteomics. In the 
In-gel-SCX workflow, only 3 fractions were used, and no optimisation of the SCX intervals in 
ammonium acetate concentration was performed. Increasing the number of fractions and 
optimisation of ammonium acetate intervals could improve the workflow performance. Indeed, it 
would be interesting to test an alternative method of peptide-level fractionation such as High pH 
reversed-phase fractionation, given the relatively poor performance of SCX as highlighted in 
Section 3.2.3. 
 
A number of interesting candidates for involvement in FEME were highlighted for future analysis 
from the workflow in Part A. Of these, JUP is a particularly exciting candidate due to the presence 
of a proline-rich motif suitable for targeting by the Endophilin-SH3 domain in its primary 
sequence. The co-enrichment of several predicted and known binding partners for JUP upon 
inhibition of FEME, and the identification of JUP as a differentially regulated protein in ANOVA, 
125 
 
lend weight to the classification of JUP as a potential adaptor for FEME-mediated uptake of 
proteins at cell-cell junctions. Indeed, higher FEME activity has been observed at cell-cell 
junctions in confluent cells (E. Boucrot, unpublished results).  DYSF also contains a putative 
Endophilin SH3 target proline-rich motif and was found to display 54-fold enrichment in FEME-
blocked cells. Previous characterisation of DYSF has focused on its function in membrane repair 
as a mediator of intracellular membrane fusion at sites of plasma membrane lesions in a Ca2+ 
dependent manner (Davis et al., 2002; Bansal et al., 2003). The dramatic upregulation of DYSF 
at the plasma membrane in EndoTKD cells could be due to a higher incidence of membrane 
lesions in EndoTKD cells, or due to dysfunctional Ca2+ regulation in these cells, both avenues 
worth investigating. To establish if JUP or DYSF are bona fide FEME adaptors/cargoes, a 
prudent first step would be to investigate their interaction with EndoSH3 through pull-down 
assays. Promising results can be followed with antibody-based confirmation of in vivo 
associations with endophilin through immunoprecipitation with western blotting and/or 
fluorescent microscopy.  
 
A key limitation introduced by the selection of the biotinylation strategy as a means of purifying 
plasma membrane proteins for the workflow in Part B was the low yield of plasma membrane 
proteins from this technique: calculated to lie between 30 µg – 80 µg (Section 3.2.1). Gentle 
elution conditions in 1mM DTT were predicted to release ~43% of bound protein, therefore an 
expected yield from elution in low DTT CHAPS is between ~13 µg - 34 µg of protein.  At these 
yields, generation of a plasma membrane fraction at a concentration of 5 mg/ml (recommended 
for EndoSH3 pulldowns) at sufficient volume to conduct an AP-MS workflow would have been 
prohibitively expensive. Future attempts to obtain a plasma membrane extract for secondary 
GST-SH3 pulldowns should begin with trials to identify a workflow which can produce sufficient 
amounts of plasma membrane starting material at an acceptable cost. Future work would include 
testing alternative plasma membrane isolation strategies such as CSC and gradient density 





An important limitation for the workflow presented in Part B is the difficulty of solubilising different 
membrane proteins in a single detergent. Functional solubilisation of the full range of membrane 
proteins is impossible with a single detergent owing to the heterogeneity of protein structure and 
the differences between a bilayer and micellar environment. Previous AP-MS studies targeting 
membrane proteins have addressed this issue by extensive detergent screening and the use of 
multiple overlapping datasets from cells solubilised in different detergents (Babu et al., 2012). 
Indeed, Babu et al. found that CHAPS detergent was not ideal for solubilisation of a large panel 
of tandem affinity purification (TAP)-tagged membrane proteins, preferring the detergents Triton 
X-100, n-dodecyl- b-D-maltopyranoside (DDM), and octaethylene glycol monododecyl ether 
(C12E8). In order to maximise the chances of solubilising FEME cargoes, membranes should be 









4. Investigating FEME regulation through affinity 




4.1.1. FEME is differentially regulated in different cell types 
 
FEME is a rapid pathway for internalisation of specific cargo and is regulated at several levels.  
Firstly, cargoes in the plasma membrane are only internalised upon receptor-ligand interaction 
(Boucrot et al., 2015). Secondly, the pre-enrichment of endophilin at the plasma membrane 
promotes prompt FEME responses (Chan Wah Hak et al., 2018). Studies of FEME in a range of 
cell types have shed further light on how FEME is regulated. 
 
FEME activity is measured by quantifying the average number of endophilin-positive assemblies 
(EPAs) proximal to the cell’s leading edge in confocal microscope images. Different cell types 
were found to display different basal rates of FEME activity when growing in their respective 
complete media. HEK293, HeLa and BSC1 cells displayed a low number of EPAs (1 to 3 per 100 
µm2), whilst RPE1, human dermal fibroblasts (hDFA) and human umbilical vein endothelial cells 
(HUVEC) displayed higher numbers of EPAs (5 to 15 per 100 µm2) (Ferreira et al., submitted). 
There was also a difference in the fraction of cells displaying FEME between cell types: HUVEC 
cells displayed the highest rate of FEME-competent cells, with an average of 60% of cells 
displaying EPAs in their cytoplasm. 
 
In addition to cell type, another factor which affected FEME rate was the concentration of serum 
in cell media. Addition of 10% serum to cell media for a few minutes (5 to 20 min) robustly 
increased the frequency of EPAs observed all cell types tested. However, FEME was never 
observed in every single cell in a culture, even upon stimulation. Consistently, exchanging cells 
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into serum-free media suppressed FEME. These observations implied the existence of a 
mechanism by which individual cells in a culture are either FEME-blocked or FEME-competent.  
 
4.1.2. GSK3β and CDK5 are negative regulators of FEME 
 
The modulation of serum concentration and therefore growth factor signalling appeared to 
influence the FEME-competency mechanism. Kinases play an important role in growth factor 
signalling cascades and are known to modulate other endocytic pathways (Liang et al., 2007; 
Clayton et al., 2010; Smillie and Cousin, 2012; Reis et al., 2015). A kinase inhibitor screen 
performed in our lab identified Glycogen synthase kinase 3 (GSK3) and Cyclin dependent kinase 
5 (CDK5) as negative regulators of FEME in RPE1 cells (Ferreira et al., submitted). A range of 
small molecule inhibitors were chosen for testing on the basis of their reported roles in 
cytoskeletal regulation. Growing cells were treated with each inhibitor for 10 minutes at 37°C, 
then fixed in paraformaldehyde to preserve FEME carriers. Confocal microscopy was used to 
assess the effects of acute inhibition on the numbers of EPAs near the cell leading edge. The 
effects were scored with reference to EPA numbers observed under conditions of “Decreased”, 
“Normal” or “Increased” FEME (Figure 4.1a). “Decreased” FEME was achieved by inhibition of 
PI3K and “Increased” FEME was induced by stimulation with the β1-AR agonist dobutamine. 
“Decreased” FEME was assigned for samples with >80% reduction in the number of EPAs, in at 
least 50% of the cells. “Increased” FEME was attributed to samples with >200% elevation in the 
number of EPAs, in at least 50% of the cells.  
 
As shown, inhibition of several CDKs, GSK3 and p38 was found to significantly increase FEME 
in RPE1 cells, whilst inhibition of CAMKK1/2, SYK, FAK and mTORC1/2 kinases significantly 
decreased FEME (Figure 4.1b). Individually, inhibition of CDKs 1 and 2 did not cause significant 
changes to FEME rate, and the nuclear localisation of CDK7 and 9 argued against their role in 
acute modification of endocytic events at the leading edge (Malumbres, 2014) (Figure 4.1b). 
Therefore, CDK5 appeared to be a negative regulator of FEME. Further work in our lab was able 
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to show that GSK3 and CDK5 inhibition enhanced FEME in a dose-dependent manner, 
confirming the results of the screen (Figure 4.1c). 
 
Kinases identified in this screen could regulate FEME at various stages of the pathways and in 
a variety of modes. Endophilin presented an ideal candidate to define this regulatory network 
owing to its central role in FEME. We designed experiments to assess if endophilin binding 













Figure 4.1   CDK5 and GSK3 negatively regulate FEME. a, Scoring criteria used in the kinase screen. 
Representative images of ‘decreased’, ‘normal’ and ‘increased’ FEME in resting human RPE1 cells 
treated with 10µM dobutamine, 10µM DMSO and 10 nM GDC-0941 (PI3Ki), respectively. 
Arrowheads point at FEME carriers. ‘Decreased’ FEME was assigned for samples with >80% 
reduction in the number of EPAs, in at least 50% of the cells. ‘Increased’ FEME was attributed to 
samples with >200% elevation in the number of EPAs, in at least 50% of the cells. The 
corresponding scoring marks were 0, 1 and 2, respectively. b, Kinase screen using small compound 
inhibitors. c, Number of FEME carriers (cytoplasmic Endophilin-positive assemblies, EPAs) upon 
titration of CHIR-99021, BIO, Roscovitine and Dinaciclib. Dobutamine and GDC-0941 were used as 
positive and negative controls, respectively. All experiments were repeated at least three times 
with similar results. Statistical analysis was performed by one-way ANOVA: NS, non-significant; *, 
P<0.05, **, P <0.01, ***, P <0.001. Scale bars, 5µm. 
(adapted from Ferreira et al., submitted) 
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4.2. Comparison of the endogenous endophilin interactome 
during high and low FEME activity by affinity purification-MS 
 
4.2.1. Experiment aim 
 
Endophilin is involved at many stages of the novel endocytic pathway, FEME. During FEME 
carrier formation, endophilin plays a role in cargo selection and membrane curvature 
stabilisation.  Endophilin recruits the GTPase dynamin to effect carrier scission and coats the 
carrier as it is trafficked into the cell interior, possibly serving as a link to the cell’s motor protein 
machinery. Work in our lab determined that FEME can be enhanced by addition of serum to cell 
culture media and suppressed by serum withdrawal, implicating growth factor signalling in FEME 
regulation. Regulation of FEME might be achieved by modification of endophilin or of its binding 
partners at any of the aforementioned stages. We designed an experiment to investigate how 
growth factor signalling impacts FEME. 
 
Affinity purification mass spectrometry (AP-MS) was used to identify proteins in endogenous 
endophilin A2 complexes purified from RPE1 cells with and without prior serum stimulation. Any 
changes in the endophilin interactome between these conditions could represent regulatory 






Figure 4.2  Investigating changes in the endophilin interactome upon serum modulation: 
experimental concept and workflow. a, Diagram to illustrate possible modes of FEME regulation 
via modification of endophilin. Activation/inhibition of FEME regulators could promote/inhibit 
endophilin functions at various stages: 1) Recruitment of dynamin to vesicle necks, 2) Cargo 
sorting via direct/indirect interaction with activated receptors (indirect interaction via cytosolic 
adaptors is shown), 3) Release of endophilin autoinhibition. b, Schematic to show experimental 
workflow. RPE1 cells were harvested under resting conditions or following stimulation with Foetal 
Bovine Serum (FBS). Endophilin A2 (EndoA2) complexes were immunoprecipitated (IP) and 
subjected to in-gel digestion. Peptides were analysed by LC-HDMSE. Differential expression 
analysis was used to identify candidate endophilin binding partners and compare their affinity 






4.2.2. Cell culture, sample preparation by in-gel digestion and LC-MS analysis of 
peptides 
 
RPE1 cells were grown on 100 mm dishes to a confluence of 80% before harvest. For the 
stimulated condition, cell media was supplemented with extra 10% FBS (20% final) for 5 min at 
37°C. For the resting condition, no additional treatment was performed prior to cell lysis. Cells 
were washed 2 times in ice-cold PBS before being gently scraped into lysis buffer, incubated on 
ice for 30 minutes and centrifuged. Anti-endophilin A2 beads were incubated with the clarified 
cell lysate overnight at 4°C with end-over-end rotation. The beads were washed to 
remove/reduce non-specific interactors and boiled in SDS sample buffer to release the captured 
protein complexes.  
 
Aliquots of the resulting eluates were subjected to western blotting and displayed successful IP 
of the known endophilin binding partner Dynamin (Figure 4.3). Samples prepared for LC-MS 
analysis 1D SDS-PAGE separation and in-gel digestion with trypsin, cutting lanes into 10 
fractions. Cell culture, immunoprecipitation and in-gel digestion were performed by J. 
Panambalana. The resulting peptides were resuspended in LC-MS running buffer and samples 
were spiked uniformly with peptides from E. coli ClpB protein to act as a standard for Hi3 
quantitation. Peptides were separated using a 60-minute gradient (0-40% acetonitrile) by 
reversed phase LC coupled online to a quadrupole time-of-flight mass spectrometer (Synapt-G2-
Si, Waters) via a nanoESI sprayer. The instrument was operated in HDMSE mode. Samples were 
analysed in biological and technical duplicate. 
 
Raw data was analysed using Progenesis v4.0 (Waters, UK) using a Human UniProt FASTA 
database to match ions to peptides and proteins. Samples were normalised to Endophilin peptide 
abundance and fractions were combined in-silico in Progenesis to obtain absolute protein 









































Figure 4.3   Western blot to assess efficacy of Endophilin IP. Bound fractions shown represent 20% 
sample loading. All other lanes represent 2% sample loading. As shown, a subset of the available 
dynamin co-immunoprecipitates with Endophilin A2, indicating that IP was successful. R – Resting, 




4.2.3. Data quality control 
 
Protein groups identified with a minimum of 3 peptides were quantified using the Hi3 method to 
give an absolute protein abundance in femtomoles (Silva et al., 2006). After removing 
contaminants, a total of 3197 protein groups were quantified. Quantitative reproducibility was 
assessed at the level of combined technical replicates (protein amounts from all 10 fractions 
summed in Progenesis). Samples displayed a high degree of quantitative reproducibility, with a 
mean within-condition Pearson correlation of 0.96 for resting samples and 0.97 for stimulated 
samples (Figures 4.4a and 4.4b) indicating reproducible sample preparation and instrument 
performance. Interestingly, the correlation in protein abundance across conditions was also very 
high, with a mean between-condition Pearson correlation coefficient of 0.93. This suggests that 
the endophilin interactome did not change dramatically between the 2 conditions. As correlation 
coefficients can only describe sample similarity insofar as protein groups are shared between 
samples, it could be argued that the high scores across conditions do not account for proteins 
not shared between conditions (unique hits). However, as Progenesis assigns a protein 
abundance to all features in all runs (sourcing from background noise if no peptides are present), 
there are no missing values present in the dataset and thus no proteins unaccounted for when 
calculating correlation coefficients in this case. 
 
A principle component analysis (PCA) was performed using the Perseus software platform to 
represent similarity in protein abundance among the samples in 2 dimensions (Figure 4.4c). The 
tight clustering of technical replicates indicates good technical precision in the data. In agreement 
with the previously described correlations, the stimulated samples display higher similarity in 
protein abundance, clustering closely in the bottom left of the plot. Samples from the resting 
condition are spread further apart in the plot, but are still well separated from the stimulated 









Figure 4.4 Evaluation of instrument performance and data structure. a, Multiscatter plot to illustrate 
correlation in protein abundance across technical replicates and experimental conditions.  Technical 
replicates are denoted x or y, colours correspond to biological sample. Red – Resting A, Orange – 
Resting B, Blue – Stimulated A, Purple – Stimulated B. b, Boxplot to show distribution of Pearson 
correlation coefficients between all samples within each condition. Whiskers represent minimum and 
maximum values. c, PCA analysis to illustrate similarity among technical replicates in 2 dimensions. 











4.2.4. Differential expression analysis 
 
Absolute protein abundances as estimated by the Hi3 method in recombined samples were 
averaged across technical replicates. Proteins were classified as differentially expressed 
(implying a significant change in protein occupancy in endophilin A2 immunoprecipitates between 
conditions) upon fulfilment of two criteria: 1) protein abundance fold-change greater than 1.3-fold 
in either direction and 2) q-value < 0.05. So-called q-values were calculated from p-values from 
Student’s t-tests comparing mean protein abundance between the 2 conditions (2-sided, 
unpaired, assuming equal variance). The obtained p-values were corrected for dataset-specific 
false discovery rate through a permutation-based methodology implemented in the Perseus 
platform to convert them into q-values (Tyanova et al., 2016). Encouragingly, Endophilin A2 itself 
was not differentially expressed across conditions, arguing for the validity of our normalisation 
strategy. Five proteins of the 3197 quantified were found to be differentially expressed between 
the resting and stimulated conditions (Table 4.1). Of these, Cutaneous T-Cell Lymphoma-
Associated Antigen 6 (CTAGE6) is the most interesting. Observed at higher levels in the 
stimulated condition, this single-pass transmembrane protein has predicted functions in 
intracellular trafficking and contains a long proline-rich C-terminal region suitable for engagement 
by the Endophilin A SH3 domain. The other identifications are either nuclear-resident proteins 
(Ribosomal RNA processing protein 1 homolog B and Sister chromatid cohesion protein PDS5 
homolog A; both enriched in the stimulated condition) or do not have an obvious connection to 
FEME (a cuticular Keratin variant and the protease inhibitor Serpin B4; both enriched in resting 
condition). A possible reason for the observation of nuclear proteins with endophilin in the IPs 
presented here is the loss of organelle integrity upon cell lysis, resulting in the interaction of 
proteins which would normally be localised in different parts of the cell in vivo. This analysis did 
not identify any high-confidence candidate regulators of FEME. 
 
Owing to the use of only 2 biological replicates, the analysis lacks power. In order to gain more 
information from the dataset, the criteria for differential expression were relaxed and the raw p-
values were used in place of the corrected q-values. This expanded pool of differentially 
expressed proteins was examined with the caveat of accepting a higher rate of type I errors. 
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Under these criteria, 141 proteins were enriched in the resting condition and 139 proteins were 
enriched in the stimulated condition (Figure 4.5 and listed in Appendix Table 8.3). The behaviour 
of known endophilin binding partners was assessed. The E3 ubiquitin-protein ligase CBL (CBL) 
was identified as an adaptor for RTK sorting into FEME carriers and interacts directly with 
endophilin (Soubeyran et al., 2002; Boucrot et al., 2015). In agreement with this, it is enriched in 
the stimulated condition, possibly reflecting increased engagement with endophilin at the plasma 
membrane and on intracellular FEME carriers. By contrast, the known FEME cargo vascular 
endothelial growth factor receptor 2 (VEGFR2) did not appear to preferentially associate with 
EndophilinA2 complexes in either condition. Unexpectedly, two proteins which directly bind to 
endophilin and play obligate roles in FEME, Dynamin-2 and lamellipodin, (Boucrot et al., 2015) 
were not enriched in either condition. 
 
Of the proteins enriched in the stimulated condition, NEDD4-like E3 ubiquitin-protein ligase 
(WWP1) displayed the second highest fold-change enrichment and represents an interesting 
potential target for future study. WWP1 can associate with the plasma membrane via its N-
terminal C2 domain and monoubiquitinates the receptor tyrosine-protein kinase erbB-4 (ERBB4), 
promoting its degradation in lysosomes and proteasomes (Feng et al., 2009; Y. Li et al., 2009). 
It’s strong enrichment in Endophilin A2 immunoprecipitates following stimulation of cells raises 
the possibility that it forms a degradative complex in a similar manner to the Endophilin-CIN85-
CBL complex which participates in EGFR and HGFR downregulation (Petrelli et al., 2002; 
Soubeyran et al., 2002). 
 
The lack of FEME activity in cells grown in serum-free conditions implies the involvement of 
protein kinases as master regulators of FEME. The dataset was specifically probed to identify 
candidate kinases for this role. To do this, t-tests were performed on the technical replicates 
without averaging and corrected using the Benjamini-Hochberg procedure to obtain corrected q-
values. A list of kinases with q-values below 0.05 and with fold changes greater than 1.3-fold in 
either direction was compiled, noting that this dataset represents a detailed comparison between 
2 biological replicates and extreme caution should be taken when generalising to RPE1 cell 
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populations (Table 4.2). Of the 27 kinases identified this way, Glycogen synthase kinase 3β 
(GSK3β) represented an interesting candidate for future investigation. In a kinase inhibitor screen 
performed in our lab, GSK3β was found to negatively regulate FEME in RPE1 cells (Ferreira et 
al., submitted). As GSK3β can be inactivated by growth factor signalling (Cross et al., 1995; Patel 
and Woodgett, 2017), the enrichment of GSK3β in resting rather than stimulated endophilin IPs 
raised the possibility that endocytic flux through the FEME pathway could be controlled by binding 









cTAGE family member 6 CTAGE6 2.317 0.0414 
Ribosomal RNA processing protein 1 homolog B RRP1B 2.233 0.0414 




Keratin_ type I cuticular Ha1 KRT31 0.679 0.0414 
Serpin B4 SERPINB4 0.382 0.0414 
Table 4.1  List of proteins differentially expressed in EndophilinA2 immunoprecipitates from Stimulated 
and Resting conditions, stringent hypothesis testing. Hypothesis testing was performed using an 
unpaired, 2-sided student’s t-test on mean protein abundance from both technical replicates per sample. 
To correct for multiple testing, a permutation-based estimate of dataset FDR was calculated and used to 












Figure 4.5  Volcano plot to illustrate quantitative differences between proteins in endophilin A2 
immunoprecipitates under Resting and Stimulated (+FBS) conditions. For each protein, mean 
abundance and standard deviation (n=2) was found and used to perform unpaired, 2-sided t-tests 
and to calculate fold change in protein abundance between conditions. These values were log 
transformed such that proteins with data in the top left and top right quadrants are enriched in 
Resting and Stimulated conditions respectively. Dashed vertical lines represent fold change cut-offs 
for significance of 1.3-fold in either direction. The dashed horizontal line represents p-value cut-off 










SRSF protein kinase 2 SRPK2 4.528 0.0072 
Diacylglycerol kinase zeta DGKZ 3.458 0.0024 
Kinase suppressor of Ras 1 KSR1 2.058 0.0232 
Mitogen-activated protein kinase kinase kinase 
kinase 5 
MAP4K5 1.662 0.0053 
LIM domain kinase 2 LIMK2 1.633 0.0379 
Serine/threonine-protein kinase RIO2 RIOK2 1.552 0.0040 
Serine/threonine-protein kinase OSR1 OXSR1 1.497 0.0006 
Cyclin-dependent kinase 17 CDK17 1.486 0.0009 
Cyclin-dependent kinase 15 CDK15 1.454 0.0433 
5'-AMP-activated protein kinase catalytic 
subunit alpha-1 
PRKAA1 1.410 0.0182 
Dual specificity protein kinase TTK TTK 1.376 0.0143 
Serine/threonine-protein kinase ICK ICK 1.341 0.0356 
Serine/threonine-protein kinase 4 STK4 1.313 0.0153 
Mitogen-activated protein kinase kinase kinase 
kinase 3 
MAP4K3 1.308 0.0299 
Protein kinase C iota type PRKCI 1.298 0.0136 
Serine/threonine-protein kinase LATS1 LATS1 0.764 0.0455 
Cyclin-dependent kinase 3 CDK3 0.745 0.0067 
Glycogen synthase kinase-3 beta GSK3B 0.628 0.0314 
Tyrosine-protein kinase JAK1 JAK1 0.608 0.0174 
Tyrosine-protein kinase Blk BLK 0.562 0.0126 
Serine/threonine-protein kinase PRP4 
homolog 
PRPF4B 0.479 0.0051 
Casein kinase II subunit alpha CSNK2A1 0.426 0.0018 
Serine/threonine-protein kinase TAO2 TAOK2 0.407 0.0221 
Cyclin-dependent kinase 18 CDK18 0.386 0.0040 
Serine/threonine-protein kinase Nek1 NEK1 0.347 0.0012 
Serine/threonine-protein kinase B-raf BRAF 0.317 0.0070 
FAST kinase domain-containing protein 2_ 
mitochondrial 
FASTKD2 0.201 0.0045 
Table 4.2  List of protein kinases differentially expressed between Stimulated and Resting conditions, 
permissive hypothesis testing. Tests was conducted on technical replicates without averaging. The 
Benjamini Hochberg correction for multiple testing was used to calculate q-values. Proteins enriched in 






4.3. Endogenous GSK3β interacts with the Endophilin A2 SH3 
domain under conditions of serum starvation 
 
The serine/threonine kinases GSK3α and β are ubiquitously expressed paralogs distinguished 
by their wide variety of intracellular targets (Lau et al., 1999; Patel and Woodgett, 2017). In a 
kinase inhibitor screen performed in our lab, GSK3α/β were shown to negatively regulate FEME 
activity in RPE1 cells (Figure 4.1). Negative regulation of FEME activity through GSK3 can 
proceed via several routes: 1) phosphorylation of endophilin resulting in blockage of partner 
binding sites/ adoption of an autoinhibited fold 2) phosphorylation of an endophilin inhibitor which 
potentiates inhibitor binding to endophilin 3) phosphorylation of endophilin partners which 
abrogate binding and 4) phosphorylation of proteins which promote sequestration of endophilin 
binding partners. Casting light on such mechanistic details could help understand the control of 
FEME competency in cells and may provide a tool for selective inhibition of the pathway for future 
study. 
 
AP-MS data presented in Section 4.2 hinted that GSK3β was more strongly associated with 
endogenous Endophilin in cells undergoing lower growth factor stimulation. GSK3 
phosphorylates serine (S) or threonine (T) residues 4 amino acids N-terminally to a pre-
phosphorylated S or T residue (Cohen and Frame, 2001). It therefore requires targets proteins 
to be initially modified by a different kinase before it propagates this signal to nearby S/T sites. 
GSK3 activity can be regulated by phosphorylation of S9 at the protein’s N-terminus. 
Phosphorylated S9 (pS9) can occupy the docking site which recognises pre-phosphorylated 
residues on target proteins, inhibiting kinase activity (Cross et al., 1995; Frame, Cohen and 
Biondi, 2001). Phosphorylation of S9 is downstream of several growth factor signalling cascades 
(Cross et al., 1995; Patel and Woodgett, 2017), and GSK3 activity is therefore enhanced under 
conditions of low growth factor stimulation. The results of the kinase screening together with the 
detection of GSK3β in endophilin IPs from resting but not stimulated cell extracts led us to wonder 




To determine if Endophilin and GSK3β could interact in the cell, and if this interaction was subject 
to growth factor signalling, we performed GST pulldowns, using the Endophilin A2 SH3 domain 
as a bait, on RPE1 cell extracts from 3 conditions: Serum-free, resting and stimulated. For 
preparation of extracts for the serum-free condition, RPE1 cells growing in complete media were 
exchanged into serum-free media for a minimum of 2 hours at 37°C prior to harvest. For the 
stimulated condition, RPE1 cell media was supplemented with Foetal Bovine Serum (FBS) to a 
final concentration of 20% v/v for 5 minutes at 37°C prior to harvesting cells. For the Resting 
condition, cell extracts were harvested without pre-treatment (growing in media supplemented 
with 10% v/v FBS). 
 
GST and GST-EndophilinA2 SH3 (GST-EndoSH3) magnetic agarose beads were exposed to 
500 µl clarified RPE1 cell lysate overnight at 4°C with agitation. Cell culture, treatment and 
pulldown assays were performed by A. Casamento. Following overnight incubation beads were 
washed and the captured proteins were eluted by boiling in SDS sample buffer. Western blotting 
was performed to assess the amount of GSK3α/β in the bound fraction of each sample. The anti-
GSK3 antibody chosen recognises an epitope present in both GSK3α and GSK3β, enabling 
quantification of both proteins on the same blot (Figure 4.6a). 
 
Western blot signal was analysed by densitometry. Neither GSK3 protein copurified strongly with 
the GST-only beads, indicating low non-specific interaction between GSK3 proteins and the GST 
tag. To assess if GSK3α/β binding to Endophilin A2 SH3 was altered by the cell treatments, 
GSK3β signal in each bound fraction was expressed as a percentage of input signal, and this % 
recovery was normalised to the % recovery of GSK3α/β in GST-only Resting pulldowns. 
Statistical analysis was performed using two-way ANOVA. Differences in mean normalised 
recovery arising from GST constructs were found to be significant whilst differences in means 
arising from treatment conditions were non-significant. Pairwise comparisons using Tukey’s 
multiple comparison test found a significant difference between GSK3β levels in GST versus 
GST-EndoSH3 eluates from cells grown in serum-free media prior to harvest, but not between 
GSK3β levels in GST vs GST-EndoSH3 eluates in the other 2 conditions (Figure 4.6b, top). 
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Interestingly, pairwise comparisons using Tukey’s multiple comparison test did not show a 
significant difference in GSK3α levels between GST and GST-EndoSH3 eluates in any condition 
(Figure 4.6b, bottom). This data suggests that GSK3β rather than GSK3α engages endophilin 






   
a b 
Figure 4.6  The association of endogenous GSK3β with Endophilin A2 SH3 domain in GST pull-down 
assays is altered by serum levels in cell media. a, Representative western blots to show GSK3α/β 
levels in different fractions of GST pulldown experiments conducted on RPE1 cell extracts. Cells were 
grown in serum-free (SF), FBS stimulated (+FBS) or normal (Resting) media prior to harvesting lysates. 
A GST-Endophilin A2 SH3 contruct (GST-EndoSH3) was used as bait and GST beads were included as 
a negative control. Black arrowheads indicate GSK3α signal, Red arrowheads indicate GSK3β signal. 
b, Bar charts to show densitometric quantitation of GSK3β (top) and GSK3α (bottom) signal in 
western blots (means ± s.e.m. from three independent experiments). Statistical analysis was 
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4.4. Profiling of the endophilin interactome following kinase 
inhibition by affinity purification-MS 
 
4.4.1. Experiment aim and strategy 
 
Endophilin is involved at many stages of the novel endocytic pathway, FEME. During FEME 
carrier formation, endophilin plays a role in cargo selection and membrane curvature 
stabilisation.  Endophilin recruits the GTPase dynamin to effect carrier scission and coats the 
carrier as it is trafficked into the cell interior, possibly serving as a link to the cell’s motor protein 
machinery. 
 
Work in our lab established a link between inhibition of the kinases CDK5 and GSK3β and 
upregulation of FEME (Ferreira et al., submitted). CDK5 and GSK3β negatively may regulate 
FEME by modifying the binding partners of proteins involved in FEME, including endophilin. 
Negative regulation of FEME activity through a kinase targeting endophilin can proceed via 4 
routes: 1) phosphorylation of endophilin resulting in blockage of partner binding sites/ adoption 
of an autoinhibited fold 2) phosphorylation of an endophilin inhibitor which potentiates binding to 
endophilin 3) phosphorylation of endophilin partners which abrogate binding and 4) 
phosphorylation of proteins which promote sequestration of endophilin binding partners. In all 
scenarios, we hypothesised that acute inhibition of CDK5 and GSK3β activity would result in 
increased numbers of endophilin molecules in complex with proteins that act in the FEME 
pathway. Affinity purification mass spectrometry (AP-MS) can be used to identify and quantify 
proteins in these complexes, identifying potential FEME proteins. We designed a quantitative 
AP-MS experiment to identify proteins which are found in complex with endophilin upon inhibition 
of CDK5 and GSK3β. 
 
Ideally, quantitative measurements of proteins in endophilin complexes would be compared 
following immunoprecipitation (IP) of complexes obtained from with and without kinase inhibitor 
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treatment. Due to time constraints, we were only able to perform experiments on cells treated 
with kinase inhibitor (Figure 4.7). This represents the widest possible net of FEME-relevant 
endophilin interactors but forgoes the opportunity to screen out cytosolic endophilin partners 
which participate in non-FEME related functions. Relatedly, IP of endogenous endophilin is 
predicated on availability of beads coated in α-endophilin antibodies, which were not available 
for this experiment. As a compromise, we opted to perform IPs of GFP-tagged endophilin A2 
(EndoGFP) expressed transiently in human RPE1 cells. To identify cytosolic proteins which non-
specifically bind to the eGFP tag, we also performed IPs from cells overexpressing the eGFP tag 
alone (hereafter GFP). An on-bead digest coupled to strong cation exchange (‘On-bead-SCX’) 
protocol was performed to facilitate faster sample preparation and MS analysis and to reduce 
NP-40 detergent contamination of peptide eluates following trypsin digestion. 
  




4.4.2. IP-MS of EndoGFP complexes and sample preparation for MS 
 
Four dishes of RPE1 cells were seeded for each sample to generate enough material for MS 
sample preparation. Each 100 mm dish of RPE1 cells was transfected with 3 µg of plasmid 
encoding eGFP-only or eGFP-EndophilinA2 and grown for 24 hours. Cells were treated with the 
CDK1/2/5/9 inhibitor Dinaciclib and the GSK3α/β inhibitor CHIR-9902 at a working concentration 
of 1 µM for 10 min at 37°C in an incubator prior to cell lysis. Following treatment, cells were 
washed in cold PBS and harvested by gently scraping into lysis buffer. Samples were incubated 
on ice to facilitate complete cell lysis then centrifuged to remove the nuclear fraction and insoluble 
material. The resulting supernatant was mixed with 20 µl of GFP-Trap® magnetic agarose slurry 
and incubated for 3 hours at 4°C with end-over-end mixing to promote capture of eGFP-tagged 
proteins in complex with cytosolic binding partners. Using a magnetic rack, beads were washed 
3 times in 500 µl Lysis buffer prior to On-bead-SCX digestion.  
 
Following immunoprecipitation, GFP-Trap® beads were washed ice-cold Tris-buffered saline 
(TBS) solution and resuspended in Tris-Urea buffer containing 400 ng of trypsin and incubated 
at 27°C for 30 min. Reduction in DTT and trypsinisation were performed simultaneously in an 
overnight step, following by alkylation of peptides. 
 
Previous MS-analysis of on-bead digests from cell lysates using an NP-40 lysis buffer displayed 
evidence of contamination by a PEGylated substance despite C18 SPE cleanup, suggesting that 
NP-40 is not removed effectively using this method. Samples were therefore desalted using C18-
SCX StageTips in an effort to reduce the amount of non-ionic NP-40 detergent in the final sample 
for injection onto the LC column. Peptides were eluted from the SCX bed using 1000mM 
ammonium acetate solution, dried in a SpeedVac and resuspended in LC-MS running buffer for 
analysis. Peptides were separated using a 60-minute gradient and ionised by nanoESI. Data 
acquisition was performed using ion-mobility assisted tandem MS/MS (HDMSE) on a Waters 




4.4.3. LC-MS analysis, database searching, quality control and normalisation 
 
Immunoprecipitated complexes from 2 RPE1 overexpression constructs (GFP and EndoGFP) 
were analysed in 3 biological and technical triplicate. HDMSE data was processed using 
Progenesis software (Waters Corp.) which performed retention time alignment and peak picking, 
followed by noise subtraction and deisotoping. Peptide precursor and fragment ions were 
matched on the basis of retention and ion mobility drift times, and used for database searching 
against a canonical Homo sapiens Uniprot FASTA database concatenated the sequences of 
eGFP,  E. coli ClpB (Hi3 standard) and a list of common MS protein contaminants obtained from 
the Global Proteome Machine (The Global Proteome Machine, 2016). 
 
The average intensity of the 3 best ionising peptides for each identified protein (Top3 intensity) 
in a given sample was summed to obtain an estimate of peptide loading for each technical 
replicate. Within-sample technical reproducibility was shown to be high (with the exception of the 
biological replicate A runs from both conditions), but inter-sample summed Top3 intensity was 
found to be highly heterogeneous (Figure 4.8a). An assessment of instrument performance was 
carried out to explain these discrepancies. Instrument mass calibration was assessed by plotting 
the distribution of peptide mass errors (all samples) (Figure 4.8b). The density plot shows a slight 
right-shift with a median ppm error of +2.2, indicating suboptimal calibration. However, the 
majority of peptide ions were identified with good mass accuracy (83.1% of ion ±10 ppm). 
Variation in LC performance was also assessed. Visual inspection of TIC and BPI 
chromatograms did not reveal major failures in LC performance. A more systematic assessment 
was performed by plotting the distribution of LC peak widths (FWHM) for all peptides in the 
experiment (Figure 4.8c). Whilst a large proportion of peptides eluted in the 0 - 20 second range 
(40.1%), most peptides displayed longer peak widths (59.9% elute in 20+ seconds), indicating a 
possible issue with LC system performance. 
 
Technical errors incurred during sample preparation could also account for the large differences 
in Top3 intensity observed. An assessment of on-bead digest efficacy was conducted by plotting 
the proportion of peptide IDs which feature a missed cleavage site grouped by condition (Figure 
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4.8d). GFP samples displayed a mean of 39% ± 4% missed cleavages (mean ± SD) and 
EndoGFP samples displayed a mean of 42% ± 7% missed cleavages (mean ± SD), indicating 
similar digestion efficacy across all samples. These values compare unfavourably with the digest 
efficacies achieved for similar on-bead digestion protocols presented in Section 3.2.3 of this 
report (average 14% missed cleavages), indicating an incomplete digest. 
 
Further issues with sample preparation were identified when comparing construct expression 
across biological replicates. As shown in Figure 4.9, expression of GFP-tagged proteins was 
heterogeneous for all samples. It was therefore concluded that major issues with sample 
preparation and suboptimal instrument performance could not be ruled out as a cause for the 
high variability observed in summed Top3 intensity across samples. 
 
Normalisation can ameliorate technical errors encountered during sample preparation and 
instrument operation. Two normalisation methods were compared for their ability to reduce intra-
sample variability in Top3 intensities. Normalisation to Global intensity (GI) was performed by 
dividing the Top3 intensity for a given protein in a given technical replicate by the sum of Top3 
intensity of all proteins in that technical replicate, then multiplying this by the median of summed 
Top3 intensity among all replicates. Data was then log2 transformed. Normalisation to Median 
intensity was performed by dividing the Top3 intensity for a given protein in given technical 
replicate by the median of Top3 intensity for all proteins in that technical replicate, then 
multiplying this by the median of summed Top3 intensity among all replicates. Data was then 
log2 transformed. Normalisation of data was implemented using the NormalyzerDE platform 
(Willforss, Chawade and Levander, 2019). 
 
Normalisation efficacy at the intra-sample level was assessed by plotting the distribution of 
pooled CV (average CV for all proteins across intra-sample replicates) and mean Pearson 
correlation among all intra-sample replicates (Figure 4.10). In comparison to simple Log2 
transformation of the data, both GI and Median normalisation reduced the median and tightened 
the spread of pooled CV values. Median normalisation was the most effective, reducing median 
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pooled CV from 3.9% to 3.2% and reducing the interquartile range in CV values from 4.4 to 2.7 
in comparison to Log2 transformed samples (Figure 4.10a). By contrast, none of the 
normalisation methods had a marked impact on the distribution of mean Pearson correlations 
(Figure 4.10b). 
 
Normalisation was also assessed at the level of individual technical replicates by plotting the 
distribution of relative log expression (RLE) values for all proteins in each technical replicate 
(Figure 4.11). RLE is defined as the ratio between Top3 intensity of a given protein in a given run 
and the median Top3 intensity of that protein across all runs. Well-normalised samples exhibit a 
distribution of RLE values centred around 0. Without normalisation, RLE distributions are not well 
centred at 0, especially for biological replicate A samples (Figure 4.11, top). Samples normalised 
to Global Intensity display distributions of RLE which are well centred about 0 with the exception 
of EndoGFP biological replicate B samples, which show a skew toward negative RLE values 
(Figure 4.11, middle). Median normalisation performed best, with all samples exhibiting RLE 
distributions centred around 0 (Figure 4.11, bottom). Based on these tests, Median normalisation 
was applied to the data and protein intensities were averaged across technical replicates prior to 










Figure 4.8  Outlier detection and evaluation of LC-MS instrument performance. a, Bar chart to show 
summed intensity of the 3 most intense peptides (Top3 intensity) for all protein groups in each 
technical replicate, without normalisation. Replicates identifiers first indicate biological replicate A-
C, then technical replicate X, Y or Z. The final letter indicates experimental condition (G – GFP, E – 
EndoGFP).  b, Density plot to show Peptide mass accuracy distribution. The distribution for all 
samples is shown. c, Histogram to show LC peak width FWHM distribution for all peptides in all 
samples. d, Bar chart to show % of all peptides featuring missed cleavages grouped by condition. 












Figure 4.9  GFP construct capture during immunoprecipitation and quantitation by LC-MS was 
heterogeneous. Western blotting against eGFP was performed on equal volumes of the bound 







Figure 4.10  Global evaluation of normalisation techniques. a, Box and whisker plot to show the 
distribution of Pooled CV across all samples upon Log2, transformation and GI or Median 
normalisation. Whiskers represent 5th and 95th percentiles. b, Box and whisker plot to show 
distribution of mean Pearson correlation within samples for Log2, GI and Median normalisation. 






Figure 4.11  Relative log expression (RLE) plots to evaluate normalisation. a, Box and whisker plot to 
show the distribution of Pooled CV across all samples upon Log2 transformation (top), GI (middle) or 
Median (bottom) normalisation. Whiskers represent 5th and 95th percentiles. 
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4.4.4. Differential expression analysis 
 
Normalised protein intensities were averaged across technical replicates. To assess if proteins 
were differentially expressed in either condition two-sided, unpaired Student’s t-tests were 
performed to compare Top3 protein intensity of biological replicates. The calculated p-values 
were corrected for multiple testing using a permutation-based estimation of dataset FDR to obtain 
q-values. No proteins displayed a q-value below the significance threshold of 0.05 and thus no 
proteins were identified as differentially expressed with high confidence. 
 
This appears to be primarily a result of high variability between EndoGFP samples despite 
normalisation. Illustrating this, a principle component analysis performed on the normalised data 
indicates that, whilst technical replicates from the same sample cluster well together, EndoGFP 
samples are poorly clustered (Figure 4.12a). Indeed, EndoGFP biological replicate 3 appears to 
cluster with the GFP samples at the bottom left of the plot. Similarly, boxplots illustrating the 
distribution of inter-sample within-condition protein CV show two-fold higher variability in 
EndoGFP samples (median CV of 10.4% in EndoGFP samples versus 5.2% in GFP samples) 
(Figure 4.12b). 
 
In an attempt to extract tentative future directions of enquiry from the data, the results of t-tests 
were plotted without correction for multiple testing, and the results were interpreted with the 
caveat of accepting a higher rate of type I errors (Figure 4.13).  Proteins were denoted as 
differentially expressed upon fulfilment of two criteria: p-value < 0.05 and a fold change (ratio of 
average protein intensity) greater than 1.3-fold in either direction. Quantitative measurements of 
proteins using MSE have been shown to display an error in signal intensity of 10-15% (Silva et 
al., 2006; Patel et al., 2009). Thus, a fold change cut-off of 1.3 represents a value 2-3 times larger 
than that expected given normal technical variation. Differentially expressed proteins are listed 




Endophilin-A2-eGFP was overexpressed in RPE1 and then enriched through IP. As expected, 
the protein is highly enriched in the EndoGFP condition. Cadherin-13 was also enriched in 
EndoGFP immunoprecipitates and is an interesting candidate for future analysis due to the 
observation of high FEME activity at cell-cell junctions in confluent cells (E. Boucrot, unpublished 
results).  
 
We assessed the behaviour of candidates endophilin partners identified in previous analyses. 
Melanoma inhibitory activity protein 2, also known as CTAGE5 is a cargo sorting receptor 
involved in ER-golgi transport (Saito et al., 2011; Santos et al., 2016; Tanabe et al., 2016). It is 
also homologous to the CTAGE6 protein identified as a potential endophilin partner as reported 
in Section 4.2, sharing a long proline-rich domain at their c-terminus which could serve as a 
binding site for the endophilin SH3 domain. The candidate endophilin partner WWP1 was also 
identified in this analysis but was not differentially expressed. 
 
Of the known endophilin partners identified, Dynamin-1, Synaptojanin 1, Synaptojanin 2 and 
vascular endothelial growth factor receptor 2 (VEGFR2) were not differentially expressed, but 
vascular endothelial growth factor receptor 1 (VEGFR1) was unexpectedly enriched in the GFP 
bound fractions. Interestingly, clathrin light chain (CLC) but not clathrin heavy chain (CHC) 







Figure 4.12  EndoGFP samples display high variability post-normalisation. a, PCA plot to represent 
sample relatedness in 2 dimensions. Plots colours indicate biological sample of origin as indicated. b, 
Boxplots to show distribution of inter-sample within-condition protein CV. Protein Top3 intensity was 






























Figure 4.13  Volcano plot to illustrate differentially expressed proteins between GFP and EndoGFP 
immunoprecipitates. Fold change (FC) was calculated by finding the ratio of average Top3 protein 
intensity in each condition. Plot colours are representative of Top3 protein intensity for the highest 
expressed protein in each comparison. Vertical dashed lines represent fold change cut-offs for 
significance (± 0.369). Horizontal dashed line represents -Log10(p-value) cutoff for significance as 
calculated using a 2-sided, unpaired t-test (α < 0.05). Proteins with data plotted in the upper left and 











Pre-mRNA-splicing factor SPF27  BCAS2 2.019 0.038 
Endoplasmic reticulum export factor 
CTAGE5  CTAGE5 1.903 0.015 
Clathrin light chain A  CLTA 1.812 0.042 
Superkiller viralicidic activity 2-like 2  SKIV2L2 1.713 0.026 
Nucleolar complex protein 3 homolog  NOC3L 1.567 0.024 
Endophilin-A2  SH3GL1 1.520 0.010 
RNA-binding protein 33  RBM33 1.485 0.043 
60 kDa heat shock protein_ 
mitochondrial  HSPD1 1.403 0.011 
Pre-rRNA-processing protein TSR1 
homolog  TSR1 1.379 0.033 
Cadherin-13  CDH13 1.330 0.009 
Eukaryotic translation initiation factor 
4B  EIF4B 0.763 0.046 
Threonylcarbamoyladenine tRNA 
methylthiotransferase  CDKAL1 0.722 0.009 
60S acidic ribomal protein P2  RPLP2 0.715 0.005 
Sarcoplasmic/endoplasmic reticulum 
calcium ATPase 2  ATP2A2 0.668 0.034 
Table 4.3  List of proteins differentially expressed between GFP and EndoGFP conditions. Proteins 






Work presented in this chapter addressed the issue of FEME regulation. Two pieces of evidence 
suggested that FEME competence and rate are regulated. Firstly, FEME rate as measured by 
the number of EPAs budding from the leading edge of growing cells varies between cell types. 
Secondly, the proportion of growing cells in culture which display any FEME at all is never 100%. 
Work in our lab established that increasing the concentration of serum in cell media increased 
FEME rate, whilst removal of serum reduced FEME. We speculated that growth factor signalling 
plays a role in regulating FEME beyond supplying ligands for activation of cargo receptors.  
 
Growth factor signalling could regulate FEME at any of the stages of an endocytic event. The 
current model of an FEME endocytic event proceeds via the following sequence: 1) GTP-loaded 
Cdc42 at the leading edge of a cell recruits lamellipodin and endophilin via the F-BAR proteins 
CIP4 and FBP17 to form endophilin clusters at the leading edge ready to internalise activated 
cargo receptors, 2) activated receptors are sorted into nascent FEME vesicles by endophilin or 
endophilin-binding adaptor proteins, 3) oligomerisation of endophilin bends the membrane to 
form a tubulovesicular invagination, 4) Endophilin recruits the GTPase dynamin to constrict the 
vesicle neck and separate the vesicle from the plasma membrane (scission), 5) Endophilin-
coated FEME carriers are transported into the cell interior through the action of Dynein. As 
illustrated, endophilin is involved in all stages of FEME after its initial recruitment by lamellipodin 
and is therefore a strong candidate for regulation downstream of growth factor signalling. 
 
AP-MS experiments were performed to assess the interactome of endophilin following changes 
in growth factor levels and thus FEME rate in RPE1 cells. This analysis identified 27 kinases with 
potential involvement in FEME. Experiments conducted in our lab identified GSK3α/β as negative 
regulators of FEME. Interestingly, GSK3β was enriched in endophilin immunoprecipitates from 
Resting rather than Stimulated cells, raising the possibility that GSK3β binds to endophilin when 
growth factor signalling is low. Pulldowns performed to assess this showed that GSK3β from 
serum starved extracts but not from Resting or Stimulated cell extracts binds to the endophilin 
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A2 SH3 domain. Interestingly, GSK3α did not bind to the endophilin A2 SH3 domain under any 
of the conditions tested. 
 
The recruitment of GSK3β but not GSK3α by endophilin SH3 may be explained by the absence 
of a suitable target PRM in GSK3α. A review of the primary sequence of both proteins reveals a 
single probable EndoSH3 target PRM (amino acids 307-311) in GSK3β which is not present in 
GSK3α.  
 
The detection of GSK3β in complex with endogenous endophilin in Resting cells by AP-MS 
conflicts with the failure to detect EndoA2SH3-GSK3β binding by pulldown from Resting cells 
extracts. It is possible that GSK3β makes additional contacts with endophilin outside of the SH3 
domain, the absence of which lowered binding affinity in the pulldown experiment. Furthermore, 
the higher sensitivity and dynamic range of LC-MS analysis may have contributed to identification 
of GSK3β binding in resting cells. Whatever the true nature of this interaction, both experiments 
agree that EndophilinA2-GSK3β binding is not favoured upon growth factor stimulation. 
 
Growth factor signalling has known effects on GSK3β activity. When phosphorylated, serine 9 of 
GSK3β can occupy the protein’s own substrate docking site and compete with true substrates, 
inhibiting kinase activity (Cross et al., 1995; Frame, Cohen and Biondi, 2001). Several protein 
kinases downstream of growth factor signalling pathways can phosphorylate GSK3β at S9 
including Protein Kinase B (as known as Akt) downstream of Insulin growth factor 1 (IGF-1) 
signalling and p90 S6 kinase (S6K) downstream of Epidermal growth factor (EGF) signalling 
(Cross et al., 1995; Eldar-Finkelman et al., 1995). It is possible that the loss of Endophilin-GSK3β 
binding upon growth factor stimulation is related to this modification. This would be true if GSK3β 
targets phosphoserine/ phosphothreonine sites on the endophilin SH3 domain for docking. Whilst 
there are several serine/threonine residues in the SH3 domain, they do not match the canonical 
GSK3 consensus (S/T-X-X-X-S/T). To shed light on this, an assessment of S9 phosphorylation 
upon serum modulation could be easily performed by western blotting, as an anti-pS9-GSK3β 




Endophilin A2 may be a direct target for GSK3β outside the SH3 domain, possessing at least 4 
GSK3 consensus sequences at other sites in the protein.  An attempt was made to detect and 
quantify changes in phosphopeptides in both AP-MS experiments reported here, but the 
phosphopeptides detected were of poor confidence. This was expected as a relatively small 
amount of protein was analysed and no effort to enrich the sample for phosphopeptides was 
made. There is no guarantee that a majority of the endophilin captured by IP would be modified 
by GSK3β. Indeed, many cells do not exhibit FEME in cell extracts from which IPs were 
conducted (no FEME is observed in ~50% of cells in Resting and ~30% of cells in +10% FBS 
conditions). The proportion of captured endophilin monomers which bear phosphorylations 
relevant to FEME is therefore expected to be small despite enrichment by IP. Further technical 
concerns related to MS analysis of phosphopeptides include ion suppression of phosphorylated 
peptides when analysis is conducted in positive mode and the tendency of collision-induced 
dissociation to remove phosphoric acid during fragmentation. To assess changes in the 
phosphorylation of endophilin upon serum withdrawal or stimulation, a TiO2 phosphopeptide 
enrichment step could be added to the workflow following tryptic digest. This step is widely used 
to exclude non-phoshorylated peptides from a sample and thus improve workflow sensitivity for 
phosphopeptides (Thingholm et al., 2006). The use of larger amounts of starting material (>1mg) 
is essential to ensure that adequate amounts of phosphopeptide will be present following 
enrichment for detection by MS, given their low expected prevalence in the sample. 
  
Even if endophilin itself is not modified by GSK3β, its recruitment to the plasma membrane by 
endophilin would assist FEME regulation. Given GSK3’s large variety of potential targets, any 
pathway in which it is involved must address the issue of specificity. An Endophilin-GSK3β 
interaction would solve this by helping to localise GSK3β to the leading edge and would allow for 
modification of other FEME proteins and cargoes to inhibit the pathway. For example, Dynamin-
1 is a known target of GSK3β at position S774 following CDK5 phosphorylation of S778 (Tan et 
al., 2003). The impact of GS3Kβ inhibition on Dynamin-1 recruitment by endophilin could be 




The discovery that GSK3 and CDK5 act as negative inhibitors of FEME prompted investigation 
of their specific impact on the endophilin interactome. This was assessed by IP of a transiently 
expressed eGFP-EndophilinA2 construct from RPE1 lysates following treatment with GSK3 and 
CDK5 inhibitors. An interesting candidate from this study is CTAGE5, which interacts with and 
shares a high degree of sequence similarity with CTAGE6 (identified in endogenous IPs from 
Stimulated cell extracts) (Huttlin et al., 2017). These proteins are known to play roles in aiding 
the assembly of large cargoes such as collagen VII and very low density lipoproteins (VLDLs) 
into carriers for onward trafficking from the ER (Saito et al., 2011; Santos et al., 2016). It is 
therefore unclear what role they would play in FEME. Both proteins feature long C-terminal PRMs 
containing several suitable EndoSH3 target sites. A first step in investigating their role in FEME 
would be to assess if an EndoSH3-CTAGE5/6 interaction is detectable by GST-pulldown. If 
successful, more detailed profiling of protein localisation relative EPAs could be performed by 
microscopy (commercial antibodies against both proteins are available). 
 
Neither AP-MS experiment identified any high confidence regulators of FEME. Whilst technical 
issues were minimal for the AP-MS study of endogenous endophilin, the experiment was critically 
underpowered as only 2 biological repeats were performed, and serum starvation was not 
included as a third condition. This was largely due to time constraints in MS instrument 
availability. In hindsight it was overenthusiastic to divide samples from IP (i.e. reduced 
complexity) into 10 bands during in-gel digestion and to analyse these samples by 60 min 
gradients. It is likely that similar digestion efficacy and instrument performance could have been 
achieved from excision in single gel bands following a short PAGE separation, with a 
compensatory longer gradient. This would have enabled analysis of a larger number of biological 
samples to achieve increased power and more confidence in candidates.  
 
The technical issues facing AP-MS of EndoGFP complexes were extensive, including poor 
digestion and chromatography. The On-bead-SCX workflow employed could potentially be 
improved by incubating digests at 37°C overnight instead of at room temperature. The largest 
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contributor to poor sample-to-sample reproducibility is likely to have been the lack of a 
normalisation step following transient overexpression of GFP constructs before IP. Normalisation 
could have been performed by western blotting, making roughly equivalent amounts of GFP 
constructs available for capture in all samples. Ultimately, the reliance on transient 
overexpression was a suboptimal strategy that was adopted due to the unavailability of anti-
endophilin A2-coated magnetic beads. A future repeat of this experiment would be best 
attempted by targeting endogenous endophilin and should also feature IP of endophilin from 
resting and serum-starved extracts. 
 
The description of CDK5 and GSK3β as negative regulators of FEME has a number of general 
implications for the control of FEME competence and rate in individual cells. Furthermore, it is 
not clear if CDK5 is the only priming kinase for GSK3β with regards to control of FEME. Control 
of FEME by kinases could also target the N-BAR protein Bridging Integrator 1 (BIN1), which was 
found to colocalise strongly with endophilin on FEME carriers (Chan Wah Hak et al., 2018). 
Future AP-MS experiments focussing on the BIN1 interactome and phosphorylation state hold 




5. Quantitative LC-MS profiling of spinal cord 





Neurodegenerative diseases feature the progressive dysfunction and eventual death of neuronal 
cells resulting in significant suffering. Worldwide, these diseases represent a major cause of 
premature death. Many neurodegenerative disorders such as Huntington’s disease, Alzheimer’s 
disease and Parkinson’s disease feature deposits of aggregated protein called inclusions in 
affected neurons (Soto, 2003). While the toxicity of these inclusions is debated, the dysfunction 
of protein folding pathways is known to play a role in disease progression. 
 
Mutations in the locus encoding DnaJ Heat Shock Protein Family Member B2 (DNAJB2), also 
known as Heat Shock Protein, Neuronal DNAJ-like 1 (hereafter HSJ1) have been causatively 
linked to distal hereditary motor neuropathy (dHMN) and Charcot-Marie-Tooth syndrome type 2 
(CMT2) in humans (Gess et al., 2014; Tazir et al., 2014). Both conditions feature the progressive 
dysfunction of motor neurons, with concomitant loss of sensory neurons in CMT2 only. HSJ1 is 
a member of the Hsp40 family of molecular co-chaperones. These proteins regulate the activity 
and specificity of the chaperone Hsp70 by binding to hydrophobic regions of misfolded proteins 
and recruiting them to Hsp70. All members of the family feature a highly conserved J-domain, a 
~70-amino acid region which is required for stimulation of Hsp70 ATPase activity. Two HSJ1 
isoforms are preferentially expressed in neurons (Cheetham, Brion and Anderton, 1992). The 
smaller HSJ1a (36kDa) lacks a C-terminal extension found in HSJ1b (42 kDa) which features a 
prenylation motif. Isoprenylation of this motif facilitates targeting of HSJ1b to the cytosolic face 





HSJ1 is unique among co-chaperones in that it possesses multiple ubiquitin-interacting motifs in 
addition to its client protein binding domain (Chapple et al., 2004; Westhoff et al., 2005), and thus 
participates in the ubiquitination and proteasomal targeting of a number of its client proteins 
(Westhoff et al., 2005). Previous work has shown that HSJ1 activity promotes disaggregation of 
Huntingtin (Htt) aggregates (Westhoff et al., 2005; Borrell-Pagès et al., 2006; Howarth et al., 
2007; Labbadia et al., 2012) and can reduce aggregation of mutant Superoxide dismutase 1 
(SOD1) in cell and mouse models of Huntington’s Disease and Amyotrophic lateral Sclerosis 
respectively (Novoselov et al., 2013). 
 
This work aims to gain an understanding of the mechanisms through which functional HSJ1 
protects motor neurons. Specifically, we aim to define potential client proteins of HSJ1 which 
contribute to cell maintenance and describe which cellular pathways are dysregulated in the 
absence of HSJ1. 
 
5.1.1. Experimental model and design 
 
The Cheetham lab generated a HSJ1-/- knockout (KO) mouse for use in the elucidation of HSJ1’s 
functional roles in motor neuropathies. The mice did not exhibit any congenital disabilities, lived 
average lifespans and did not manifest any behavioural signs of motor neuropathy sooner than 
control mice. Comparison of motor neuron number in lumbar spinal cords of HSJ1 wild-type (WT) 
and KO mice revealed a consistent 11.6% decrease in motor neuron counts by postnatal day 20 
(P20), starting after P15 (Heather Smith, unpublished work). At P120, HSJ1 KO mice showed a 
~28% reduction in lumbar spinal cord motor neuron counts compared to WT mice. Further 
analysis revealed that heightened levels of phosphorylated PRKR-like endoplasmic reticulum 
kinase (Perk) and phosphorylated Eukaryotic translation initiation factor subunit α (eIF2α) were 
detectable by P10 in the spinal cord of HSJ1 KO animals, indicating activation of the unfolded 
protein response (UPR) (Figure 5.1a). Other indicators of a defect in protein folding included 
heightened levels of ubiquitinated proteins and autophagy marker proteins such as LC3-II in 
lumbar spinal cord extracts from HSJ1 KO mice relative to HSJ1 WT mice. (Cheetham Lab, 




Two mechanisms by which loss of HSJ1 function can lead to motor neuron death are proposed: 
Loss of HSJ1 may lead to death of motor neurons through a failure in the biogenesis or quality 
control of a specific client protein or, loss of HSJ1 might lead to a failed motor neuron stress 
response and thus result in aberrant expression of essential proteins. These mechanisms are 
not mutually exclusive. To address these hypotheses, label-free quantitative mass spectrometry 
was performed on lumbar spinal cord extracts from HSJ1 WT and HSJ1 KO mice (Figure 5.1b). 
We hypothesised that HSJ1 client proteins would misfold in the KO condition and either 
aggregate or be degraded and therefore lost from the soluble fraction upon protein extraction. 
These phenomena would be detectable as a protein enrichment in the WT sample. HSJ1 has 
been shown to play a role in targeting misfolded plasma membrane components to the 
proteasome (Chapple and Cheetham, 2003; Westhoff et al., 2005; Borrell-Pagès et al., 2006) 
Thus, loss of HSJ1 could also result in an accumulation of misfolded transmembrane proteins in 







Figure 5.1  Lumbar spinal cord phenotype of the HSJ1 knockout mouse and experimental design. a, 
Timeline to illustrate postnatal events occurring in HSJ1 KO lumbar spinal cord relative to wild-type 
animals. At postnatal day 10 (P10) markers of the unfolded protein response (UPR) are detectable. 
At P15, increased levels of ubiquitinated proteins and autophagy markers are present, but motor 
neuron counts are not significantly different from WT mice. From P20 onwards, a significant 
reduction in motor neuron number is observed in lumbar spinal cords from HSJ1 KO mice relative to 
WT mice. b, Schematic to show proposed experimental design to compare P10 Lumbar spinal cord 
extracts from HSJ1 WT and HSJ1 KO mice. Following Lumbar spinal cord excision and protein 
extraction, sample preparation will be performed by in-gel digestion or filter-aided sample 
preparation (FASP). Peptides will then be analysed by quantitative LC-MS and subjected to 
differential expression analysis. Three classes of interesting proteins could be observed in this 







5.2. Optimisation of mass spectrometry sample preparation 
and LC-MS acquisition for whole proteome samples 
 
Our experimental strategy represents an effort to characterise quantitative changes in the whole 
proteome of tissue extracts from mouse lumbar spinal cord. The greatest barrier to obtaining 
good quantitative measurements in such a format is the limited dynamic range of the mass 
spectrometer relative to the proteome. Samples must, therefore, be fractionated to reduce 
complexity and the instance of highly abundant peptides masking the signal from peptides of 
lower abundance. We tested two methods of sample fractionation (Figure 5.2).  
 
Conventional “in-gel” digestion following SDS-PAGE-mediated protein-level fractionation has 
been effective in generating maps of whole proteomes (M. S. Kim et al., 2014; Wilhelm et al., 
2014). However, the technique is time-consuming (both in labour and instrument time) and 
suffers from issues with variable efficiency of peptide recovery from the gel matrix (Speicher et 
al., 2000). Additionally, the manual excision of gel bands is inevitably prone to experimental error, 
a major concern in quantitative workflows. 
 
Filter-aided sample preparation (FASP) is an on-filter digestion technique which has been 
successfully utilised to achieve deep proteome coverage when combined with secondary peptide 
level fractionation (Wiśniewski et al., 2009, 2012). Samples can be prepared in SDS, ensuring 
near-complete solubilisation and denaturing with subsequent desalting and detergent removal 
through centrifugation and buffer exchange in a spin-filter prior to on-column tryptic digest 
(Wiśniewski et al., 2009). 
 
In-gel digestion and FASP coupled to strong cation exchange (FASP-SCX) were tested on 
extracts of RPE1 cells grown in single 100 mm dishes (95% confluence). Cells were lysed in 8M 
Urea Lysis buffer (8M Urea in 0.1 M Tris pH 7.8), sonicated (3 x 10-second pulses, 10 µm) and 





Figure 5.2  Schematic representation of whole cell sample preparation trial. 230 µg of RPE1 cell 
extract was digested via FASP (left) or in-gel digestion (right.) SDS-PAGE gel shown is illustrative. 
Samples were split into an equal number of fractions at the protein (In-gel) or peptide (FASP) level. 





RPE1 cells were lysed in Tris-Urea buffer and samples were quantified by UV absorbance. 230 
µg of protein was used for each sample preparation workflow. For in-gel digestion, 230 ug 
aliquots of RPE1 extract were separated on a 4-12% Bis-Tris polyacrylamide gel and lanes were 
cut into 8 fractions. Proteins in gel pieces were reduced and alkylated before digestion overnight 
at 37°C with 10 ng/µl trypsin (Promega) in 50 mM ammonium bicarbonate. Peptides were 
extracted from gel pieces and dried in a vacuum concentrator prior to resuspension in LC-MS 
running buffer for analysis.  
 
For FASP-SCX, 230ug aliquots of RPE1 extract were concentrated in Vivaspin 500 (30kDa 
MWCO) filter units, reduced using 50mM DTT and alkylated with 50mM Iodoacetamide then 
digested overnight at 37°C with trypsin (Promega) in a 1:100 enzyme/protein ratio. Peptides were 
collected by centrifugation and dried in a vacuum concentrator.  SCX was performed using C18-
SCX StageTips, eluting the sample into eight fractions. Fractions were collected by serial elution 
in buffers containing an increasing concentration of ammonium acetate (0, 20, 50, 80, 150, 250, 
500 and 1000 mM) and dried in a vacuum concentrator. 
 
Peptides were analysed on a Waters Synapt G2 Si QTOF instrument operating in Resolution 
mode via a NanoESI source. Data were acquired in MSE or high-definition MSE (HDMSE) mode 
with the following settings:  Low energy scan (4 eV), High energy scan (15 – 35 eV in MSE mode 
or 25 – 55 eV in HDMSE mode). Measurements were made over an m/z range of 50 – 2000 Da 
with a scan time of 0.6s. Raw data were processed using PLGS v3.0.2. Data were queried 
against a Homo sapiens protein FASTA database concatenated with a list of contaminant FASTA 
sequences (The Global Proteome Machine, 2016). Protein identifications had to fulfil the 
following search criteria: a maximum of 2 missed cleavages, a minimum of 3 fragments required 
per peptide identification and a minimum of 7 fragment ions required per protein. A protein level 
false discovery rate of 1% was implemented using a decoy database. 
 
In terms of protein identifications, in-gel digestion with HDMSE acquisition performed returned 
the highest number of hits, with 1685 protein groups identified. In-gel digestion with MSE 
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acquisition returned the second-most protein identifications with 1269 identifications. FASP-SCX 
with HDMSE and MSE acquisition identified the fewest protein groups (674 and 572 respectively). 
On average, 19% more protein groups were identified per fraction when using HDMSE acquisition 
(Figures 5.3 a and b).  
 
 
The high performance of in-gel digestion workflows could be attributed to better fractionation of 
the sample, with an average of >10-fold more unique protein groups identified per fraction (Figure 
5.4, in-gel HDMSE vs FASP-SCX HDMSE). Similarly, in-gel workflows exhibited an average three-
fold increase in percentage of unique peptides per fraction. Based on these results, tissue 
digestion of murine lumbar spinal cords was performed using in-gel digestion. 
 
Figure 5.3  Comparison of sample preparation workflow and LC-MS acquisition mode performance. 
a, Barchart to show no. of protein groups identified per fraction using MSE or HDMSE using identical 
samples and injection volumes. b, Barchart to show no. of protein groups identified per gel band 
using MSE or HDMSE acquisition on identical samples (means ± s.e.m of 2 technical replicates). c, Venn 








Figure 5.4  In-gel workflow exhibits superior fractionation of RPE1 cell lysate. Left, Line chart to show 





5.3. Comparative analysis of mouse lumbar spinal cord 
extracts from HSJ1 wild-type and knockout mice 
 
5.3.1. Preparation of Hsj1+/+ and Hsj1-/- lumbar spinal cord samples 
 
HSJ1 knockout mice (Hsj1-/-) were generated by genOway corporation (Lyon, France) and 
subsequently bred and maintained at the UCL Institute of Neurology Biological Services. Dr D. 
Parfitt (Cheetham Lab, UCL) prepared lumbar spinal cord extracts and performed in-gel 
digestion. Sections of lumbar spinal cord, spanning L1-L5 vertebrae, weighing between 20–25 
mg were prepared from three Hsj1+/+ (WT) and three Hsj1-/- (KO) mice ten days after birth (P10), 
coincident with a detectable unfolded protein response (UPR), but before neuronal death, and 
lysed in a Tris-SDS lysis buffer. Samples were boiled and centrifuged, and the cleared lysate 
was mixed with SDS-PAGE sample buffer. Proteins in each sample were separated on a 1D 
SDS-PAGE gel and prepared for LC-MS analysis by in-gel digestion (6 bands) followed by C18-
StageTip clean-up. Peptides were resuspended in LC-MS running buffer and were analysed in 
technical triplicate by nanoLC-ESI-HDMSE. Peptide and protein identification were performed 
using PLGS (Waters Corp.) and identified protein groups were quantified using the Hi3 method 
to obtain absolute protein abundance measurements in femtomoles (fmols). The average protein 
abundance from all technical repeats for a given protein from a given fraction was summed 
across all fractions to generate a single protein abundance value for each protein in each 
“reconstituted” sample.  
 
5.3.2. Data processing and quality control 
 
A large multi-fraction LC-MS experiment using relatively long gradients such as the one reported 
here is subject to many sources of technical error. These include issues with sample preparation 
including quality of protease digestion or losses/inconsistencies owing to sample handling. 
Inconsistencies in LC-MS instrument performance such as variable chromatography and mass 
calibration can also cause data analysis problems. Label-free LC-MS experiments rely on 
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accurate measurements of signal intensity and are especially prone to problems with instrument 
performance, as samples must be analysed separately. 
 
Data was examined to determine if it was of sufficient quality to proceed with statistical testing 
and draw meaningful biological inferences. An examination of total protein and peptide 
identifications per sample was undertaken. Samples from WT mice displayed 2160 ± 18% (mean 
± CV) total protein groups and samples from KO mice displayed 2012 ± 52% (mean ± CV) total 
protein groups. A similar pattern was observed when comparing peptide identifications, with 
115928 ± 11% (mean ± CV) peptides in WT samples and a 99995 ± 56% (mean ± CV) peptides 
observed in KO samples (before combining intensities across fractions). The large spread in 
identification numbers for KO samples is primarily due to low protein and peptide identification 
rates in the KO sample from biological repeat B (BKO) and relatively high numbers of protein and 
peptide identifications for the KO sample from biological repeat C (CKO) (Figures 5.5a and 5.5b). 
Several parameters were assessed to determine if this spread in peptide and protein 
identifications reflected genuine biological variation or technical issues.  
 
A fundamental parameter in the performance of an LC-MS workflow is instrument calibration. 
The SYNAPT-G2Si used in this study was calibrated using a lockspray infusing a peptide of 
known mass ([Glu-1] Fibrinopeptide B; doubly charged m/z of 785.8426) which was sampled 
every 30 seconds. During database searching, mass spectra are calibrated via reference to the 
sampled mass of [Glu-1] Fibrinopeptide B fragments and a calibration file created prior to starting 
all runs to correct for drift in instrument performance. Over the course of an experiment, changes 
in ambient temperature and build-up of residue from analytes on the internal components of the 
mass spectrometer can cause the calibration file to be unrepresentative, compromising mass 
accuracy. As illustrated in Figure 5.5d, the distribution of MS1 peptide mass errors for all 
samples, including BKO samples, lies almost entirely between ± 10 ppm. The distributions are 
overlapping with BKO samples displaying a tighter distribution with a slight offset: the average 
mass error for all samples and the subset of BKO samples is similar at 0.13 ppm and 0.21 ppm, 





The disparity in protein and peptide identifications described above could also be due to issues 
with liquid chromatography performance. Visual inspection of the base peak intensity (BPI) and 
total ion current (TIC) chromatograms for all runs did not indicate any significant failures in LC 
performance, blockages or evidence of sputtering.  
 
A coarse measure of sample preparation and instrument reproducibility can be gained through 
comparison of total protein amounts per sample. Hi3 quantitation relies on the observation that 
the summed intensity of the three most abundant peptide ions for a protein is proportional to the 
concentration of that protein in the sample. If equal amounts of peptide were present in each 
sample, one would expect that the total protein amount for all protein groups would be 
approximately equal across samples. As shown in Figure 5.5c, total protein amount was highly 
Figure 5.5  Evaluation of instrument performance. a, Bar chart to show the total number of protein 
groups identified in each sample (sum of all fractions). b, Bar chart to show the total number of 
peptides identified in each sample (sum of all fractions). c, Bar chart to show summed protein 
abundance (as quantified with reference to the Hi3 standard) for all protein groups across all 
fractions for each sample, without normalisation. d, Density plot to show peptide mass accuracy 






variable across biological replicates in both conditions. WT samples displayed a higher average 
protein abundance and a smaller spread in abundance values (14136 fmol ± 32%; mean ± CV) 
than KO samples (9405 fmol ± 62%; mean ± CV), with the highest intensity observed in the  AKO 
sample and the lowest intensity observed in the BKO sample. Notably, the BKO sample also 
displayed the lowest rate of protein and peptide identifications (Figure 5.5a and 5.5b), raising the 
possibility of an instrument or sample preparation issue for the sample. BWT samples were run 
in alternate with BKO samples and thus shared the most similar instrument running conditions. 
BWT samples do not display a systematic reduction in protein abundance or identifications, thus 
ruling out instrument error as a cause for the low numbers of protein IDs in BKO samples. 
Together, these data indicate that error introduced by LC-MS instrumentation was very small and 
is unlikely to be the main reason for the differences observed among WT and KO samples. 
 
The quality of sample preparation was assessed to determine if an error was introduced at this 
stage. Tryptic digest efficiency could vary among samples due to pipetting error or the use of an 
old batch of trypsin during sample preparation. Incomplete digestion could result in a high 
proportion of generated peptides being too large for detection using the 50-2000 m/z mass range 
of the quadrupole and thus reduce workflow sensitivity. Digest efficiency was assessed indirectly 
by measuring the proportion of peptide intensity in a given sample originating from peptides with 
missed cleavages (peptides which contain lysine or arginine residues within the peptide 
sequence in addition to the C-terminal basic residue). As shown in Figure 5.6a, this proportion is 
similar for all samples (7.5%), and the subset of BKO (8.1%) and CKO samples (7%), indicating 
that inefficient trypsin digest is also unlikely to explain the disparity in protein amount and 
identifications between KO samples. 
 
If protein samples were not well normalised at the level of loading for gel electrophoresis, issues 
with the total amount of peptide yield would necessarily be incurred. Prior to tryptic digest, 
proteins were separated by 1D-PAGE and stained with Coomassie dye. This gel was imaged, 
and densitometric quantitation reveals that total sample load was variable for samples from 
biological replicates B and C at the point of gel loading (Figure 5.6 b and c). A comparison of on-
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gel loading amount (using Coomassie signal as a proxy measure) with summed total absolute 
protein abundance for biological repeats B and C displayed a moderate correlation (R2 =0.65) 
(Figure 5.6c). For both measures, the lowest signal values were observed for the BKO sample. 
Taken together, these results indicate that the variation in KO sample protein identification and 
total protein abundance are not a result of instrument error or a poor-quality tryptic digest but 
rather a reflection of poor sample normalisation at the point of gel loading for BKO samples in 
particular.  




Figure 5.6  Evaluation of sample preparation steps. a, Bar chart to compare the proportion of total 
peptide intensity from peptides with 1 or 2 missed cleavages among all samples, BKO samples and 
CKO samples. b, Coomassie staining of indicated samples following 1D SDS-PAGE prior to band 
excision and in-gel digestion. c, Comparison of densitometric quantification of signal from 
corresponding lanes in b with summed protein abundance for the indicated samples. d, Scatterplot 
to indicate positive correlation between protein abundance and Coomassie signal. AU – arbitrary 
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5.3.3. Data filtering and normalisation 
 
A total of 3094 proteins were quantified in this analysis. Only proteins which were observed in at 
least two biological replicates were taken forward for comparison. In addition, proteins were 
designated as unique to a condition if they satisfied the above criteria and were not observed in 
any of the replicates in the other condition. This filtering process resulted in a dataset of 1538 
well-replicated proteins, 88 of which were unique to WT samples and 76 unique to KO samples. 
 
Data were normalised at the level of reconstituted biological samples to account for variation 
introduced during sample preparation. Three normalisation strategies were compared: simple log 
transformation of the summed protein abundances (Log2), normalisation to global intensity (GI) 
and normalisation to median intensity (Median). Normalisation was implemented using the 
NormalyzerDE platform (Willforss, Chawade and Levander, 2019). All normalisation steps were 
performed on absolute protein abundances as calculated using the Hi3 method. GI normalisation 
is accomplished by dividing measured protein abundance by the total abundance of all proteins 
in the sample, then multiplying these values by the mean of summed protein abundance of all 
samples. Values are then log2 transformed. Normalisation to median intensity was performed by 
dividing the measured protein abundance for a given protein in given technical replicate by the 
median of protein abundance for proteins in that sample, then multiplying this by the median 
protein abundance of all proteins in all replicates. Data was then log2 transformed. 
 
To assess the suitability of each normalisation method, the distribution of within-condition % CV 
for all proteins was plotted. The median CV observed when using simple log2 transformation 
(30%) was reduced by both GI normalisation (25%) and normalisation to median intensity (24%), 
but normalisation to median intensity was more effective at tightening the spread of the data 
(Figure 5.7a). Inspection of relative log expression (RLE) plots indicates that the BKO sample is 
best normalised (displays a median close to 0) under median normalisation as opposed to GI 






 Using all normalisation methods, samples displayed an average within-condition Pearson 
correlation coefficient of 0.64, indicating a moderate correlation in protein abundance across 
biological replicates. Principle component analysis was performed to assess the similarity 
between biological samples in two dimensions. Samples did not appear to cluster by condition 
(WT or KO) when using any normalisation method (Figure 5.8), indicating low within-condition 























Figure 5.7  Evaluation of normalisation methods. a, Box and whisker plot to show the distribution of 
% CV for all proteins in Log2-transformed and GI normalised samples. Whiskers indicate 5th and 95th 
percentiles. b, Relative log expression (RLE) plots to show the distribution of deviations from the 
population median under different normalisation strategies. Plots with medians deviating from 0 are 
poorly normalised. Log2 – log2-transformed, GI – normalised to global intensity, Median – normalised 
to median intensity. The 3-letter sample identifiers first indicate biological replicate (A, B or C) and 





Figure 5.8  Samples do not cluster by condition under any normalisation method tested. PCA 
illustrates changes in data structure in 2 dimensions upon using different normalisation methods. 
Red diamonds indicate WT samples and blue diamonds indicate KO samples. The 3-letter sample 




5.3.4. Comparison of Lumbar extract dataset with published motor neuron and spinal 
cord datasets 
 
To assess dataset validity, comparisons were performed to 4 published murine datasets from 
different backgrounds (Table 5.1). P10 lumbar spinal cords (Lumbar SC) displayed poor 
correlation with Hepa 1-6 cells (Pearson correlation 0.17), a slightly better correlation to the 
Embryonic spinal cord (0.36), and a moderate correlation with primary motor neurons (0.50) and 
adult spinal cord (0.55) (Figure 5.9a). Given the large disparities in animal age and culture 
conditions between these sample types, the presence of even a moderate correlation supports 
the notion that our dataset is of spinal cord origin. Specific markers of neuronal lineage in our 
data were examined next. 
 
Dataset Sample type Publication 
Proteome 
size 
Hepa 1-6 Mouse Hepatoma cell line 




Mouse primary motor neurons 
(3-7 days culture, following enrichment of 
neural progenitors from mouse embryos) 
(Hornburg et al., 
2014) 
6670 
Embryonic SC Embryonic Spinal cord extract (E12.5) 




Whole spinal cord extract from adult mice 
(15 weeks) 
(Hasan et al., 2019) 7211 
Table 5.1  Source and description of datasets used for benchmarking of lumbar spinal cord samples. In 
each case the control dataset was used for comparison to the WT lumbar spinal cord sample. 
 
Overlap in protein identifications between our lumbar spinal cord dataset and the published 
primary motor neuron and adult spinal cord datasets was assessed. The majority of proteins 
detected in our lumbar spinal cord dataset (82%) are shared with both of these datasets. 
Consistent with the notion that our lumbar spinal cord dataset represents a mixed population of 
spinal cord tissue, the adult spinal cord dataset shares the largest number of pairwise IDs with 
our lumbar spinal cord samples, including glial-specific proteins such as Glial fibrillary acidic 




Figure 5.9  Global comparison of wild-type neuronal datasets. a, Scatter plots to show correlation 
in protein abundance across datasets. Numbers inset indicate Pearson correlation. b, Venn 
diagram to show overlap in protein IDs across datasets. Selected lineage specific marker proteins 
of interest are indicated. Lumbar SC – Lumbar Spinal Cord, Hepa 1-6 – Mouse hepatoma cell line, 
Embryonic SC – embryonic spinal cord, Primary MN – primary motor neuron, Adult SC – adult 





Six of the fourteen neuron-specific markers tested were found in the lumbar spinal cord dataset 
(Figure 5.9b). All three isoforms of the neuron-specific protein neurofilament heavy (Nefh), 
neurofilament medium (Nefm) and neurofilament light (Nefl) were detected, along with 
microtubule-associated protein 2 (Map2), tubulin β3 (Tubb3) and synaptophysin (Syp). The 
commonly used marker of mature neurons NeuN (Rbfox3) was not detected in our dataset but 
was found in both primary motor neuron and adult spinal cords. 
 
None of the 16 motor neuron markers tested were observed in our dataset. Notably, only one of 
these markers was observed in the primary motor neuron and adult spinal cord datasets: the 
homeobox domain protein Zinc Finger E-Box Binding Homeobox 2 (Zeb2). Additionally, neuronal 
growth factor receptor (Ngfr) and Zinc Finger E-Box Binding Homeobox 1 (Zeb1) were observed 
in primary motor neuron, with choline acetyltransferase (Chat) and fibroblast growth factor (Fgf1) 
observed in adult spinal cords (Figure 5.9b). The commonly used motor neuron markers Islet-1 
(Isl-1) and Motor Neuron and Pancreas Homeobox 1 (HB9) were not observed in any datasets. 
This result is perplexing given the depth of proteome coverage achieved in the published 
datasets and the fact that both proteins can generate >10 tryptic peptides suitable for MS 
detection, suggesting that these proteins are expressed at very low levels in neurons. 
 
The microtubule-associated protein doublecortin (Dcx) is commonly used as a marker of 
immature neurons as it appears to be involved in neuron differentiation and migration during 
embryonic development and postnatally (Des Portes et al., 1998; Francis et al., 1999; Brown et 
al., 2003). Interestingly, Dcx is detected in our dataset and in the primary motor neuron dataset, 
but not in the adult spinal cord dataset (Figure 5.9b). 
 
As almost all motor neurons (including those connecting to skeletal muscle on the lumbar spinal 
cord) are cholinergic, datasets were assessed for the presence of proteins involved in the 
synthesis and/or neurotransmitter cycling of acetylcholine. Similar tests were performed for the 
other major neurotransmitter types. None of the cholinergic neuron marker proteins were 
detected. Five markers of GABAergic neurotransmission were detected; two of which were 
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present in the lumbar spinal cord dataset, indicating the presence of GABAergic neurons in our 
samples (Figure 5.9b). 
 
Lastly, several glial cell markers were detected in the lumbar spinal cord samples, including Glial-
fibrillary acidic protein (Gfap), the oligodendrocyte-specific Myelin basic protein (Mbp) and the 
pan-astrocyte marker 10-formyltetrahydrofolate dehydrogenase (Aldh1l1) (Neymeyer, Tephly 
and Miller, 1997; Cahoy et al., 2008; Tong et al., 2014), indicating the presence of a mixed 
population of neuronal and glial cells in our lumbar spinal cord dataset. These results, including 
all marker proteins used, are provided in Appendix Table 8.5.  
 
To obtain a better understanding of the depth of proteome coverage, the dynamic range of 
quantified proteins in the lumbar dataset was compared to those in the adult spinal cord dataset 
(Hasan et al., 2019). Proteins quantified in the lumbar dataset span a range of ~3.5 orders of 
magnitude, whereas the adult spinal cord dataset spans a dynamic range of ~5.5 orders of 
magnitude. This difference is likely due to the authors’ use of an extensive 40-fraction HPLC 
fractionation step.  
 
Taken together, these data suggest that the lumbar dataset obtained originates from a mixed 
pool of neuronal and glial cells, sharing highest similarity in protein abundance and identifications 
with an adult spinal cord dataset, validating our sample preparation pipeline. Unfortunately, the 
data do not confirm the presence of motor neurons. Notably, many motor neuron markers were 
not detected in datasets with much deeper coverage, suggesting that these proteins are 
expressed at low abundance. Their absence in our dataset does not, therefore, exclude the 
presence of motor neurons in our lumbar extract samples. 
 
5.3.5. Differential expression analysis 
 
Unpaired, two-sided t-tests were performed to compare the average normalised absolute protein 
abundance between conditions, assuming equal variances and correcting for multiple testing 
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using an FDR cut-off of 0.05. These tests did not identify any significant differences between the 
conditions. We turned to our qualitative data and performed functional analysis on the subset of 
proteins which were defined as unique in WT or KO conditions. Notably, HSJ1 itself was detected 
uniquely in WT samples, lending credibility to this approach. A full list of these proteins is given 
in Appendix Table 8.4.  
 
The behaviour of proteins known to aggregate in various neurodegenerative diseases were 
evaluated. Htt, Sod1 and α-synuclein were not detected in our dataset, whilst Tau and TAR DNA-
binding protein 43 (TDP-43), which is linked to ALS (Arai et al., 2006; Ling, Polymenidou and 
Cleveland, 2013; Tan et al., 2017), were detected in our data but were not differentially 
expressed. 
 
Three proteins observed uniquely in WT samples stood out as candidate HSJ1 client proteins. 
Ubiquilin-1 (Ubqln1) is a component of the ubiquitin-proteasome system, and is known to interact 
with HSJ1a (Heir et al., 2006). In addition, Ganglioside Induced Differentiation Associated Protein 
1 (Gdap1) and Ataxin-10 (Atxn10) were observed at relatively high abundance in all 3 WT 
samples but in none of the KO samples, and therefore represent high confidence candidates. 
Intriguingly, mutations in the human homologue of Gdap1 have been shown to cause CMT2 
(Cuesta et al., 2002), a neurodegenerative disease bearing very similar clinical features to that 
caused by some HSJ1 mutations. 
 
Gene Ontology (GO) enrichment analysis was performed using the DAVID functional annotation 
suite assessing biological process and cellular compartment terms for enrichment. The software 
calculates the chance that a given GO term is over-represented in a query gene list relative to a 
background gene list. Enrichment analysis of the proteins defined as unique in WT or KO 
conditions was performed using all 1538 well-replicated proteins as a background. Enrichment 
was defined as a p-value ≤ 0.05, corrected for multiple testing using an FDR cut-off of 0.05 
(Benjamini-Hochberg procedure). No GO functional annotations were significantly enriched 




Analysis of functional annotation enrichment does not account for protein-protein interactions 
(PPI). Network analysis was performed on the unique IDs to identify patterns in the data. PPI 
information from published sources and curated databases were ranked and scored by STRING 
(Szklarczyk et al., 2019) and high confidence interactions (score > 0.7) were used to construct a 
PPI network (Figure 5.10) This analysis identified several interesting clusters of proteins which 
differ in expression between P10 lumbar spinal cords. Several proteins which form the large 
ribosomal subunit were identified in KO samples only, indicating a possible upregulation of 
protein synthesis. Three proteins linked to lipolysis in adipocytes, Perilipin-1 (Plin1), Hormone-
sensitive factor (Lipe) and 1-acylglycerol-3-phosphate O-acyltransferase (Abhd5) were found 
exclusively in KO samples, suggesting impaired lipid homeostasis. A group of proteins involved 
in phosphatidylinositol 3-kinase (PI-3K) and mammalian target of rapamycin complex 1 
(mTORC1) signalling were not detected in KO samples. Another group of related proteins unique 
in WT samples included Plexins A2 and A3 and their co-receptor Neuropilin 2 (Nrp2), possibly 
indicating a loss of sensitivity to semaphorin signalling, which has roles in axon guidance 





Figure 5.10 Protein-protein interaction network to show connectivity among proteins uniquely 
identified in HSJ1 WT or HSJ1 KO lumbar spinal cord extracts. Proteins detected in ≥2 biological 
samples from one condition and in none of the samples from the other condition are denoted 
unique in WT/KO. Proteins detected in all 3 biological replicates are highlighted with a thick 
border. Nodes represent proteins and edges represent protein-protein interactions as annotated 
and scored in the STRING network analysis tool. Node colours indicate the condition in which the 
protein was uniquely identified (Blue – WT, Pink – KO). Node size is scaled to mean absolute 
protein abundance and edge thickness to STRING interaction score. Nodes without high 
confidence interactions to other nodes in the network are shown below for completeness. 
Lipid droplet and 








A large network of chaperones and co-chaperones actively maintain protein copy number and 
folding state in the cell. Failures in the chaperone network often result in neurodegenerative 
disease (Hartl, Bracher and Hayer-Hartl, 2011). In this work, we attempted to identify the 
molecular clients of the HSJ1 cochaperone and characterise cellular dysregulation in its absence. 
A HSJ1-/- mouse was used as a model system for the study of motor neurons. Motor neurons 
innervating the lower limbs are located in the lumbar spinal cord. Previous work in the Cheetham 
group established that motor neuron numbers in the lumbar spinal cord of HSJ1 KO mice are 
reduced by 11.6% relative to their wild-type counterparts, and that this loss occurs between 
postnatal day 15 (P15) and postnatal day 20 (P20). Also, the elevated levels of total ubiquitinated 
proteins (1.9-fold increase versus WT) and the autophagy marker protein LC3-II (1.3-fold higher 
versus WT) were observed in lumbar spinal cord extracts at least as early as P15. Finally, 
elevated levels of phosphorylated eIF2α and phosphorylated IRE-1, were detectable in P10 
lumbar spinal cord extracts from HSJ1 KO mice indicating an active unfolded protein response 
(UPR). Together, these markers indicate a defect in proteostasis in the cells of the lumbar spinal 
cord as early as P10 involving high levels of misfolded proteins, an increase in autophagy and 
induction of the UPR. This defect appears to cause the death of ~11% of neurons in the lumbar 
spinal cord by P20. Whilst HSJ1 KO mice are behaviourally normal, investigating the mechanism 
by which HSJ1 loss induces a stress response in the lumbar spinal cord could shed light on motor 
neuron disease in humans. 
 
Towards this end, a sample preparation and data acquisition workflow was optimised, identifying 
in-gel digestion with HDMSE acquisition as the most sensitive protocol for future experiments to 
characterise complex samples. When applied to murine lumbar extracts, this protocol achieved 
good quantitative data for 1538 proteins. However, total protein amounts in each sample, as 
measure by Hi3 quantitation, were found to be heterogeneous. This variability could not be 
attributed to poor mass calibration, chromatography or digest quality. Densitometric quantitation 
gel loading amounts indicated that the lack of a pre-digestion normalisation step was the most 
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likely source of KO sample variability. In future, this issue could be avoided by measuring protein 
amount in aliquots of each extract using a detergent compatible protein quantification method 
and normalising protein amounts prior to gel loading. 
 
The depth of proteome coverage achieved in this study compares poorly with recent studies in 
the literature (e.g. Hasan et al., 2019), and suggests that the identifications reported in this 
analysis are likely to be biassed towards abundant proteins. Modifications to the sample 
preparation protocol could improve this. The simplest change would be to increase sample 
loading. During sample preparation for the experiments reported in this work, ~6% of the total 
lumbar sample extract was loaded onto gels for in-gel digestion. Coomassie staining following 
1D-PAGE showed that gel lanes were far from overloaded, emphasising the scope for improving 
workflow sensitivity at this stage. Furthermore, the use of six fractions is relatively low, so 
increasing the degree of sample fractionation can be expected to improve coverage. This is 
exemplified by Hasan et al. (2019), who used a 40-fraction HPLC step to measure a larger 
proportion of the adult mouse spinal cord proteome. An inherent technical challenge when 
performing in-gel sample preparation is the reproducibility of SDS-PAGE separation and manual 
gel band excision. Gel-free sample preparation techniques such as in-StageTip (iST) and single 
pot solid phase-enhanced sample preparation (SP3), coupled with peptide fractionation, have 
achieved deep proteome coverage from low starting sample material and represent a promising 
alternative to the in-gel digestion workflow (Hughes et al., 2014; Kulak et al., 2014; Sielaff et al., 
2017). 
 
Protein expression in WT lumbar extracts correlated well with published datasets from primary 
motor neuron and adult spinal cord samples but correlated poorly with proteomes from embryonic 
spinal cords and a mouse hepatoma cell line. This correlation, together with the observation of 
neuronal and glial lineage markers in WT lumbar extracts, indicates that samples analysed here 




Despite being unable to identify differentially expressed proteins via statistical analysis, 
qualitative information in the form of proteins identified as unique in a single condition could be 
used as a proxy for enrichment. It should be noted that, due to the stochastic nature of peptide 
ionisation and detection in ESI-MS studies, failure to detect protein in this study cannot be used 
as proof of absence in the sample. Functional enrichment analysis did not indicate enrichment 
of any GO terms in either set of unique proteins relative to the background. The failure to identify 
enriched GO terms is consistent with the results of principal component analysis, which showed 
poor separation between samples from different conditions. Together, these factors indicate that 
HSJ1 deficiency does not induce major alterations in proteome composition at the depth of 
proteome coverage attained and at this time point (P10). 
 
As expected, HSJ1 protein was uniquely detected in WT spinal cord extracts. HSJ1 client 
proteins are predicted to misfold and be degraded or lost in the detergent-insoluble fraction upon 
protein extraction. In either case, this would be observable as an enrichment in WT samples. 
Among the 88 proteins defined as unique in WT samples, two were detected in all 3 WT samples: 
Atxn10 and Gdap1. 
 
Ataxin-10 is linked to spinocerebellar ataxia type 10 (SCA10), a hereditary neurological disorder. 
Disease onset has been catalogued as early as age 12 and symptoms include uncoordinated 
muscle movement and seizures (Grewal et al., 1998; Rasmussen et al., 2001; Teive and 
Ashizawa, 2013). Interestingly, a subset of SCA10 patients also display motor neuropathy. Whilst 
the SCA10 disease mechanism is currently unclear (Wakamiya et al., 2006; Keren et al., 2010; 
White et al., 2010, 2012), knockdown of Atnx10 in cultured rat cerebellar neurons resulted in 
neuronal death (März et al., 2004) and Atnx10-null mice displayed embryonic lethality (Wakamiya 
et al., 2006), suggesting that Atxn10 loss can cause severe disruption of cell function. To 
investigate if Atnx10 folding is assisted by HSJ1, pulldown assays or immunohistochemistry 





Gdap1 represents a particularly interesting candidate for future study, as mutations in this protein 
have been linked to CMT2 (Cuesta et al., 2002; Tazir et al., 2014). This disease closely 
resembles the pattern of motor neuron loss without demyelination observed in HSJ1-linked 
CMT2, raising the possibility that a failure to correctly fold Gdap1 underlies HSJ1-linked CMT2 
disease mechanistically. Gdap1 is a relatively short 367-amino acid protein which is highly 
expressed in neurons (Cuesta et al., 2002). It is localised to the outer mitochondrial membrane, 
where its exact function is unclear. Study of Gdap1 in cell and mouse models have proposed a 
role for Gdap1 in mitochondrial fission (Niemann et al., 2009) and positioning (Pla-Martín et al., 
2013), resistance to reactive oxygen species (ROS) (Noack et al., 2012; Niemann et al., 2014; 
Huber et al., 2016) and Calcium homeostasis (Pla-Martín et al., 2013; Barneo-Muñoz et al., 2015; 
González-Sánchez et al., 2017). 
 
Indeed, studies of Gdap1 deficiency in a neuroblastoma cell line and in a mouse model 
demonstrated that loss of Gdap1 resulted in lowered ER calcium levels (Barneo-Muñoz et al., 
2015; González-Sánchez et al., 2017). As depletion of ER calcium is a well-documented UPR 
initiator (Shore, Papa and Oakes, 2011), Gdap1 misfolding in the absence of HSJ1 may underlie 
activation of the UPR in P10 lumbar spinal cord extracts. 
 
The known HSJ1 interaction partner Ubqln1 was identified uniquely in WT samples, indicating 
that Ubqln1 levels in HSJ1-/- samples are strongly reduced by P10 in the lumbar spinal cord. 
Ubqln1 is a ubiquitously expressed member of the ubiquilin protein family, all members of which 
possess a C-terminal ubiquitin-like domain (UBL) and an N-terminal ubiquitin-associated domain 
(UBA). The UBA domain facilitates binding to polyubiquitin (Zhang, Raasi and Fushman, 2008) 
and the UBL domain mediates interactions with HSJ1a and with the proteasome (Kleijnen et al., 
2000). This domain composition allows ubiquilins to serve as shuttling factors, delivering 
ubiquitinated substrates to the proteasome for degradation. It is conceivable that Ubqln1 is a 
client of HSJ1, as an interaction between the HSJ1 ubiquitin-interacting motifs (UIMs) and the 
Ubqln1 UBL domain has been demonstrated (Heir et al., 2006). However, no explicit link between 
Ubqln1 folding and HSJ1 has been shown in the literature. If Ubqln1 is indeed misfolded at a 
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higher rate in the absence of HSJ1, loss of Ubqln1’s proteasome shuttling function may result in 
less efficient clearance of ubiquitinated proteins. This could explain the 1.9-fold increase in 
ubiquitinated proteins observed in HSJ1-/- lumbar spinal cord extracts at P15. In the context of 
neurodegeneration, overexpression of Ubqln1 has been shown to be beneficial in mouse and 
cell models of Alzheimer’s and Huntington’s disease (Wang et al., 2006; Wang and Monteiro, 
2007; Safren et al., 2014). Furthermore, the ubiquilins were recently proposed to act as the 
primary cytosolic chaperones for transmembrane proteins destined for insertion in the 
mitochondrial membrane (Itakura et al., 2016). Loss of these functions may compromise 
proteostasis in HSJ1-deficient motor neurons, possibly causing the observed UPR induction by 
P10 in HSJ1-/- spinal cords. It would be prudent to confirm the reduction of Ubqln1 levels in 
HSJ1-/- spinal cord extracts using an using an orthologous method such as western blotting or 
immunohistochemistry. If confirmed, experiments to explicitly test if Ubqln1 stability is affected 
by loss of HSJ1 should be pursued. 
 
PPI network analysis of the unique IDs helped glean deeper insights into the dataset. One group 
of interconnected proteins found exclusively in KO samples play roles in lipid storage: Perilipin-
1 (Plin1), Hormone-sensitive factor (Lipe) and 1-acylglycerol-3-phosphate O-acyltransferase 
(Abhd5). The upregulation of this cluster may indicate a general dysregulation of lipid 
homeostasis in HSJ1-deficient motor neurons. Defects in lipid metabolism have been proposed 
as major pathogenic drivers in motor neuron diseases such as ALS and spinal muscular atrophy 
(SMA) (Schmitt et al., 2014; Tracey et al., 2018). Plin1, identified in all 3 KO samples, is a 
transmembrane protein found in the unilamellar coat of lipid droplets. Lipid droplets are 
intracellular stores of neutral lipids which have been shown to exist in most eukaryotic cells 
including neurons and glial cells (Savage, Goldberg and Schacher, 1987; Papadopoulos et al., 
2015; Renvoisé et al., 2016; Olzmann and Carvalho, 2019). Increased levels of Plin1 may 
indicate an increase in the biogenesis of lipid droplets. Lipid droplet biogenesis in glial cells was 
recently reported to protect neural stem cells from ROS-induced peroxidation of polyunsaturated 
fatty acids (PUFAs) (Bailey et al., 2015). This raises a possible link to Gdap1, which has been 
shown to play a role in the mitigation of ROS-induced stress (Noack et al., 2012; Niemann et al., 
2014). If Gfap1 misfolding is indeed a consequence of HSJ1 deficiency, the upregulation of Plin1 
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in HSJ1-deficient lumbar spinal cords may signal increased lipid droplet biogenesis to mitigate 
oxidative stress. 
 
PPI network analysis also highlighted a seven-member cluster of proteins involved in Protein 
kinase B (Akt) and mammalian target of rapamycin complex 1 (mTORC1) signalling, which were 
mostly downregulated in KO samples. Akt and Phosphatase and tensin homologue deleted in 
chromosome 10 (Pten) were not detected in any of the KO samples. These proteins are key 
components of the Phosphatidylinositol 3 kinase (PI3K)-Akt signalling cascade, which promotes 
growth and neuronal survival when active (Brunet, Datta and Greenberg, 2001; Hanada, Feng 
and Hemmings, 2004; Endo et al., 2006; Manning and Cantley, 2007). Akt mediates its anti-
apoptotic effects in neurons through phosphorylation and inactivation of the pro-apoptotic protein 
Β-cell CLL/lymphoma (Bcl-2) associated agonist of cell death (Bad) (Datta et al., 1997), indirect 
inhibition of Caspase-9 activation (Zhou et al., 2000) and inhibition of Forkhead Box O3 
(FKHRL1) nuclear translocation (Brunet et al., 1999). If Akt were a client protein of HSJ1, its 
misfolding and loss would promote apoptotic pathways and could explain the loss of motor 
neurons identified in the lumbar spinal cord of HSJ1 KO mice. However, one would have to 
explain the relatively mild phenotype (11.6% motor neuron loss), given the central role of Akt in 
anti-apoptotic signalling in neurons. 
 
Another interesting group within the seven-member cluster are the Regulatory-associated protein 
of mTOR (Rptor) and Ras-related GTP-binding protein A (Rraga) proteins, both of which play 
roles in mTORC1 signalling. The mTORC1 complex acts as a nutrient sensor in the cell, 
promoting or inhibiting protein synthesis in response to nutrient/ energy levels in the cell as well 
as extracellular cues such as growth factors (Laplante and Sabatini, 2012). Rptor is an important 
member of mTORC1, acting as a scaffold and protein-protein interaction hub for assembly, 
regulation and localisation of the complex (Sancak et al., 2008; Dunlop et al., 2009). Rraga is a 
GTP-binding protein which directly functions in the activation of mTORC1 in response to 
increased amino acid availability (Sancak et al., 2010). Therefore, the loss of Rptor and Rraga 
proteins could indicate a defect in mTORC1 assembly and/or activation. When active, mTORC1 
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antagonises macroautophagy (hereafter autophagy) through phosphorylation of Autophagy and 
Beclin 1 Regulator 1 (AMBRA1) (Noda and Ohsumi, 1998; Nazio et al., 2013). Inhibition of 
mTORC1 signalling, caused by loss of Akt signalling or loss of HSJ1 co-chaperone activity, could 
stimulate chronic autophagy in motor neurons. This could explain the increased levels of 
autophagosome marker LC3-II in HSJ1 lumbar spinal cords (Heather Smith, unpublished 
results).  
 
The connections proposed above are purely speculative and require substantial validation. A 
logical next step would be to confirm the phenotypes described above using an orthogonal 
measure of protein abundance such as western blotting or immunohistochemistry on spinal cord 
extracts or sections, respectively. If the loss of Gdap1 is confirmed, characterisation of 
mitochondrial distribution and ER calcium levels in motor neurons would be interesting.  
 
Mass spectrometry experiments utilising a different experimental paradigm could also be brought 
to bear to find novel candidates HSJ1 clients. Affinity-purification MS would be an ideal tool to 
retrieve HSJ1 binding partners from a lumbar spinal cord extract. An alternative experimental 
design would be to profile the detergent-insoluble fraction by LC-MS to positively identify any 
aggregated proteins, instead of relying on non-detection to assign candidates. This approach 
has the advantage of avoiding the issue of stochastic peptide ionisation intrinsic to MS analyses. 
Spatial proteomics also presents an exciting methodology for identifying client HSJ1 proteins. 
This experimental strategy involves tagging a protein of interest with an enzyme that chemically 
labels nearby proteins in the cell. Two popular methods are proximity-dependent Biotin 
identification (BioID) and APEX2. In BioID, a protein of interest is tagged with the BirA enzyme 
and heterologously expressed in cultured cells. When Biotin monomers are provided in cell 
media, BirA ligase attaches Biotin to lysine residues ~10 nm distant from the BirA ligase (Kim et 
al., 2014). These proteins can then be purified affinity chromatography and identified by MS. 
Whilst such experiments have mostly been performed in cell culture, BioID was recently applied 
to the study of mouse brains in vivo. These studies have enabled the characterisation of at least 




A major limitation faced in this work was cross-contamination from non-neuronal cell types. An 
exciting opportunity to obtain more homogenous samples for MS profiling is the use of patient-
derived induced pluripotent stem cells (iPSCs), which have been successfully generated for 
studies of motor neuron disease. The use of iPSCs incurs many benefits in addition to sample 
homogeneity such as the ability to make targeted interventions in motoneuron biology such as 
protein overexpression and knockdown. For example, iPSCs sourced from CMT2 patients were 
stimulated to differentiate into motor neurons and used to test the potential of therapeutic 
intervention of Histone deacetylase 6 (HDAC6) inhibition. The patients had mutations in Heat 
shock protein B1 (HSPB1), which features disruption of mitochondrial transport in axons 
(Evgrafov et al., 2004; Irobi et al., 2004; Ackerley et al., 2006; Kalmar et al., 2017). HDAC6 is a 
major regulator of microtubule accessibility, as deacetylation of tubulin prevents attachment of 
motor proteins to the microtubule and hence axonal transport of mitochondria (Reed et al., 2006). 
Treatment with HDAC6 inhibitors ameliorated the mitochondrial transport defects in iPSCs and 
was later shown to improve motor and sensory issues in a mouse model of HSPB1-related CMT2 
(Kim et al., 2016). Quantitative proteomic profiling of induced pluripotent stem cells derived from 
patients with mutations in HSJ1 could provide cross-validation of the patterns identified here and 
with greater relevance to human disease. Candidate HSJ1 clients identified in this way would 
then be subjected to extensive validation through mutagenesis or overexpression studies. The 





6. General Discussion 
 
The analysis of proteins by mass spectrometry is now a mature field and, as exemplified in this 
work, has great utility when applied to a variety of biological problems. In the field of bottom-up 
proteomics, a number of exciting milestones have been reached in recent years, including the 
first draft of the human proteome (Kim et al., 2014), in-depth mapping of subcellular proteomes 
(Bausch-Fluck et al., 2015; Thul et al., 2017), important advances in sample preparation for 
microproteomics (Hughes et al., 2014; Kulak et al., 2014; Sielaff et al., 2017), and large scale 
efforts to compare proteomes across the kingdoms of life (Müller et al., 2020). Relative to 
genomics technology, there is still great scope for improvement, as bottom-up proteomics 
experiments are still more labour intensive and require longer instrument times per sample. In 
this work, quantitative proteomics was used to study the recently described endocytic pathway, 
FEME, and to help elucidate the causes of neuron death in a murine model of motor neuron 
degeneration. 
 
6.1. Identifying and validating new cargoes for FEME 
 
Boucrot et al. (2015) recently reported the discovery of a novel clathrin independent endocytic 
route in mammalian cells. The pathway featured rapid uptake of ligand stimulated cargo in tubular 
carriers. This was dependent on dynamin, Rac, phosphatidylinositol-3-OH kinase, PAK1 and 
actin polymerization. The authors also demonstrated a regulatory mechanism involving 
phosphatidylinositol phosphate patterning of the plasma membrane. The pathway showed 
heterogeneity in its cargo receptors, transporting GPCRs, RTKs and the cytokine receptor IL-2R. 
Like many CIE pathways, a major impediment for further study of the pathway was the lack of 
marker cargoes (cargoes exclusively trafficked by FEME). Due to its novelty, FEME’s 
physiological roles were poorly understood. The main thrust of my research was to discover and 
validate new FEME cargoes in the hopes of understanding the role of FEME and to find useful 




New cargoes for FEME had been discovered by rational selection of candidates: the amine 
GPCRs were tested because β1-AR had been the first cargo identified and, similarly, the 
discovery of EGFR as a FEME cargo prompted the investigation of a panel of other RTKs. I set 
out to discover new FEME cargoes in an unbiased manner. The pool of receptors at the plasma 
membrane is maintained by a homeostatic balance between secretory/ recycling pathways which 
localise receptors to the plasma membrane, and endocytic pathways which remove them. 
Blockade of an endocytic pathway can result in accumulation of receptors which are normally 
internalised via that pathway at the plasma membrane. Recently published studied had taken 
advantage of this, using quantitative proteomics to assess changes in the abundance of plasma 
membrane proteins in response to genetic interventions (Steinberg et al., 2013; Bitsikas, Corrêa 
and Nichols, 2014). I hypothesised that RNAi-mediated disruption of endophilin would cause 
accumulation of many FEME cargoes at the cell surface. These cargoes could be then identified 
in an unbiased manner using quantitative mass spectrometry and later validated using 
microscopy and biochemical assays. 
 
I optimised conditions for enrichment of the plasma membrane, RNAi-mediated knockdown of 
endophilins A1, A2 and A3 (EndoTKD) and that of the µ2-subunit of adaptor protein complex 2 
(AP2M KD) and, finally, sample preparation for proteomics. The final workflow identified 129 
plasma membrane proteins. While differential analysis identified junction plakoglobin (JUP) and 
dysferlin (DYSF) as interesting candidate FEME proteins, I did not have time to validate them, 
so this study failed to answer my research questions. 
 
Nevertheless, these candidates do represent exciting opportunities for follow up. JUP is an 
interesting candidate due to the presence of a proline-rich motif (PRM) suitable for targeting by 
the endophilin-SH3 domain in its primary sequence. The co-enrichment of several predicted and 
known binding partners for JUP upon inhibition of FEME, and the identification of JUP as a 
differentially regulated protein in ANOVA, lend weight to the classification of JUP as a potential 
adaptor for FEME-mediated uptake of proteins at cell-cell junctions. Indeed, higher FEME activity 




Dysferlin (DYSF) was identified as enriched in EndoTKD plasma membrane fractions relative to 
resting extracts but was not enriched upon CME blockade, thus representing a candidate for 
exclusive uptake via FEME (“marker cargo”). DYSF is a single-pass type II transmembrane 
protein found to be 54-fold enriched in the plasma membrane of FEME- blocked cells relative to 
Control. Structurally, the protein consists of a small extracellular C-terminal domain and a large 
N-terminal cytoplasmic domain containing a number of PRMs, one of which is a putative target 
for the endophilin SH3 domain. 
 
A limitation of this study is that none of the cargoes known to accumulate in the plasma 
membrane upon EndoTKD could be used for verification. β1-AR was not detected, and EGFR 
was not observed to accumulate in any of the conditions, casting doubt on the validity of the 
identified candidate proteins. The failure to detect β1-AR may be due to its relatively low 
abundance in RPE1 cells (Boucrot et al., 2015). A possible remedy would be to try different 
methods of surface protein labelling. The strategy I used relies on the availability of primary 
amines in receptor ectodomains, possibly limiting the number of proteins available for affinity 
purification. Alternative strategies for surface protein labelling and enrichment have had success 
(Deeb et al., 2014; Bausch-Fluck et al., 2015), and could be employed to widen the scope of the 
analysis.  
 
A further weakness was the incomplete knockdown observed for the AP2M KD condition (~36%) 
in the full-scale experiment. Given that clathrin-coated pits could still form in cells with no 
detectable µ2-adaptin (by western blotting) it is possible that the knockdown achieved was 
insufficient to cause strong accumulation CME cargoes at the cell surface, which could explain 
the lack of EGFR accumulation (Motley et al., 2003; Boucrot et al., 2010). In future studies, it 
may be useful to generate knockout mutants of µ2-adaptin and endophilin using CRISPR-Cas9 
technology. Drawbacks of this approach include the length of time required to select and expand 
suitable clones, and the danger of selecting clones which have reverted to a wild-type phenotype 
stochastically (so-called “escapers”). There is also a risk that cells with complete knockout of 




An unexpected observation was the strong improvement in µ2-adaptin knockdown upon 
switching transfection reagent (Oligofectamine to RNAiMAX). The composition of these 
transfection reagents is proprietary, so it is hard to explain why the improvement in knockdown 
quality was observed, but preliminary immunostaining confocal microscopy analysis revealed 
tentative clues. RNAiMAX appeared to induce some knockdown in most of the cells in a culture, 
whilst Oligofectamine only induced strong knockdown in some cells, with many cells unaffected 
(E. Boucrot, unpublished results). These observations underscore the importance of testing 
multiple transfection reagents, and verifying their effects using microscopy in addition to western 
blotting, when optimising RNAi experiments. 
 
In my effort to identify novel FEME cargoes, I attempted an affinity purification mass-spectrometry 
experiment from a membrane protein fraction using an endophilin A2 SH3 domain bait. After 
establishing conditions for release of biotin-labelled proteins for secondary pulldown, I found that 
the cost of generating a plasma membrane fraction using biotin-labelling at sufficient volume and 
concentration to conduct an AP-MS workflow would have been prohibitive, with the biotinylation 
reagent representing the highest expense. An alternative strategy worth pursuing would be to 
use centrifugation to generate a crude membrane fraction for affinity purification (e.g. as in Lai, 
2013). A sufficient quantity of plasma membrane fraction could also be generated using gradient 
density centrifugation (Duve, 1975; Dormeyer et al., 2008; Lewandrowski et al., 2009). These 
options rely on high starting numbers of cells and may result in a less pure plasma membrane 
fraction (high contamination from ER proteins would be expected) but avoids the high cost of 
reagents. 
 
Another exciting alternative would be the use of spatial proteomics for identification of potential 
cargoes. Two popular methods are proximity-dependent Biotin identification (BioID) and APEX2. 
In BioID, a protein of interest is tagged with the BirA ligase and heterologously expressed in 
cultured cells. When biotin monomers are provided in cell media, BirA ligase attaches biotin to 
lysine residues ~10 nm distant from the BirA ligase (Kim et al., 2014). These proteins can then 
be purified using affinity chromatography and identified by MS. As the central FEME component, 
204 
 
endophilin is a perfect candidate for tagging with BirA ligase. Whilst this experiment is highly 
dependent on the expressed construct being correctly localised, subsequent purification would 
not require a plasma membrane enrichment step. 
 
6.2. Investigating how growth factor signalling regulates FEME 
 
In addition to expanding knowledge of FEME’s functional roles through identification of candidate 
cargoes, I also had the opportunity to elucidate details of FEME regulation. Boucrot et al. (2015) 
identified phosphatidyl inositol phosphate patterning of the inner leaflet of the plasma membrane 
at the leading edge of cells as a key mechanism through which FEME was controlled. Later work 
undertaken in our lab expanded this picture, establishing that a priming mechanism involving the 
recruitment of the F-BAR proteins FBP17 and CIP4 downstream of Cdc42 prompts conversion 
of PI(3,4,5)P3 into  PI(3,4)P2 at the leading edge by SHIP1/2 phosphatases. This is followed by 
recruitment of lamellipodin and finally endophilin. This “priming complex” disassembles within a 
few seconds in the absence of FEME cargo stimulation (Chan Wah Hak et al., 2018). The 
discovery of this constant priming process helped explain a key feature of FEME: its prompt 
response to ligand stimulation.  
 
Boucrot et al. (2015) also observed an interesting phenotype that hinted at a separate 
mechanism of FEME regulation. Addition of extra serum to cell media was observed to strongly 
increase the rate of FEME whilst removal of serum caused a strong decrease in FEME. Further 
study showed that this increase in FEME rate upon serum stimulation was observable in multiple 
cell types. These observations suggested that growth factor signalling plays a role in the control 
of FEME. 
 
Endophilin plays a central role in FEME events. Following its recruitment to the plasma 
membrane by lamellipodin, endophilin serves as an adaptor for cargoes and scission factors 
(dynamin). The endophilin N-BAR domain is capable of inducing and stabilising the high degree 
of curvature observed on FEME tubules, and the protein marks tubules after they detach from 
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the plasma membrane and are transported into the cell interior. Regulation of FEME could disrupt 
the intermolecular contacts that endophilin makes when performing each of these roles. I 
designed an AP-MS experiment to investigate how the endophilin interactome changes upon 
growth factor stimulation.  
 
Anti-endophilin magnetic beads were used to purify native endophilin complexes from the lysates 
of resting or serum stimulated cells. Quantitative bottom-up mass spectrometry was used to 
identify proteins strongly associated with endophilin complexes in a particular condition. 
Differential expression analysis identified an interesting candidate cargo adaptor, WW Domain 
Containing E3 Ubiquitin Protein Ligase 1 (WWP1), which appeared to associate with 
immunocomplexes isolated from the stimulated lysates. Due to their key role in growth factor 
signalling, the behaviour of any kinases differentially expressed was also noted. In total, 27 
kinases were found to be differentially expressed and, intriguingly, Glycogen synthase kinase 3β 
(GSK3β) was enriched in resting rather than stimulated cells. 
 
The behaviour of GSK3β was interesting as, during the wider investigation of FEME regulation 
in our lab, a panel of kinases had been screened using small molecule inhibitors. This screen 
had identified CDK5, p38 and GSK3 as potential inhibitors of FEME (see Figure 4.1, Ferreira et 
al., submitted).  GSK3 is an unusual kinase in that it recognises pre-phosphorylated residues, 
which occupy a docking site in GSK3, to guide the positioning of its kinase domain. This confers 
specificity for target serine/threonine residues 4 amino acids N-terminal of the “priming 
phosphate”. GSK3 is regulated by phosphorylations targeting the unstructured N-terminus of the 
protein (S9 in GSK3β and S21 in GSK3α), allowing it to act as a pseudosubstrate for its own 
docking site, thereby inhibiting substrate recognition by the kinase (Cross et al., 1995; Frame, 
Cohen and Biondi, 2001). These phosphorylations can be induced by growth factor signalling, 
including through phosphorylation by AKT and p90 S6 kinase (S6K) (Cross et al., 1995; Eldar-
Finkelman et al., 1995). Lastly, GSK3β has been shown to participate in the regulation of 
endocytic events, inhibiting dynamin activity in CME but also potentiating activity-dependent bulk 
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endocytosis (ADBE) in synapses (Clayton et al., 2010; Smillie and Cousin, 2012; Reis et al., 
2015). These factors prompted further study of GSK3 in the context of FEME regulation. 
 
I investigated how GSK3 was being recruited to the leading edge to inhibit FEME. I performed a 
pulldown experiment and showed that GSK3β, but not GSK3α, was capable of binding directly 
to the EndophilinA2 SH3 domain in serum-starved but not resting cells. This discovery was built 
upon and has proven a fruitful route to understand FEME regulation.  
 
Further work conducted in our lab has shown that GSK3β strongly colocalises with endophilin at 
the leading edge of cells, but that the majority of the GSK3β at the leading edge is in active form. 
Experiments also showed that GSK3β activity sets the upper and lower bounds within which 
FEME can be modulated. Indeed, FEME competence (the proportion of cells in a culture which 
display FEME at any one time) is strongly correlated with GSK3β activity. Finally, inhibition of 
GSK3 and/or CDK5 enhanced FEME at the levels of cargo sorting, dynamin and dynein 
recruitment to FEME carriers (Ferreira et al., submitted). Interestingly, one of the cargoes shown 
to be under GSK3 control, ROBO1, triggers an intracellular cascade which has been shown to 
inactive GSK3β (Jiang et al., 2005; Byun et al., 2012).  
 
The local recruitment of GSK3β by endophilin, whilst initially surprising, makes sense in the 
context of the need for spatial control of GSK3’s activity. For a kinase, GSK3 has many targets, 
so restricting its activity to a specific region of the cell is crucial. EndophilinA2’s inability to bind 
to GSK3α is likely explained by the absence of a suitable PRM in GSK3α for engagement by the 
Endophilin SH3 domain. GSK3β, by contrast, does possess such a PRM (amino acids 307-311). 
 
My contribution and these further studies have built a picture of FEME regulation in which active 
GSK3β is recruited to the leading edge by endophilin to locally inhibit FEME. GSK3β inhibition 
can be quickly relieved by growth factor signalling. Given GSK3β’s reliance on priming kinases, 
this implicates other kinases in FEME inhibition. CDK5 has been shown to prime GSK3 
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phosphorylation of dynamin and the PlexinA1 adaptor CRMP4 (Ferreira et al., submitted), but is 
likely not the only priming kinase for GSK3β. 
 
Several avenues for future investigation of FEME regulation exist. Firstly, it is likely that 
endophilin itself is a target for kinases during FEME regulation. Endophilin is phosphorylated at 
its N-terminal helix 0 (T14) by ROCK and at two positions in helix 1 (T73 and S75) by LRRK2. 
Both of these modifications are capable of inhibiting endophilin’s membrane binding capacity and 
thus inhibiting the pathway (Kaneko et al., 2005; Ambroso, Hegde and Langen, 2014; Arranz et 
al., 2015). An attempt was made to detect and quantify changes in phosphopeptides in both AP-
MS experiments reported here, but the phosphopeptides detected were of low confidence. This 
was expected as a relatively small amount of protein was analysed and no effort to enrich the 
sample for phosphopeptides was made. Furthermore, there is no guarantee that a majority of the 
endophilin captured by IP would be modified by GSK3β. Indeed, many cells do not exhibit FEME 
in cell extracts from which IPs were conducted (no FEME is observed in ~50% of cells in Resting 
and ~30% of cells in +10% FBS conditions). The proportion of captured endophilin monomers 
which bear phosphorylations relevant to FEME is therefore expected to be small despite 
enrichment by IP.  
 
To assess changes in the phosphorylation of endophilin upon serum withdrawal or stimulation, a 
TiO2 phosphopeptide enrichment step could be added to the workflow following tryptic digest. 
This step is widely used to exclude non-phoshorylated peptides from a sample and thus improve 
workflow sensitivity for phosphopeptides (Thingholm et al., 2006). The use of larger amounts of 
starting material is essential to ensure that adequate amounts of phosphopeptide will be present 
following enrichment for detection by MS, given their low expected prevalence in the sample. 
 
A second direction for future study is related to the question of how the inhibitory 
phosphorylations imposed by GSK3β and CDK5 are removed so quickly. It is possible that a 
single phosphatase rapidly removes the inhibitory signals upon ligand stimulation. A similar 
scenario is observed in neurons, where many endocytic proteins are inhibited by 
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phosphorylations (Tomizawa et al., 2003; Liang et al., 2007). An influx of Ca2+ upon axon 
depolarisation activates calcineurin phosphatase, which removes these phosphate groups and 
permits swift compensatory endocytosis. It has not been established if Ca2+ controls FEME in 
non-neuronal cells and it is not clear which phosphatase could be specifically activated 
downstream of the many FEME cargo receptors (calcium-dependent or otherwise). This raises 
an alternative possibility, whereby the inhibitory phosphorylations applied to FEME proteins are 
constantly being removed by a set of constitutive phosphatases. In this schema, FEME is held 
off through the constant activity of a kinase or group of kinases, inactivation of one of all of which 
tips the system toward favouring FEME. This notion makes sense in light of the fact that many 
phosphatases are constitutively active and have a wide range of substrates. It would be 
interesting to investigate which hypothesis is correct. 
 
Further investigation of the candidate FEME adaptors/ cargoes identified in this work (WWP1, 
JUP and DYSF) would proceed by first testing if these candidates can bind to the endophilin SH3 
domain. Promising results can be followed with antibody-based confirmation of in vivo 
associations with endophilin through immunoprecipitation, fluorescent microscopy and ultimately 
antibody feeding assays. 
 
In this work I have been privileged to investigate a newly discovered endocytic pathway. What 
are the prospects for improving human health that spring from this work and how might FEME 
contribute to new therapies? Aside from the knowledge that Shiga and cholera toxins can gain 
entry to cell via FEME, it is possible that some viruses also exploit the pathway. Enterovirus 71 
(EV71) causes infections via the oral-faecal route and mainly affects children. A subset of 
infections cause severe disease which may feature neurological defects and or cardiopulmonary 
failure (Solomon et al., 2010). The virus has recently been described to enter cells via an 
endophilin-dependent, dynamin-dependent route that was independent of (Chen et al., 2019). 
While the dynamics of the entry process were different (viral entry took a longer timeframe), 
knowledge of FEME characteristics helped direct study of the process and will undoubtedly 




In the field of cancer therapeutics, a new strategy for enhancing monoclonal antibody treatment 
relying on inhibition of endocytosis has shown great promise. Chew et al. (2020) tested a novel 
treatment paradigm: the use of endocytosis inhibitors to potentiate antibody dependent cellular 
cytotoxicity (ADCC). ADCC is an important mechanism of tumour clearance during monoclonal 
antibody therapy, whereby opsonised tumour cells are recognised by natural killer cells of the 
innate immune system, which destroy the target cells through the release of granzymes and 
perforin (Wang et al., 2015). An important factor in the success of a monoclonal antibody’s ability 
to induce ADCC is the residence time of target receptors at the cell surface (Scott, Wolchok and 
Old, 2012). Using a squamous cell carcinoma cell line, Chew et al. (2020) showed that dynamin 
inhibition in the context of monoclonal antibody treatment caused a greater potentiation of ADCC 
than clathrin inhibitors alone. They attributed this to CME and FEME inhibition-dependent 
accumulation of EGFR at the surface of the cells. Finally, using a tumour ex-vivo model, the 
authors showed that a single dose of the dynamin inhibitor prochlorperazine (PCZ), redistributed 
EGFR to the surface of tumour cells, indicating that such potentiation of ADCC could work in 
humans. 
 
Whilst FEME has not, so far, constituted a “magic bullet” opportunity for the development of novel 
therapies, the examples above demonstrate how an understanding of FEME has helped guide 
experiment designs and explain observations. This is likely to continue as the pathway is further 
elucidated. 
 
6.3. Quantitative LC-MS profiling of spinal cord samples in a 
mouse model of motor neuron degeneration  
 
A network of molecular chaperones ensures the correct folding of proteins in cells. This network 
is particularly important in neurons, where failures in proteostasis are associated with a number 
of neurological disorders (Hartl, Bracher and Hayer-Hartl, 2011). HSJ1 (DNAJB2 in humans) is 
a neuronally enriched HSP40 cochaperone that acts as an adaptor for the HSP70 chaperone 
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(Cheetham, Brion and Anderton, 1992). Interestingly, HSJ1 possesses two ubiquitin interacting 
motifs (UIM) which allows it to function as a shuttle linking the proteasome, ubiquitination and 
chaperone machinery of the cell (Westhoff et al., 2005). Loss-of-function mutations in the locus 
encoding HSJ1 have been causally linked to distal hereditary motor neuropathy (dHMN) and 
Charcot-Marie-Tooth syndrome type 2 (CMT2) in humans (Gess et al., 2014; Tazir et al., 2014). 
Both conditions feature the progressive dysfunction of motor neurons, with concomitant loss of 
sensory neurons in CMT2 only. Interestingly, HSJ1 overexpression is neuroprotective a number 
of cell models of neurodegenerative disease (Westhoff et al., 2005; Borrell-Pagès et al., 2006; 
Howarth et al., 2007; Labbadia et al., 2012, Novoselov et al., 2013). This investigation aimed to 
define the motor neuron clients of HSJ1 to explain the protein’s neuroprotective effects. 
 
A HSJ1 KO mouse was used as a model system for this study. Motor neurons innervating the 
lower limbs are located in the lumbar spinal cord. Previous work in the Cheetham group 
established that motor neuron numbers in the lumbar spinal cord of HSJ1 KO mice are reduced 
by 11.6% relative to their wild-type counterparts, and that this loss occurs between postnatal day 
15 (P15) and postnatal day 20 (P20). Also, the elevated levels of total ubiquitinated proteins (1.9-
fold increase versus WT) and the autophagy marker protein LC3-II (1.3-fold higher versus WT) 
were observed in lumbar spinal cord extracts at least as early as P15. Finally, elevated levels of 
phosphorylated eIF2α and phosphorylated IRE-1, were detectable in P10 lumbar spinal cord 
extracts from HSJ1 KO mice indicating an active unfolded protein response (UPR). Together, 
these markers indicated a defect in proteostasis in the cells of the lumbar spinal cord as early as 
P10 involving high levels of misfolded proteins, an increase in autophagy and induction of the 
UPR. This defect appears to cause the death of ~11% of neurons in the lumbar spinal cord by 
P20. Whilst HSJ1 KO mice are behaviourally normal, investigating the mechanism by which 
HSJ1 loss induces a stress response in the lumbar spinal cord could shed light on motor neuron 
disease in humans. 
 
I hypothesised that HSJ1 client proteins would fail to fold correctly at a higher rate in HSJ1 KO 
animals, and would be degraded at the proteasome or lost in the insoluble fraction. Furthermore, 
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if HSJ1 is important for shuttling ubiquitinated clients to the proteasome, these would be expected 
to accumulate in KO animals. Therefore, by comparing the proteome complement of WT and KO 
mouse lumbar spinal cords at P10 using quantitative proteomics, I could identify any proteins 
which are differentially expressed as potential HSJ1 clients for further validation. In addition, 
sufficient coverage of the lumbar spinal cord proteome could independently confirm the observed 
induction of the UPR and increased autophagy in KO mice. 
 
My analysis obtained quantitative information for 1538 proteins. The dataset displayed highest 
similarity (in protein abundances) to a dataset from adult mouse spinal cords, and an analysis of 
marker proteins showed that the sample originated from a mixed population of neuronal and glial 
cells. Finally, HSJ1 itself was only observed in WT samples. Together, these results confirmed 
that the sample preparation and MS analysis workflow had worked well and argue for the validity 
of any conclusions drawn. Unexpectedly, no differentially expressed proteins were identified and 
no significant changes in the proportion of GO terms in either condition were observed, indicating 
that HSJ1 loss does not induce major changes in protein abundance at the depth of coverage 
achieved and at this timepoint. 
 
Turning to my qualitative data, I found 88 proteins unique to WT mouse samples and 76 unique 
in KO mice. Of these, three proteins unique in WT samples stood out as interesting candidates: 
Ubiquilin-1 (Ubqln1), Ganglioside Induced Differentiation Associated Protein 1 (Gdap1) and 
Ataxin-10 (Atxn10). 
 
Gdap1 represents a particularly interesting candidate for future study, as mutations in this protein 
have been linked to CMT2 (Cuesta et al., 2002; Tazir et al., 2014). This disease closely 
resembles the pattern of motor neuron loss without demyelination observed in HSJ1-linked 
CMT2, raising the possibility that a failure to correctly fold Gdap1 underlies HSJ1-linked CMT2 
disease mechanistically. Gdap1 is a 367-amino acid protein which is highly expressed in neurons 
(Cuesta et al., 2002). It is localised to the outer mitochondrial membrane, where its exact function 
is unclear. Study of Gdap1 in cell and mouse models have proposed a role for Gdap1 in 
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mitochondrial fission (Niemann et al., 2009) and positioning (Pla-Martín et al., 2013), resistance 
to reactive oxygen species (ROS) (Noack et al., 2012; Niemann et al., 2014; Huber et al., 2016) 
and Calcium homeostasis (Pla-Martín et al., 2013; Barneo-Muñoz et al., 2015; González-
Sánchez et al., 2017). Indeed, studies of Gdap1 deficiency in a neuroblastoma cell line and in a 
mouse model demonstrated that loss of Gdap1 resulted in lowered ER calcium levels (Barneo-
Muñoz et al., 2015; González-Sánchez et al., 2017). As depletion of ER calcium is a well-
documented UPR initiator (Shore, Papa and Oakes, 2011), Gdap1 misfolding in the absence of 
HSJ1 may underlie activation of the UPR in P10 lumbar spinal cord extracts.  
 
To test the candidates identified above, a prudent next step would be to confirm the phenotypes 
described using an orthogonal measure of protein abundance such as western blotting or 
immunohistochemistry on spinal cord extracts or sections. If the loss of Gdap1 is confirmed, 
characterisation of mitochondrial distribution and ER calcium levels in motor neurons would be 
interesting. 
 
The main limitation of my approach in this study was the relatively low depth of proteome 
coverage achieved. This is likely attributable to insufficient sample fractionation. During sample 
preparation, gels were cut into only six fractions, limiting the degree to which peptides could be 
separated before ionisation by nanoESI and thus compromising workflow sensitivity. Protocols 
for achieving deeper proteome coverage involve extensive sample fractionation. For example, 
the adult spinal cord sample dataset used for comparison in this work utilised a 40-fraction HPLC 
step, quantifying 7211 proteins (Hasan et al., 2019). Further fractionation at the peptide level 
could also be employed, perhaps using high pH RPLC fractionation or SCX after protein level 
fractionation. 
 
The experiment design used here is suitable for identifying global changes in the proteomes of 
lumbar spinal cords but cannot directly define the HSJ1 interactome. Any candidates displaying 
differential expression may reflect adaptations to the loss of HSJ1. To find proteins which directly 
interact with or form a complex with HSJ1, AP-MS experiments could be used (using HSJ1 as a 
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bait). Indeed, the availability of HSJ1 KO samples presents the opportunity to perform a powerful 
controlled AP-MS experiment. 
 
A further limitation of the model system is that only a subset of the cells from which proteins are 
extracted are likely to be affected by HSJ1 loss (the neurons). Proteins from the surrounding glia 
and muscle are also released, obscuring the neuronal proteome. A solution to this would be to 
use patient-derived induced pluripotent stem cells (iPSCs) to generate a homogeneous culture 
for profiling. Quantitative proteomic comparisons of case and control iPSC cultures could help 
narrow down the list of potential clients identified from orthologous techniques. It is hoped that a 
better understanding of how HSJ1 contributes to proteostasis will shed light on the disease 
mechanisms of motor neuron degeneration. 
 
In summary, quantitative proteomics was applied to discover novel cargoes of the recently 
described endocytic pathway, FEME. Plasma membrane extracts from mammalian cells were 
profiled by MS following genetic perturbation of different endocytic routes, identifying several 
candidate FEME cargoes/ cargo sorting adaptors for future study. An investigation of the 
mechanisms which regulate FEME identified GS3Kβ as a binding partner for endophilin A2, 
helping to explain how GS3Kβ activity exerts such tight control over FEME events. Quantitative 
proteomics experiments were also conducted to help elucidate the causes of neuron death in a 
murine model of motor neuron degeneration. Spinal cord extracts from mice lacking the HSP40 
co-chaperone HSJ1 were compared to their wild-type counterparts. Whilst quantitative 
measurements failed to identify differentially expressed proteins at the depth of coverage 
achieved, analysis of our qualitative highlighted several proteins as candidate HSJ1 clients 
including Gdap1. The datasets presented here serve as a valuable resource for future studies of 
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8.1.  Yield of plasma membrane protein from surface 
biotinylation 
 














1.0 0.229 0.23 0.229 0.229 0.220 0.013 
1.0 0.211 0.207 0.214 0.211  0.004 
0.2 0.088 0.086 0.088 0.087 0.084 0.005 
0.2 0.08 0.081 0.079 0.080  0.001 
0.5 0.137 0.14 0.135 0.137 0.130 0.010 
0.5 0.123 0.125 0.122 0.123  0.002 
Diluted Sample  
6X PM 1 (0.75X) 0.169 0.174 0.169 0.171  0.003 






Table 8.1  Quantitation of concentrated plasma membrane (PM) fraction from 6 x 100 mm dishes 
of RPE1 cells at 2 dilutions with reference to BSA standards. 







6X Pmx 1 0.96 
6X Pmx 2 1.14 
Mean + SD 1.05 ± 0.1  
 
  
Table 8.2  Corrected sample concentrations and final estimate of protein concentration. 
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8.2. Differentially expressed proteins (endogenous Endophilin 
A2 IP) 
 




Dynein assembly factor 5_ axonemal  DNAAF5 8.545 0.0311 
Ubiquitin carboxyl-terminal hydrolase BAP1  BAP1 8.061 0.0320 
USP6 N-terminal-like protein  USP6NL 8.003 0.0155 
Uncharacterized protein C14orf80  C14orf80 5.698 0.0321 
DNA polymerase delta subunit 4  POLD4 4.649 0.0088 
SRSF protein kinase 2  SRPK2 4.528 0.0389 
NEDD4-like E3 ubiquitin-protein ligase WWP1  WWP1 3.936 0.0340 
Diacylglycerol kinase zeta  DGKZ 3.458 0.0340 
Death domain-associated protein 6  DAXX 3.440 0.0168 
PAB-dependent poly(A)-specific ribonuclease 
subunit PAN3  
PAN3 3.072 0.0496 
General transcription factor IIF subunit 2  GTF2F2 3.032 0.0193 
Kinesin-like protein KIF18B  KIF18B 2.966 0.0188 
Zinc finger CCCH domain-containing protein 7B  ZC3H7B 2.738 0.0067 
MICAL-like protein 1  MICALL1 2.718 0.0257 
E3 ubiquitin-protein ligase TRIM33  TRIM33 2.615 0.0494 
DTW domain-containing protein 2  DTWD2 2.474 0.0322 
Mediator of RNA polymerase II transcription 
subunit 20  
MED20 2.317 0.0427 
cTAGE family member 6  CTAGE6 2.317 0.0001 
Protein YIF1B  YIF1B 2.291 0.0130 
Ribosomal RNA processing protein 1 homolog B  RRP1B 2.234 0.00004 
Four and a half LIM domains protein 1  FHL1 2.191 0.0011 
Probable E3 ubiquitin-protein ligase DTX3  DTX3 2.176 0.0167 
Serine/threonine-protein kinase NIM1  NIM1K 2.170 0.0073 
Rho GTPase-activating protein 17  ARHGAP17 2.168 0.0040 
28S ribosomal protein S2_ mitochondrial  MRPS2 2.167 0.0069 
T-complex protein 1 subunit alpha  TCP1 2.084 0.0221 
Protein timeless homolog  TIMELESS 2.046 0.0402 
Liprin-beta-1  PPFIBP1 2.039 0.0275 
39S ribosomal protein L15_ mitochondrial  MRPL15 1.943 0.0137 
Aminoacyl tRNA synthase complex-interacting 
multifunctional protein 2  
AIMP2 1.942 0.0255 
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily E 
member 1-related  
HMG20B 1.880 0.0490 
Protein RCC2  RCC2 1.875 0.0249 
B-cell CLL/lymphoma 7 protein family member C  BCL7C 1.871 0.0394 
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Tropomyosin alpha-4 chain  TPM4 1.839 0.0221 
Actin-related protein 6  ACTR6 1.837 0.0101 
Disabled homolog 2-interacting protein  DAB2IP 1.831 0.0015 
General transcription factor 3C polypeptide 5  GTF3C5 1.811 0.0219 
Anaphase-promoting complex subunit 16  ANAPC16 1.808 0.0408 
F-actin-capping protein subunit alpha-1  CAPZA1 1.775 0.0351 
Beta-crystallin A3  CRYBA1 1.758 0.0218 
Protein Smaug homolog 1  SAMD4A 1.726 0.0314 
Pleckstrin homology domain-containing family N 
member 1  
PLEKHN1 1.724 0.0328 
Endonuclease III-like protein 1  NTHL1 1.720 0.0290 
Fructose-bisphosphate aldolase B  ALDOB 1.714 0.0377 
WD repeat-containing protein 11  WDR11 1.701 0.0060 
Phosphatidylglycerophosphatase and protein-
tyrosine phosphatase 1  
PTPMT1 1.698 0.0046 
Headcase protein homolog  HECA 1.698 0.0241 
Protein diaphanous homolog 1  DIAPH1 1.696 0.0176 
Elongation factor 1-beta  EEF1B2 1.686 0.0255 
CDGSH iron-sulfur domain-containing protein 2  CISD2 1.684 0.0348 
BUB3-interacting and GLEBS motif-containing 
protein ZNF207  
ZNF207 1.673 0.0491 
Putative uncharacterized protein C20orf78  C20orf78 1.665 0.0255 
Forkhead box protein C2  FOXC2 1.652 0.0288 
DNA repair and recombination protein RAD54B  RAD54B 1.636 0.0321 
Keratin_ type II cuticular Hb4  KRT84 1.629 0.0437 
Centromere protein V  CENPV 1.594 0.0497 
Fatty acid desaturase 3  FADS3 1.590 0.0333 
Importin subunit alpha-1  KPNA2 1.587 0.0171 
Importin subunit alpha-5  KPNA1 1.581 0.0320 
Glial fibrillary acidic protein  GFAP 1.560 0.0390 
ATP-dependent RNA helicase DDX55  DDX55 1.558 0.0236 
Ankyrin repeat domain-containing protein 34A  ANKRD34A 1.554 0.0091 
Serine/threonine-protein kinase RIO2  RIOK2 1.552 0.0499 
Importin-9  IPO9 1.551 0.0031 
E3 ubiquitin-protein ligase CBL-B  CBLB 1.551 0.0460 
Histone deacetylase 1  HDAC1 1.550 0.0215 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 10  
NDUFB10 1.547 0.0030 
Sister chromatid cohesion protein PDS5 homolog A  PDS5A 1.544 0.0005 
Partitioning defective 3 homolog B  PARD3B 1.539 0.0141 
Eukaryotic translation elongation factor 1 epsilon-1  EEF1E1 1.538 0.0111 
Long-chain-fatty-acid--CoA ligase 4  ACSL4 1.528 0.0250 
ATP-dependent zinc metalloprotease YME1L1  YME1L1 1.525 0.0368 
Putative heat shock 70 kDa protein 7  HSPA7 1.525 0.0160 
247 
 




TFIIH basal transcription factor complex helicase 
XPB subunit  
ERCC3 1.522 0.0497 
Nucleotide exchange factor SIL1  SIL1 1.521 0.0354 
Importin subunit alpha-4  KPNA3 1.520 0.0016 
E3 ubiquitin-protein ligase CHIP  STUB1 1.516 0.0314 
Antigen peptide transporter 1  TAP1 1.507 0.0397 
Monoacylglycerol lipase ABHD12  ABHD12 1.504 0.0131 
Serine/threonine-protein kinase OSR1  OXSR1 1.497 0.0063 
Elongation factor Tu_ mitochondrial  TUFM 1.496 0.0437 
Deoxynucleoside triphosphate 
triphosphohydrolase SAMHD1  
SAMHD1 1.494 0.0496 
Coiled-coil domain-containing protein 47  CCDC47 1.492 0.0029 
Coiled-coil domain-containing protein 17  CCDC17 1.486 0.0383 
Cyclin-dependent kinase 17  CDK17 1.486 0.0023 
SH3 and PX domain-containing protein 2B  SH3PXD2B 1.484 0.0168 
Glycerol-3-phosphate dehydrogenase_ 
mitochondrial  
GPD2 1.482 0.0321 
Transcription factor Dp-1  TFDP1 1.481 0.0038 
Sulfide:quinone oxidoreductase_ mitochondrial  SQOR 1.476 0.0052 
TOX high mobility group box family member 4  TOX4 1.473 0.0373 
Importin subunit alpha-7  KPNA6 1.464 0.0033 
F-box/LRR-repeat protein 6  FBXL6 1.460 0.0479 
E3 ubiquitin-protein ligase RNF25  RNF25 1.457 0.0246 
Polyadenylate-binding protein-interacting protein 
1  
PAIP1 1.454 0.0462 
Protein TBRG4  TBRG4 1.452 0.0266 
Histone deacetylase 2  HDAC2 1.451 0.0260 
60 kDa heat shock protein_ mitochondrial  HSPD1 1.451 0.0438 
Testican-1  SPOCK1 1.449 0.0392 
Regulator of nonsense transcripts 3B  UPF3B 1.443 0.0381 
Endothelial differentiation-related factor 1  EDF1 1.438 0.0031 
Protein argonaute-4  AGO4 1.428 0.0050 
WAS/WASL-interacting protein family member 1  WIPF1 1.427 0.0035 
Ankyrin repeat and zinc finger domain-containing 
protein 1  
ANKZF1 1.426 0.0421 
Ankyrin repeat and LEM domain-containing 
protein 2  
ANKLE2 1.416 0.0068 
Putative RNA polymerase II subunit B1 CTD 
phosphatase RPAP2  
RPAP2 1.412 0.0259 
Zinc finger protein-like 1  ZFPL1 1.407 0.0159 
Lamin-B receptor  LBR 1.405 0.0331 
DNA topoisomerase 3-alpha  TOP3A 1.399 0.0431 
PHD finger protein 23  PHF23 1.390 0.0192 
Vitronectin  VTN 1.381 0.0190 
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Plasminogen activator inhibitor 1  SERPINE1 1.381 0.0116 
Probable C-mannosyltransferase DPY19L1  DPY19L1 1.376 0.0292 
Catenin delta-1  CTNND1 1.371 0.0067 
THAP domain-containing protein 11  THAP11 1.365 0.0049 
U4/U6 small nuclear ribonucleoprotein Prp31  PRPF31 1.364 0.0182 
T-complex protein 1 subunit gamma  CCT3 1.359 0.0360 
Peroxidasin homolog  PXDN 1.358 0.0351 
SH3KBP1-binding protein 1  SHKBP1 1.354 0.0380 
Ras GTPase-activating protein-binding protein 1  G3BP1 1.353 0.0022 
A disintegrin and metalloproteinase with 
thrombospondin motifs 1  
ADAMTS1 1.351 0.0453 
Trifunctional enzyme subunit alpha_ mitochondrial  HADHA 1.350 0.0138 
T-complex protein 1 subunit delta  CCT4 1.347 0.0098 
Metastasis-associated protein MTA2  MTA2 1.346 0.0123 
Mapk-regulated corepressor-interacting protein 1  MCRIP1 1.342 0.0451 
Protein ECT2  ECT2 1.340 0.0419 
Unconventional myosin-If  MYO1F 1.338 0.0160 
Transportin-1  TNPO1 1.336 0.0062 
Proteasome subunit beta type-6  PSMB6 1.334 0.0244 
Katanin p60 ATPase-containing subunit A-like 1  KATNAL1 1.334 0.0002 
Nuclear pore complex protein Nup50  NUP50 1.328 0.0314 
GTP-binding protein 1  GTPBP1 1.318 0.0005 
Inner nuclear membrane protein Man1  LEMD3 1.315 0.0083 
Ornithine aminotransferase_ mitochondrial  OAT 1.314 0.0202 
GRIP and coiled-coil domain-containing protein 2  GCC2 1.313 0.0037 
Twinfilin-1  TWF1 1.310 0.0297 
Ras GTPase-activating protein nGAP  RASAL2 1.307 0.0319 
Methyl-CpG-binding domain protein 2  MBD2 1.298 0.0482 
Probable ATP-dependent RNA helicase DDX28  DDX28 1.296 0.0444 
DEP domain-containing protein 1B  DEPDC1B 1.293 0.0164 
Keratin_ type I cuticular Ha6  KRT36 0.764 0.0038 
Rho guanine nucleotide exchange factor 17  ARHGEF17 0.763 0.0074 
Cofilin-2  CFL2 0.756 0.0417 
Replication factor C subunit 1  RFC1 0.741 0.0332 
Serine protease HTRA3  HTRA3 0.740 0.0146 
Hemoglobin subunit epsilon  HBE1 0.735 0.0204 
Protein LLP homolog  LLPH 0.734 0.0227 
Keratin_ type I cytoskeletal 20  KRT20 0.729 0.0112 
Keratin_ type II cytoskeletal 2 epidermal  KRT2 0.720 0.0138 
Unconventional prefoldin RPB5 interactor 1  URI1 0.720 0.0134 
Protein bicaudal C homolog 1  BICC1 0.720 0.0443 
Trypsin-3  PRSS3 0.714 0.0234 
Thrombospondin-1  THBS1 0.712 0.0376 
Cell division cycle 5-like protein  CDC5L 0.710 0.0056 
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Cep170-like protein  CEP170P1 0.708 0.0444 
ATP-binding cassette sub-family F member 1  ABCF1 0.701 0.0226 
Deoxynucleotidyltransferase terminal-interacting 
protein 2  
DNTTIP2 0.690 0.0131 
Enhancer of rudimentary homolog  ERH 0.687 0.0149 
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily B 
member 1  
SMARCB1 0.686 0.0229 
DNA-directed RNA polymerase II subunit RPB1  POLR2A 0.685 0.0204 
YLP motif-containing protein 1  YLPM1 0.684 0.0288 
Keratin_ type I cuticular Ha1  KRT31 0.680 0.0001 
AT-rich interactive domain-containing protein 5B  ARID5B 0.672 0.0387 
Poly [ADP-ribose] polymerase 4  PARP4 0.669 0.0466 
Immunoglobulin heavy constant gamma 1  IGHG1 0.663 0.0108 
Keratin_ type II cytoskeletal 4  KRT4 0.659 0.0188 
CREB-regulated transcription coactivator 3  CRTC3 0.650 0.0474 
Microtubule-associated protein 2  MAP2 0.645 0.0165 
Desmoglein-1  DSG1 0.644 0.0049 
Keratin_ type I cytoskeletal 10  KRT10 0.638 0.0065 
Myotubularin-related protein 5  SBF1 0.636 0.0449 
Heat shock 70 kDa protein 1A  HSPA1A 0.634 0.0446 
Nuclear mitotic apparatus protein 1  NUMA1 0.631 0.0163 
Homeobox protein Hox-D10  HOXD10 0.623 0.0025 
Intraflagellar transport protein 74 homolog  IFT74 0.622 0.0339 
Chromodomain-helicase-DNA-binding protein 1  CHD1 0.619 0.0028 
PHD finger protein 3  PHF3 0.606 0.0240 
Thyroid hormone receptor-associated protein 3  THRAP3 0.603 0.0126 
Regulation of nuclear pre-mRNA domain-
containing protein 2  
RPRD2 0.598 0.0046 
Plasma membrane calcium-transporting ATPase 4  ATP2B4 0.598 0.0265 
AT-rich interactive domain-containing protein 1A  ARID1A 0.598 0.0475 
Oxysterol-binding protein-related protein 3  OSBPL3 0.596 0.0370 
U5 small nuclear ribonucleoprotein 200 kDa 
helicase  
SNRNP200 0.595 0.0138 
Actin-related protein 3  ACTR3 0.592 0.0039 
Zinc finger protein 629  ZNF629 0.587 0.0315 
Septin-7  SEPT7 0.578 0.0135 
Centrosomal protein kizuna  KIZ 0.576 0.0011 
E3 ubiquitin-protein ligase RBBP6  RBBP6 0.574 0.0462 
Next to BRCA1 gene 2 protein  NBR2 0.569 0.0331 
Myosin regulatory light polypeptide 9  MYL9 0.567 0.0220 
Splicing factor_ suppressor of white-apricot 
homolog  
SFSWAP 0.566 0.0128 
Ral GTPase-activating protein subunit beta  RALGAPB 0.564 0.0209 
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Probable ATP-dependent RNA helicase DDX46  DDX46 0.564 0.0027 
Filaggrin-2  FLG2 0.562 0.0271 
Nck-associated protein 5-like  NCKAP5L 0.561 0.0299 
Prolactin-inducible protein  PIP 0.560 0.0118 
Torsin-1A-interacting protein 1  TOR1AIP1 0.560 0.0391 
Centrosomal protein of 89 kDa  CEP89 0.559 0.0207 
Protein S100-A8  S100A8 0.553 0.0008 
CD166 antigen  ALCAM 0.550 0.0130 
Uncharacterized protein KIAA0754  KIAA0754 0.545 0.0123 
DNA topoisomerase 2-beta  TOP2B 0.537 0.0427 
Microtubule cross-linking factor 1  MTCL1 0.534 0.0364 
Bromodomain adjacent to zinc finger domain 
protein 1A  
BAZ1A 0.533 0.0211 
Dermcidin  DCD 0.533 0.0120 
Death-inducer obliterator 1  DIDO1 0.530 0.0234 
N-acylneuraminate cytidylyltransferase  CMAS 0.529 0.0108 
Methionine aminopeptidase 1  METAP1 0.527 0.0071 
Protein polybromo-1  PBRM1 0.521 0.0191 
Calumenin  CALU 0.520 0.0469 
FERM domain-containing protein 4A  FRMD4A 0.519 0.0025 
Caspase-14  CASP14 0.515 0.0143 
Exocyst complex component 6B  EXOC6B 0.512 0.0340 
E3 SUMO-protein ligase PIAS1  PIAS1 0.509 0.0294 
Proline-rich protein 12  PRR12 0.506 0.0211 
Sorting nexin-33  SNX33 0.500 0.0014 
Clusterin  CLU 0.498 0.0151 
Flap endonuclease GEN homolog 1  GEN1 0.497 0.0335 
Alpha-actinin-4  ACTN4 0.490 0.0454 
Collagen and calcium-binding EGF domain-
containing protein 1  
CCBE1 0.487 0.0424 
Reticulocalbin-2  RCN2 0.484 0.0405 
Splicing factor U2AF 35 kDa subunit-like protein  U2AF1L5 0.483 0.0118 
Macoilin  TMEM57 0.482 0.0338 
Serine/threonine-protein kinase PRP4 homolog  PRPF4B 0.479 0.0366 
Guanine nucleotide-binding protein G(s) subunit 
alpha isoforms XLas  
GNAS 0.474 0.0109 
Pleckstrin homology domain-containing family A 
member 2  
PLEKHA2 0.473 0.0451 
60S ribosomal protein L35a  RPL35A 0.471 0.0423 
DNA ligase 3  LIG3 0.471 0.0023 
AT-rich interactive domain-containing protein 1B  ARID1B 0.470 0.0394 
Sorting nexin-16  SNX16 0.468 0.0075 
Exportin-2  CSE1L 0.467 0.0063 
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Uveal autoantigen with coiled-coil domains and 
ankyrin repeats  
UACA 0.461 0.0175 
Lysozyme C  LYZ 0.461 0.0095 
Pleckstrin homology-like domain family B member 
1  
PHLDB1 0.456 0.0107 
Serpin H1  SERPINH1 0.456 0.0498 
RNA-binding protein 10  RBM10 0.455 0.0074 
Casein kinase II subunit alpha  CSNK2A1 0.426 0.0169 
Myosin-9  MYH9 0.426 0.0283 
General transcription factor 3C polypeptide 1  GTF3C1 0.423 0.0151 
Serpin B3  SERPINB3 0.420 0.0052 
La-related protein 6  LARP6 0.413 0.0426 
Aldehyde dehydrogenase_ dimeric NADP-
preferring  
ALDH3A1 0.408 0.0138 
Keratin_ type I cytoskeletal 14  KRT14 0.403 0.0228 
Phosphorylated adapter RNA export protein  PHAX 0.401 0.0089 
Peripherin  PRPH 0.400 0.0072 
E3 ubiquitin-protein ligase TRIM56  TRIM56 0.400 0.0002 
Calcium signal-modulating cyclophilin ligand  CAMLG 0.397 0.0435 
Serpin B4  SERPINB4 0.383 0.0007 
28S ribosomal protein S31_ mitochondrial  MRPS31 0.367 0.0040 
Keratin_ type I cytoskeletal 17  KRT17 0.363 0.0053 
Keratin_ type I cytoskeletal 24  KRT24 0.354 0.0451 
Serine/threonine-protein kinase Nek1  NEK1 0.347 0.0111 
Poly [ADP-ribose] polymerase 14  PARP14 0.338 0.0078 
Tyrosine-protein phosphatase non-receptor type 2  PTPN2 0.336 0.0181 
Dual specificity protein phosphatase 16  DUSP16 0.333 0.0160 
UNC119-binding protein C5orf30  C5orf30 0.330 0.0368 
Keratin_ type II cytoskeletal 71  KRT71 0.330 0.0204 
Eukaryotic translation initiation factor 2 subunit 2  EIF2S2 0.327 0.0331 
LIM domain-binding protein 2  LDB2 0.323 0.0428 
Sperm flagellar protein 2  SPEF2 0.321 0.0221 
Hsp90 co-chaperone Cdc37  CDC37 0.312 0.0114 
Keratin_ type I cytoskeletal 12  KRT12 0.297 0.0113 
Heat shock 70 kDa protein 1-like  HSPA1L 0.289 0.0420 
Replication factor C subunit 5  RFC5 0.262 0.0221 
DNA topoisomerase 3-beta-1  TOP3B 0.257 0.0262 
Hippocalcin-like protein 1  HPCAL1 0.256 0.0154 
Keratin_ type I cytoskeletal 26  KRT26 0.250 0.0155 
Keratin_ type I cytoskeletal 40  KRT40 0.249 0.0416 
Histone-arginine methyltransferase CARM1  CARM1 0.247 0.0399 
Kinesin-like protein KIF14  KIF14 0.240 0.0019 
Mitochondrial import receptor subunit TOM40B  TOMM40L 0.206 0.0349 
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FAST kinase domain-containing protein 2_ 
mitochondrial  
FASTKD2 0.201 0.0138 
Isoleucine--tRNA ligase_ cytoplasmic  IARS 0.190 0.0433 
Partitioning defective 3 homolog  PARD3 0.182 0.0354 
AP-1 complex subunit mu-1  AP1M1 0.181 0.0368 
Protein FAM84B  FAM84B 0.175 0.0068 
DNA (cytosine-5)-methyltransferase 1  DNMT1 0.169 0.0404 
Chromodomain-helicase-DNA-binding protein 2  CHD2 0.160 0.0496 
Putative Ras-related protein Rab-1C  RAB1C 0.090 0.0129 
Actin-binding LIM protein 3  ABLIM3 0.074 0.0214 
Ribosome production factor 1  RPF1 0.007 0.0011 
Table 8.3  List of proteins differentially expressed between endogenous IPs of endophilin from 
Stimulated or Resting RPE1 cell extracts. Proteins enriched in the Resting condition are shaded in grey.  
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8.3. List of proteins uniquely identified in HSJ1+/+ and HSJ1-/- 











Dock11 3.362 A2AF47 Dedicator of cytokinesis protein 11 WT 
Slc8a1 3.237 G3X9J1 Slc8a1 protein WT 
Gdap1 3.224 O88741 
Ganglioside-induced differentiation-
associated protein 1 
WT 
Ubr4 3.174 A2AN08-2 
E3 ubiquitin-protein ligase UBR4 
(Fragment) 
WT 
Cit 2.609 D3YU89 Citron Rho-interacting kinase WT 






Serine/threonine-protein kinase MRCK 
beta (Fragment) 
WT 
Phldb1 2.459 D3Z0X5 
Isoform 2 of Pleckstrin homology-like 
domain family B member 1 
WT 
Igsf3 2.444 A0A0A6YX40 Immunoglobulin superfamily member 3 WT 
Cep170 2.373 A0A0A6YVZ3 
Centrosomal protein of 170 kDa 
(Fragment) 
WT 
Itsn2 1.953 B2RR82 Intersectin-2 WT 
Agap2 1.939 Q3UHD9 
Arf-GAP with GTPase_ ANK repeat and PH 





Predicted pseudogene 5580 WT 
Taok2 1.831 Q6ZQ29 






Isoform 2 of Neuron navigator 1 WT 




Serine (or cysteine) peptidase inhibitor_ 





Interferon-induced protein with 





Isoform 2 of Rho GTPase-activating 
protein 44 
WT 
Plxna2 1.728 P70207 Plexin-A2 WT 
Grm5 1.725 E9QMC2 
Isoform 2 of Metabotropic glutamate 
receptor 5 
WT 
Mast1 1.699 E9Q6Q5 
Microtubule-associated serine/threonine-





Tubulin alpha chain (Fragment) OS WT 
Usp9x 1.633 E9PWA9 
Probable ubiquitin carboxyl-terminal 
hydrolase FAF-X (Fragment) 
WT 
Zc2hc1a 1.625 Q8BJH1 
Isoform 2 of Zinc finger C2HC domain-
containing protein 1A 
WT 




Sugt1 1.610 Q9CX34 Protein SGT1 homolog WT 
Pde9a 1.559 D3YTQ4 
High affinity cGMP-specific 3'_5'-cyclic 













Kif21b 1.527 E9Q0A4 Kinesin-like protein KIF21B WT 
Slc25a25 1.516 A2ASZ8 
Calcium-binding mitochondrial carrier 
protein SCaMC-2 
WT 
Nagk 1.511 D3YXG2 N-acetyl-D-glucosamine kinase WT 
Sarm1 1.506 Q6PDS3 
Isoform 2 of Sterile alpha and TIR motif-
containing protein 1 
WT 
Rptor 1.488 A2ACM0 
Isoform 2 of Regulatory-associated 
protein of mTOR 
WT 
Plxnb1 1.480 Q8CJH3 Plexin-B1 WT 
Cntnap4 1.475 D3YWB9 Contactin-associated protein-like 4 WT 
Slc12a6 1.398 A2AGJ9 






Ataxin-2-like protein (Fragment) WT 
Nrp2 1.383 O35375 Isoform A0 of Neuropilin-2 WT 
Rasgrf1 1.381 P27671 
Ras-specific guanine nucleotide-releasing 
factor 1 
WT 
Lrrc16a 1.335 D3Z030 
F-actin-uncapping protein LRRC16A 
(Fragment) 
WT 
Gpr158 1.306 Q8C419 Probable G-protein coupled receptor 158 WT 
Fkbp15 1.300 Q6P9Q6 FK506-binding protein 15 WT 




Slc25a4 1.257 P48962 ADP/ATP translocase 1 WT 
Btbd17 1.253 Q9DB72 BTB/POZ domain-containing protein 17 WT 
Wdr44 1.235 Q6NVE8 
Isoform 2 of WD repeat-containing 
protein 44 
WT 
Dock4 1.231 A0A1Y7VLY2 Dedicator of cytokinesis protein 4 WT 
Magi2 1.216 A0A0G2JE00 
Isoform 2 of Membrane-associated 
guanylate kinase_ WW and PDZ domain-




1.215 Q6GQX8 AU042671 protein (Fragment) WT 
Atat1 1.212 Q8K341 Alpha-tubulin N-acetyltransferase 1 WT 
Slmap 1.210 D3Z7V3 
Isoform 2 of Sarcolemmal membrane-
associated protein 
WT 
Cacnb4 1.179 J3QK20 
Isoform 1 of Voltage-dependent L-type 
calcium channel subunit beta-4 
WT 
Atxn10 1.172 P28658 Ataxin-10 WT 
Pten 1.141 O08586 
Phosphatidylinositol 3_4_5-trisphosphate 
3-phosphatase and dual-specificity protein 
phosphatase PTEN 
WT 
Slc12a7 1.121 Q9WVL3 
Isoform 2 of Solute carrier family 12 
member 7 
WT 
Ywhaq 1.105 F6VW30 14-3-3 protein theta (Fragment) WT 
Ppfia1 1.080 B2RXQ2 Ppfia1 protein WT 
Dhcr24 1.045 Q8VCH6 Delta(24)-sterol reductase WT 
Dnajb2 1.022 Q9QYI5 DnaJ homolog subfamily B member 2 WT 
Alad 1.015 P10518 Delta-aminolevulinic acid dehydratase WT 
Ubr3 1.012 A2AV05 
E3 ubiquitin-protein ligase UBR3 
(Fragment) 
WT 
Ythdf2 1.004 Q91YT7 YTH domain-containing family protein 2 WT 
Jmy 0.991 A0A0R4J0V4 
Isoform 2 of Junction-mediating and -
regulatory protein 
WT 
















Liprin-alpha 4 WT 
Lingo1 0.918 A9DA50 
Leucine-rich repeat and immunoglobulin-
like domain-containing nogo receptor-
interacting protein 1 
WT 
Nsun2 0.875 H3BKN0 






Predicted gene 9040 WT 
Armc2 0.859 Q3URY6 Armadillo repeat-containing protein 2 WT 
Ythdf3 0.850 Q8BYK6 
Isoform 2 of YTH domain-containing 
family protein 3 
WT 
Rraga 0.799 Q80X95 Ras-related GTP-binding protein A WT 
Polr1c 0.787 G3UX92 
DNA-directed RNA polymerases I and III 
subunit RPAC1 
WT 
Lgi2 0.776 Q8K4Z0 
Isoform 2 of Leucine-rich repeat LGI family 
member 2 
WT 
Asrgl1 0.771 Q8C0M9 Isoaspartyl peptidase/L-asparaginase WT 
Tom1l2 0.763 F6RBX1 Isoform 2 of TOM1-like protein 2 WT 
Traf3 0.728 D3Z343 








family member 6 
WT 
Plxna3 0.723 P70208 Isoform 2 of Plexin-A3 WT 
Ubqln1 0.711 Q8R317 Isoform 2 of Ubiquilin-1 WT 
Kifc3 0.684 A0A0R4J220 Isoform 2 of Kinesin-like protein KIFC3 WT 
Steap2 0.630 D3YUM6 MCG2960_ isoform CRA_a WT 
Luc7l3 0.553 Q5SUF2 Isoform 2 of Luc7-like protein 3 WT 
Tmem30
a 
0.487 D3YVV1 Cell cycle control protein 50A WT 
Syngr3 0.448 Q8R191 Synaptogyrin-3 WT 




Trim2 0.288 E9QKC6 Tripartite motif-containing protein 2 WT 
Ythdf1 0.035 A2AWN8 YTH domain family 1_ isoform CRA_a WT 
Gm1312
5 
4.419 B1ARV6 PRAME family member 20 KO 
Ndufa9 3.410 A0A0R3P9C8 
NADH dehydrogenase [ubiquinone] 1 
alpha subcomplex subunit 9_ 
mitochondrial 
KO 
Rpl5 3.137 D3YYV8 60S ribosomal protein L5 (Fragment) KO 
Hist1h1d 3.107 P43277 Histone H1.3 KO 
Nnt 3.101 E9Q8F4 NAD(P) transhydrogenase_ mitochondrial KO 




Cpt1b 2.972 Q924X2 






Isoform 2 of Perilipin-1 KO 
Rpl7 2.930 F6XI62 60S ribosomal protein L7 (Fragment) KO 
Cd36 2.910 Q08857 Platelet glycoprotein 4 KO 














2.785 Q00897 Alpha-1-antitrypsin 1-4 KO 
Ighg2b 2.690 A0A075B5P3 
Immunoglobulin heavy constant gamma 
2B (Fragment) 
KO 
Pdhb 2.654 Q9D051 
Pyruvate dehydrogenase E1 component 
subunit beta_ mitochondrial 
KO 
Ewsr1 2.557 Q5SUS9 RNA-binding protein EWS KO 
Mylk 2.485 B1B1A8 
Isoform 2 of Myosin light chain kinase_ 
smooth muscle 
KO 
Rpl13 2.439 P47963 60S ribosomal protein L13 KO 




Spermatogenesis-associated protein 5 KO 
Mvp 2.249 E9Q3X0 Major vault protein KO 
Abcb6 2.196 Q9DC29 
ATP-binding cassette sub-family B 
member 6_ mitochondrial 
KO 




L-lactate dehydrogenase (Fragment) KO 
Capn1 2.057 O35350 Calpain-1 catalytic subunit KO 
F13a1 2.028 Q8BH61 Coagulation factor XIII A chain KO 
Ywhae 1.952 D6REF3 14-3-3 protein epsilon KO 
Acat3 1.909 F2Z459 Acetyl-Coenzyme A acetyltransferase 3 KO 
Plg 1.900 P20918 Plasminogen KO 
Rpl15 1.900 B8JKK2 60S ribosomal protein L15 KO 
Fgg 1.860 Q3UER8 Fibrinogen gamma chain KO 
Acss1 1.850 Q99NB1 





1.849 Q8CBB6 Histone H2B KO 
Golga5 1.828 Q9QYE6 Golgin subfamily A member 5 KO 








Sclt1 1.629 G5E861 









Acsl5 1.505 Q8JZR0 Long-chain-fatty-acid--CoA ligase 5 KO 
Gfm1 1.469 Q8K0D5 Elongation factor G_ mitochondrial KO 
Lipe 1.393 E9Q4M2 Hormone-sensitive lipase KO 
Ugdh 1.379 O70475 UDP-glucose 6-dehydrogenase KO 
Aldh1a1 1.373 P24549 Retinal dehydrogenase 1 KO 
Itih2 1.369 G3X977 
Inter-alpha trypsin inhibitor_ heavy chain 
2 
KO 
Rbm25 1.356 B2RY56 RNA-binding protein 25 (Fragment) KO 




Lamin-B receptor (Fragment) KO 
Ighg2c 1.311 A0A0A6YY53 
Immunoglobulin heavy constant gamma 
2C (Fragment) 
KO 




















Janus kinase and microtubule-interacting 
protein 1 
KO 
Aarsd1 1.192 Q3THG9 Alanyl-tRNA editing protein Aarsd1 KO 
Fam129a 1.189 E9PYV4 Protein Niban KO 
Mapk9 1.186 Q9WTU6 
Isoform Alpha-1 of Mitogen-activated 
protein kinase 9 
KO 




Acetolactate synthase-like protein KO 




Nucleolysin TIAR (Fragment) KO 
Nans 1.007 Q99J77 Sialic acid synthase KO 
Cpq 0.924 A0A2I3BPG0 Carboxypeptidase Q (Fragment) KO 
Pbxip1 0.897 D3YUE1 
Pre-B-cell leukemia transcription factor-
interacting protein 1 (Fragment) 
KO 




Sorting nexin-6 KO 
Ppm1g 0.861 A0A0J9YVG0 Protein phosphatase 1G KO 
Asph 0.842 A2AL85 Aspartyl/asparaginyl beta-hydroxylase KO 
Eif2b5 0.830 Q8CHW4 
Translation initiation factor eIF-2B subunit 
epsilon 
KO 
Ptpn6 0.773 P29351 
Isoform 2 of Tyrosine-protein 
phosphatase non-receptor type 6 
KO 
Napb 0.754 D6RHL2 Beta-soluble NSF attachment protein KO 
Uap1l1 0.734 Q3TW96 
UDP-N-acetylhexosamine 
pyrophosphorylase-like protein 1 
KO 
Sord 0.666 Q64442 Sorbitol dehydrogenase KO 




Rpa1 0.438 Q5SWN2 
Replication protein A 70 kDa DNA-binding 
subunit 
KO 
Eln 0.407 P54320 Elastin KO 








Glucose phosphate isomerase 1 
(Fragment) 
KO 
     
Table 8.4  List of proteins uniquely detected in HSJ1 wild-type (WT) or HSJ1 knockout (KO) lumbar spinal 
cord extracts. Proteins detected in ≥2 biological samples from one condition and in none of the samples 
from the other condition were denoted unique in WT or KO as appropriate. Log2 Protein abundance 
reflects normalised log2 Hi3 protein abundance. Proteins in bold possess a GO Cellular compartment 





8.4. Co-occurrence of neuronal and astrocytic lineage markers 










Table 8.5  List of cell lineage markers used in this study. Overlap with the indicated datasets is also shown. 
 
 
